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Over the last forty years there has been a substantial growth in workforce drug testing. 
Most notably, this proliferation has occurred across U.S. industry and federal 
organisations. Developments in the U.S. have become the catalyst for an international 
debate on the issue of substance use in the workplace and ways of responding to it. 
 
Beyond the U.S., much less is known about workforce drug testing (Verstraete and 
Pierce 2001). Little research has been conducted on the nature, size and role of the 
drug testing industry, on the numbers of employees who are exposed to it, and on the 
number of companies who test employees. What is known is that workforce drug 
testing is delivered usually, but not exclusively, in many ‘safety and security critical’ 
industries and professions, including transportation and the armed forces.  
 
Recently, there has been a movement towards aligning workforce drug testing with 
more rehabilitative and educational responses to workplace substance use. 
Nevertheless, punitive measures in response to those identified as alcohol and drug 
users in the workplace continue to be proposed by many as useful in reducing both 
workplace use and wider societal drug use. 
 
Research carried out on alcohol, drugs, the workplace and drug testing programmes 
can be divided between laboratory based studies and empirical studies carried out in 
the workplace. Across laboratory and empirical field studies, there are a variety of 
specific ways in which research into workforce drug testing has been carried out. 
While each research approach offers benefits in terms of outcome, they also suffer 
various methodological and conceptual limitations. In addition, researchers have 
carried out secondary documentary analysis and literature searches and reviews on 
workplace drug testing. Most of the literature is North American based, and focuses 
upon the U.S.  
 
The Extent and Development of Workforce Drug Testing 
 
•  There is little reliable data on the numbers of U.S. companies that test, and on the 
nature and size of the drug testing industry. At best, the extent of workforce 
testing, and the numbers of employees tested, can only be guesstimated. 
•  In 1995, 95% of Fortune 500 companies tested employees for alcohol and / or 
drug use. For all U.S. companies, it is estimated that in 1996 81% of companies 
tested for drugs, a figure that fell to 70% in 1999. The number of employees tested 
for alcohol and drug use annually across the U.S. has been estimated to be 
between four and thirty million.  
•  Workforce drug testing is a multi-billion $U.S. industry, involving a workforce 
delivering drug testing and a service and consultancy sector that supports and 
promotes it. Research indicates that workforce drug testing in the U.S. differs 
across industry type and characteristic, employee group and size, and is informed 
by Federal and State laws. Larger employee organisations are more likely to test. 
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•  A proportion of smaller organisations in the U.S. have abandoned workforce drug 
testing due to the financial cost involved and the limited extent of substance 
misuse among particular employee groups. 
•  A high prevalence of drug misuse amongst U.S. soldiers returning from the 
Vietnam conflict and substance use amongst middle class college students 
attending high school and university in the U.S. during the 1960s and 1970s 
provided the impetus for the emergence of workforce drug testing policies.  
•  The first mass drug testing programme was introduced by the U.S. Department of 
Defense during the late 1970s / early 1980s. At the same time several U.S. law 
enforcement agencies introduced drug testing as a method of identifying and 
controlling substance misuse and criminal activity. 
•  Perceived widespread drug misuse during the 1980s and early 1990s in the U.S. 
and the resultant Republican governments ‘war on drugs’, led to the 
implementation of workforce drug testing across many organisations and 
industries facilitated by Executive Order 12564 (1986), The Drug Free Workplace 
Act (1988) and the Omnibus Transportation Employee Testing Act (1991). These 
have been revised during the last twelve years. 
•  As a consequence of a number of safety critical accidents during the 1980s and 
1990s, the justification for workforce drug testing in the U.S. expanded beyond 
increased employee performance and productivity to include workplace health and 
safety issues. 
•  Employee Assistance Programmes (EAPs) have developed, especially in the U.S. 
and Canada. EAPs offer remedial and supportive, rather than punitive, responses 
to employee welfare issues, including drug and alcohol use. 
•  There is little research evidence on the nature, extent and size of workforce drug 
testing beyond the U.S.. In Canada, UK and European countries, workforce drug 
testing policies have been targeted towards security and safety sensitive industries 
and organisations rather than across all industrial groups, justified on performance 
related grounds. 
 
Rationale For and Methods of Workforce Drug Testing 
 
•  Employer justifications for workforce drug testing centre upon the potential for 
increased risks in the workplace environment resultant from employee alcohol and 
drug misuse. These ‘increased risks’ can be identified as: 
 employee risk - relating to workforce occupational injury (fatal and non fatal). 
 employer risk - relating to costs of workforce drug use, usually in terms of 
decreased productivity and performance. 
 customer risk - referring to the impact workforce alcohol and drug use may have 
on the delivery of a service or product to the general population. 
•  Workforce alcohol and drug testing is seen as an effective tool to reduce such 
risks. An associated justification for workforce drug testing is that it will help 
reduce workforce substance misuse and therefore societal use more generally. 
•  Across U.S., Canada and western European countries there is legislation 
specifying the remit of workforce alcohol and drug testing policies. 
•  There are many and varied ways in which alcohol and drug use can be identified. 
These include hair, blood, breath and urine. Additionally psychometric tests can be 
used. 
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•  There are several different ways of delivering workforce drug testing. Workforce 
drug testing varies as to the stage of employment at which it is implemented, and 
the ways in which employees are selected for testing. 
•  There are a number of possible outcomes of workforce drug testing. Usually 
applicants will not be offered employment following a positive pre-employment 
drug test. Consequences of other workforce drug testing mechanisms include 
dismissal, welfare, support and treatment. In some cases no further action will be 
taken against the employee concerned. 
 
Employee Alcohol and Illicit Drug Use and Workplace Occupational Accidents 
and Injury 
 
•  There is a relatively large body of research that seeks to demonstrate the 
association between employee substance misuse patterns and the frequency of 
fatal and non-fatal occupational injury. 
•  Research evidence suggests that there is insufficient evidence to conclude that 
illicit drugs play any substantial causal role in fatal and non-fatal occupational 
injury. A number of studies do provide evidence of a link between illicit drug use 
and occupational accident and injury. Others, however, do not make the link. 
•  There is some research evidence in relation to the causal role played by employee 
alcohol use in occupational accident and injury. 
•  A number of research studies identify the causal role of non-substance misuse 
factors in explaining workplace fatal and non-fatal occupational injury. Non-
substance misuse factors include dangerous working conditions; noise and dirt; 
conflict among the workforce and employee fatigue exacerbated by sleeping 
problems and shift work. 
 
Alcohol and Drug Use and Employee Productivity and Performance 
 
•  There is a large body of research that seeks to demonstrate the association 
between employee substance misuse patterns and a reduction in employee 
productivity. 
•  A number of research studies indicate evidence that alcohol use, and particularly 
alcohol abuse, is associated with high employee absenteeism rates. Some studies 
identify an association between illicit drug use and absenteeism.   
•  There is conflicting evidence as to the relationship between, and the effects of, 
alcohol and drug taking and job performance. 
•  As in the case of job performance, evidence of a relationship between alcohol and 
drug use and turnover is unclear. 
•  Overall, there is evidence that alcohol use, and particularly alcohol abuse, is 
associated with decreased productivity. With regard to illicit drugs, research 
evidence appears to be inconclusive, although a small number of studies do 
provide cursory evidence of an association between illicit drug misuse and 
lowered employee productivity and performance. 
•  Studies have also indicated other negative outcomes of employee alcohol and drug 
use including tardiness and aggression. 
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The Effectiveness of Workforce Drug Testing 
 
•  Particular research studies have indicated that the frequency of occupational injury 
has reduced, and employee performance and productivity has increased following 
the implementation of workforce alcohol and drug testing. Other research studies 
have indicated that workforce drug testing has reduced workforce alcohol and 
drug use. 
•  However, too few empirical studies on the effectiveness of workforce alcohol and 
drug testing exist to conclude that it reduces employee health and safety problems 
and increases employee productivity and performance.  
•  The majority of research studies fail to take account of the possible and actual 
effect of non-drug testing factors (such as increased employee training, superior 
capital equipment and better management and supervisory arrangements) in 
reducing employee and employer risk. 
 
Employment Issues and Workforce Drug Testing 
 
•  While there is a growing trend among employers to introduce workforce drug 
testing, especially in the U.S., some employers are choosing not to test. 
•  The reactions of employees to testing are mitigated by perceptions of fairness.  
These perceptions of fairness are formed by the type of testing programme they 
are exposed to, their individual drug taking histories, and more general social 
values and norms 
•  Pre-employment testing in particular, may be deterring some quality candidates 
from applying for jobs.  As a response, some employers in times of low 
unemployment, are foregoing this type of testing. 
•  Drug and alcohol use and abuse can significantly impact on employment status, 
occupational attainment and wage levels. 
 
Workforce Drug Testing, Surveillance and Social Control 
 
•  For a number of researchers, the emergence and development of workforce drug 
testing has led to a blurring of boundaries between the personal and professional 
lives of employees 
•  Workforce drug testing may discriminate against certain groups of employees, and 
the testing process is not immune to error 
•  Workforce drug testing does not establish impairment and may cause tension in 
employee and employer relations 
•  Information produced as a result of workforce drug testing may be used 
inappropriately, or not in accordance with stated aims and objectives 
 
The Extent and Nature of Societal Alcohol and Illicit Drug Use and Workforce 
Alcohol and Illicit Drug Use 
 
•  In the U.S. and UK alcohol, rather than illicit drug use, is reported to be the most 
used substance amongst the population. Reported alcohol use does not appear to 
decrease with age. Individuals aged 18-21 years old consume the highest levels of 
alcohol.  
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•  In the U.S. and UK illicit drug use is generally thought to be increasing, although 
rates vary across drug type, country, race, gender and age. Marijuana is the most 
commonly reported illicit drug used. Individuals aged 18-25 years old, particularly 
men, are reported as the most prolific illicit drug users. 
•  Estimates on workplace alcohol and drug use vary across type of employees, 
research study, country and substance reported. Alcohol is reported as being the 
most used substance within the workplace while marijuana is reported as being the 
most commonly used illicit drug within the workplace.  
•  It is broadly accepted that unemployed individuals are more likely to use alcohol 














Over the last forty years there has been an almost exponential growth in workforce 
drug testing. This proliferation has occurred most notably across U.S. industry. 
Accurate information on the number of workers tested for alcohol and illicit drugs is 
limited (Martin et al 1994). The research literature also indicates that there is little 
reliable data on the numbers of U.S. companies that test, and on the nature and size of 
the drug testing industry. At best, the extent of workforce testing, and the numbers of 
employees tested, can only be guesstimated.  
 
Ambrose (2000) reports that drug testing in U.S. organisations increased 277% 
between 1982 and 1995. She suggests that in 1982 less than 5% of Fortune 500 
companies conducted drug tests, while for 1995 she reports the number had increased 
to 95%. Beck (2001) reports evidence from the American Management Association 
(AMA) for 1996 indicating that 81% of all U.S. companies tested for drugs, a figure 
that fell to 70% for 1999. According to Lloyd (1998) 44% of all U.S. workers were 
subject to drug testing in 1998, with various estimates indicating that the number of 
employees tested for alcohol and drug use annually across the U.S. is between four 
and thirty million  (Martin et al 1994; Smith 1996; Williams 1998). Research 
indicates that workforce drug testing in the U.S. differs across industry type and 
characteristic, employee group and size, and is informed by Federal and State laws. 
What is not disputed within the literature is that in the U.S. today, drug testing has 
become a multi-billion $U.S. a year industry. Ozminkowski et al (2001) estimate that 
the volume of current workplace drug testing in the U.S. is nearly 40 million tests 
annually, with approximately 95% yielding negative results. 
 
The research literature indicates that it was escalating societal use of illicit drugs, 
especially amongst U.S. university and college students, together with the discovery 
of widespread drug use in the U.S. military during the 1960s and 1970s that provided 
the impetus for the introduction of workforce drug testing (Konovsky and Cropanzano 
1993). Drug testing across the U.S. military commenced in the early 1980s. The 
growth in drug testing across U.S. industry was driven during this time by employers 
concerned about the impact of employee alcohol and drug use. Their concerns centred 
upon lowered employee productivity and performance (Macdonald and Wells 1994). 
Such concerns were intensified by heightened publicity surrounding the use of alcohol 
and drugs by certain groups of workers, especially those involved in ‘safety and 
security critical’ industries. Several major accidents, including the grounding of 
Exxon Valdez in 1989, highlighted the health and safety implications of employee 
alcohol and drug use to the Federal government (Zwerling 1993). The emergence and 
development of drug testing in the U.S. was further driven, during the 1980s and 
onwards, by the Federal governments ‘war on drugs’ campaign aimed at eliminating 
the illicit drugs market, and by legislative enactment. The research literature has also 
indicated the role of the media in the construction of a moral panic over societal and 
workforce illicit drug use which has intensified calls for increased workplace 
regulation, promulgated by a drug testing industry actively seeking diversification and 
expansion across industry and commerce. 
 
A literature review on the state of knowledge of drug testing at work 
 9
Such developments have become the catalyst for an international debate on the issue 
of alcohol and illicit drug use in the workplace and of ways of controlling it. Yet 
outside the U.S., much less is known about workforce drug testing (Verstraete and 
Pierce 2001). Little research has been conducted on the nature, size and role of the 
drug testing industry, on the numbers of employees who are exposed to it, and on the 
number of companies who test employees. What is known is that workforce drug 
testing is delivered in a number of Western European countries and further afield, 
usually but not exclusively in many ‘safety and security critical’ industries and 
professions, including transportation and the armed forces. It is also known that there 
are various developments taking place seeking to further expand drug testing across 
industry and commerce outside of the U.S. (Verstraete and Pierce 2001). For example, 
in the UK the Forensic Science Service (FSS), an executive ‘trading’ arm of the Home 
Office has expanded its role to one of delivering drug testing services to assist 
employers in identifying job applicants and employees who may have used alcohol 
and illicit drugs.  Beyond the U.S., the official justification for drug testing is to 
reduce the likelihood of occupational injury rather than the more generic one of 
reducing productivity and performance problems. 
 
Researchers and social commentators often propose or oppose workforce drug testing 
based upon their own political viewpoints and the research evidence they wish to call 
upon to substantiate their claims. A number are engaged in the industry itself, others 
as consultants to it. Many again are employed within academic and research 
institutions and organisations. The majority of them are North American. To its 
proponents, the aims of workforce drug testing are three fold. First, to reduce safety 
concerns across industry and commerce. Second, to address issues of cost resultant 
from lowered employee productivity and performance. Third to reduce general 
workforce drug and alcohol use, and potentially, wider societal use. Loup (1994: 19), 
writing in Employee Counselling Today states, ‘Having drug and alcohol abusers on 
the payroll is expensive and dangerous. The exact toll is difficult to calculate because 
so many factors are involved. Diminished productivity, increased accidents, 
management difficulties, and security problems all contribute to the costs. One 
estimate puts the costs to industry of drug and alcohol misuse at a billion pounds a 
year; another puts the social costs of alcohol misuse at two billion’.  
 
To its detractors, workforce drug testing is one aspect of a wider movement to 
survielle and regulate employees, and their activities both in the workplace and 
beyond. As Heckler and Kaplan (1989: 701) have argued, ‘One’s own bodily fluids 
can tell tales, not about one’s being impaired on the job, but about one’s activities last 
Saturday night, or perhaps a week ago, or about other personal characteristics or 
medical conditions unrelated to work or to illegal drug use’. Moreover, detractors of 
workforce drug testing argue that its justification is based on misinformation rather 
than robust research evidence. For Jardine-Tweedie and Wright (1998: 538), ‘Few 
scientific studies have been conducted to determine whether or not testing 
programmes reduce possible work difficulties resulting from alcohol and drug use. 
Furthermore, the available data do not produce sufficient evidence to show that 
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1.2 Research approaches 
 
Most research has been conducted in North America and most studies are U.S. based, 
although there are a number of Canadian focused research studies. Very little 
academic and scholarly empirical research has been carried out in the UK and 
Western European Countries and beyond. Research carried out into the relationship 
between alcohol and illicit drug use and the workplace can be divided between 
empirical studies carried out within the workplace, and laboratory based studies (see 
Macdonald 1997; Coambs and McAndrews 1994). In addition, there are numerous 
reviews of the research based primarily or solely on secondary documentary analysis. 
 
There are numerous ways in which empirical research - field studies - have been 
conducted. Research indicates that approaches vary greatly across employee, 
employer, industry and country. The means of measuring workplace alcohol and drug 
use, and its impact, include specific alcohol and illicit drug surveys conducted on the 
general population, surveys conducted on particular employee groups, extrapolations 
from other surveys (for example driving and drugs or crime surveys), the collation 
and analysis of particular company surveys of staff drug misuse; perceptions of 
supervisors or employers, studies of employer and trade union perceptions of alcohol 
and illicit drug use amongst employee populations, results from specific employee 
testing programmes and pre-employment screening programmes; post accident 
investigations (for example autopsies), evidence taken from drug screening studies 
which compare drug positive and drug negative employees, records of notifiable 
addicts receiving treatment at clinics who report their employment status; research 
literature and documentary collection and analysis, as well as information detailed in 
the media and anecdotal evidence based upon hearsay or observation (Newcomb 
1994; Beswick 2002). Field based studies, are open to numerous criticisms 
(Macdonald and Wells 1994: 129). One point worth noting is that it is important to 
consider the local context of the research, given the cultural differences in what is 
acceptable and unacceptable regarding drug and alcohol use. 
 
Laboratory based research frequently involves subjects performing psychomotor tasks 
under drug and non-drug conditions. These experimental studies usually identify that 
an individual’s motor coordination and perceptual abilities decrease considerably with 
the ingestion of alcohol and some drugs. Workplace effects are then inferred from 
these findings (Coambs and McAndrews 1994). For example, high correlations have 
been reported for blood and breath tests for alcohol and impairment (with the potential 
to cause accidents and impact upon performance) (Jardine-Tweedie and Wright 1998: 
537). For some, this provides evidential support for workplace alcohol testing. 
Regarding illicit drugs, experimental studies show that some drugs produce large 
performance deficits, while other drugs produce minor changes in performance 
(Jardine-Tweedie and Wright 1998). As Osterloh and Becker (1990: 507) detailed 
over a decade ago, experts continue to disagree on the consequences for the human 
function resultant from the use of drugs (Jardine-Tweedie and Wright 1998: 537). As 
Coambs and McAndrews (1994: 96), argue, there remains much still to know on 
laboratory testing and alcohol and drug use. ‘The gaps that remain in our 
understanding of the effects of drugs … need to be addressed. Without such 
knowledge, it is difficult or impossible to establish whether an employee is actually 
impaired by a particular drug’ (1994: 96). A further criticism directed at laboratory 
studies (Macdonald and Wells 1994), is the extent to which performance deficits 
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observed in the laboratory are replicated in the workplace (Coambs and McAndrews 
1994: 94). That is, to what extent can laboratory studies be generalized to the 
workplace environment? 
 
1.3 The present study 
 
Workforce drug testing is both controversial and complex. Ethical, legal, social, 
political, economic and methodological issues arise in any discussion of it. The 
purpose of this review is to offer a sober yet critical assessment and review of the 
academic and scholarly research literature relating to drug testing in the workplace. 
The broad aim of this study, as commissioned by the Independent Inquiry into Drug 
Testing at Work, is to present ‘the international state of knowledge of drug testing at 
work, with particular reference to the United States of America’ (personal 
correspondence from Yolande Burgin, Director of the Inquiry 12/08/02). The study 
comprises an extensive review of the published English language academic and 
scholarly research literature. Mostly, the review draws upon research literature 
deriving from the U.S., given that it is the one country that has embraced the desire to 
test, and has a sizable research literature on various aspects of it. Beyond the U.S., the 
paucity of academic debate and discussion surrounding workplace drug testing 




In commencing this review we drew upon the work of Hart (1998), Robinson et al 
(1998), Robinson and Keithley (2000) and Harris et al (1992). Hart (2002) offers 
excellent advice on conducting a literature search and review in the social sciences, 
while Robinson et al (1998) and Robinson and Keithley (2002) provide excellent 
illustration and exemplification of a literature review (especially in relation to 
structuring content, given its focus was into the impact of crime on health and health 
services). Harris and Heft (1992) provide an early, but interesting, literature review on 
the issues, controversies and directions for future research on alcohol and drug use in 
the workplace. These sources helped frame our own approach to carrying out the 
literature search, as well presenting the research evidence and in writing the review. 
 
Various search services were consulted and utilised. The Internet provided access to 
recent and relevant online journal articles. It also proved invaluable in identifying and 
locating other recent and relevant articles, books and newspaper sources many of 
which could not be accessed electronically. The Internet also proved useful in 
exploring various aspects of the drug testing industry, as well as the ‘home testing’ 
phenomenon and the ‘beat the testing’ cottage industry. In addition we searched 
newspaper archives, mainly through LexisNexis and the BBC website. Government 
websites were consulted, primarily in the UK and the U.S., although Canada, 
Australia and a number in Western Europe were also searched. Websites and 
Directories of related organisations including the Trades Unions Congress, the 
Institute for Personnel Development, the European Monitoring Centre for Drugs and 
Drug Addiction, Income Data Services and the Drug and Alcohol Testing Industry 
Association amongst others provided information. 
 
Keyword searches were carried out on relevant search engines, social sciences based 
search facilities and computerised databases including: Google, Ingenta, Elsevier, 
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Scirus, BIDS, Sociological Abstracts, ASSIAnet, Sociological Research Online, 
Emerald, Science Direct, PsychINFO, INSPEC, ProQuest Nursing Journals, Social 
Sciences Citation Index, OPAC97, ESRC Data Archive and SOSIG. Specific Journals 
were searched where abstracts, full text or contents pages could be viewed 
electronically; the British Journal of Criminology and British Journal of Sociology are 
two examples. Databases at Northumbria, Newcastle, Durham, Teesside and 
Sunderland Universities were all searched in addition to COPAC and the British 
Library, both at London and the Document Supply Centre, at Wetherby. Keyword 
searches, limited to English language, were performed. These involved combining 
‘drugs’ and ‘alcohol’ with a variety of related keywords and phrases to produce 
‘history of drug and alcohol use’, ‘alcohol use’, ‘drug use’, ‘societal alcohol use’, 
‘societal drug use’, ‘workforce alcohol use’, ‘workforce drug use’, ‘prevalence of 
alcohol and drug use’, ‘drug testing’ ‘workplace drug testing’ ‘war on drugs’, 
‘Employee Assistance Programmes’, ‘drug treatment’, ‘harm reduction’, 
‘surveillance’ ‘employment testing’ ‘drug testing industry’, ‘drugs and occupational 
injury’, ‘drugs and productivity and performance’, ‘drug testing techniques’, 
‘surveillance technology’ ‘labour force participation’, ‘employment’ and ‘social 
control’. 
 
The British Library was visited on several occasions (London: 28/08/02 and 
Document Supply Centre, Wetherby: 05/09/01-06/09/02; 23/12/02). These visits 
allowed for various sources of information to be obtained and for further searches to 
be conducted as some facilities allowed onsite access only, with only limited time in 
which to obtain resources via the traditional method of inter library loan. DrugScope 
library was also visited on several occasions during the course of the study (27/08/02; 
29/08/02; 09/09/02-11/09/02; 24/09/02-26/09/02; 14/10/02).  The DrugScope library 
contains one of the largest single collections of information on drug use and related 
themes in the UK and as such it proved invaluable through the course of the review, 
although it must be noted that there was limited access to a number of more recent 
sources of information.  
 
The literature review generated a substantial number of references to journal articles, 
periodicals, monographs, edited collections, newspaper articles and stories, and 
practitioner and industry reports and magazines, and in addition we have consulted 
various abstracts and official publications. In order to handle this material, and in 
order to ensure that the review corresponded with the original request from 
DrugScope for an international review of the literature with particular reference to the 
United States of America, the review was undertaken using the following main 
categories: 
 
•  Extent and nature of societal drug use and employee drug use 
•  Extent and development of workforce drug testing 
•  Rationale for and methods of workforce drug testing 
•  Alcohol and illicit drug use and occupational injury 
•  Alcohol and illicit drug use and productivity and performance 
•  Effectiveness of workforce drug testing 
•  Employment issues and workforce drug testing 
•  Debates on justice, surveillance and social control 
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These categories proved useful in mapping out the field and providing some structure 
to the search and review. In a number of instances there is some overlap between 
them. Four key points must be noted in relation to the literature review and the use of 
these categories. First, there is a relatively large body of academic and scholarly 
research literature on workforce drug testing available on North America, notably the 
U.S. but also Canada, yet there is much less English language research literature that 
addresses these themes and categories with regards to the countries of Western 
Europe and beyond. We have utilised that which is available to present a picture of 
what is known about workforce drug testing in North America and beyond. As a 
result, there are several gaps in the research literature, particularly with reference to 
the UK and the countries of Western Europe. Second, during the course of the review, 
we found an abundance of information on the technical ‘components’ associated with 
workforce drug testing, such as testing types, methods and techniques. Given our need 
to maintain the focus of the review in line with the Inquiry’s written request, it was 
decided that all but the seminal research literature in relation to these categories was 
beyond the scope of this review. This was also the case with regards the use of drug 
testing in the criminal justice system, and to a lesser extent the emergence of the 
‘home testing’ phenomenon and the growth of the ‘beat the testers’ counter-
enterprises. Third, workforce drug testing and the associated research literature in 
North America have gathered apace over the last four decades. Given the need for 
clarity and conciseness, this review does not list, either in the text nor in the 
bibliography, every reference uncovered and identified by the literature search. Often, 
older, and therefore more outdated literature was eliminated from the review, with the 
exception of what appeared to be seminal research studies. The review notes, 
discusses and presents key references that appear to offer important, relevant, recent, 
innovative and interesting research evidence and information on workforce drug 
testing. The aim is to provide an overview of the research literature, highlighting the 
key themes and issues relating to the international state of knowledge of drug testing 
at work. Finally, there are a number of academic and scholarly reviews examining 
various aspects of the research on workplace drug testing. We acknowledge and draw 
upon a number of these reviews, as well as their reportage and commentary. In doing 
so, we combine discussion of these reviews with discussion and comment arising 
from our own reading and examination of original research papers and scholarly 
monographs.  
 
This review is an ongoing project. As and when new books and articles are published, 
and when other relevant sources of information are made available to the research 
team, the review will be amended, added to, updated and refined over the course of 
the Inquiry. We would hope to present a further version of this report to the Inquiry 
during the course of the next six months. We would encourage comments on this 
version. 
 
1.5 ‘Workforce’ drug ‘testing’ – a note on usage 
 
Throughout this review we refer to ‘workforce’ drug testing. This is because the focus 
of testing is the workforce rather than the workplace. Second, by ‘testing’ we include 
both screening and testing. Screening sometimes refers to the process of drug testing 
individuals pre-employment, whereas testing is usually taken to refer to the process of 
delivering drug testing during employment. For the purposes of this review, both are 
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subsumed under the one word of testing, although as and when appropriate we do 
differentiate in the text. 
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The research literature provides detail of, and explanation for, the emergence, 
development and prevalence of workforce drug testing over the last four decades (see 
for example Gilliom 1994; Husbands 1993). Most of this research literature is North 
American (for example Macdonald and Roman 1994; Butler 1993), reflecting the 
enormous growth in workplace drug testing across the U.S. and Canada. 
 
Since the 1960s there has been an almost exponential growth in drug testing across 
industry and commerce in the U.S.. From the mid to late 1980s onwards the number 
of organisations drug testing employees intensified. Workforce drug testing in the 
U.S. has become a multi-billion dollar industry (Zwerling 1993), with a reported 95% 
of Fortune 500 companies carrying out some form of drug testing in 1995, and a 
reported 30 million employees tested annually for drug use (Smith 1996). Testing is 
more likely to focus upon employee illicit drug use rather than alcohol use. There is 
limited research indicating that in recent years there has been some decline in the 
number of companies drug testing employees, particularly smaller sized companies. 
 
Reasons cited for the emergence and expansion of workforce drug testing in the U.S. 
include concern, especially during the 1960s, regarding the extent and nature of drug 
use amongst students and military personnel, and more recently amongst the general 
population. For some researchers, a moral panic has emerged over the nature and 
extent of societal drug use, the consequence being that workplace drug testing 
developed as one aspect of the Federal governments ‘war on drugs response’. 
Research indicates that workforce drug testing in the U.S. was driven primarily by the 
Federal government’s concern about the relationship between drugs and organised 
crime, and the perceived association between drug use and performance and 
productivity problems. It was only towards the mid to late 1980s that the potential 
health and safety implications of alcohol and illicit drug use amongst employees were 
acknowledged, highlighted by a number of critical accidents. Finally, it has been 
suggested that U.S. workforce drug testing has proliferated as a result of the 
development of an industry capable of delivering testing and eager to promote its 
services across business and commerce.  
 
Beyond the U.S., there is limited research literature examining the nature of, and 
explanations for, the emergence, development and prevalence of workforce drug 
testing (Husbands 1993). This is partly a consequence of the limited nature of 
workforce drug testing in Canada and Western European countries, and partly a 
failure of the research community to engage with the topic area. What is known about 
workforce drug testing beyond the U.S., for example in Canada, and Western 
European countries, is that it has been promoted on the grounds of health and safety, 
and is delivered in mostly safety and security critical industries and businesses.  More 
generally, it can be suggested that there has been a greater welfare and education 
orientated approach to alcohol and illicit drug use in the workplace setting. Canada, in 
particular, is an example of a country that has embraced the welfare approach. 
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The remainder of this section provides a review and summary of the research 
literature examining: (a) the emergence and development of workforce drug testing in 
the U.S.; (b) the extent and prevalence of workforce drug testing in the U.S.; (c) 
explanations and reasons forwarded to understand this growth in workforce drug 
testing; and (d) workforce drug testing developments in Canada and parts of Western 




Most of the research literature explores the emergence and development of workforce 
drug testing. Often there is similarity and consistency in narrative, content and 
explanation within the literature. Konovsky and Cropanzano (1993: 171-4) detail that 
U.S. workforce drug testing first emerged in the changing social, political and 
economic climate of the mid to late 1960s, and in particular as a consequence of a 
perceived increase in drugs consumption amongst upper middle class university and 
college students and reportedly high levels of drug use amongst U.S. military service 
personnel returning from the Vietnam war (see also Husbands 1993, Macdonald and 
Wells 1994; Macdonald 1995; Ackerman in Coombs and West 1991; Willette and 
Radehjian in Autry and Friedman 1992; Jacobs and Zimmer 1991). The reported 
prevalence of drug use amongst students and military personnel led, Konovsky and 
Cropanzano (1993) go on to report, to a heightened concern over the effect of drug 
use on both academic and military performance, resulting in a move – especially 
within the U.S. military – towards drug testing to correct ‘behavioural problems of its 
personnel’ (Macdonald and Wells 1994: 122). Macdonald and Wells (1994) identify 
that the first use of drug testing was by the U.S. Department of Defense, which 
implemented a testing policy for heroin use among its service personnel. This 
programme was extended during the late 1970s, according to Husbands (1993), to 
include testing soldiers reporting for active duty. By the late 1970s, Gilliom (1994) 
acknowledges the expansion of drug testing across a number of security industries, 
detailing that many law enforcement agencies in the U.S. began to employ drug 
testing measures, particularly in prisons, as a method of identifying and controlling 
substance abuse and criminal activity (Ackerman in Coombs and West 1991). 
According to Burt (1981), in 1980 the U.S. Department of Defense published a report 
indicating that 26% of military personnel used drugs. More damaging, Husbands 
(1993) reports, was evidence that the figure was 47% among young enlisted men aged 
18-25 years old in the Navy and Marine Corps (see also Willette and Radehjian in 
Autry and Friedman 1992). As a consequence, the first large scale-testing programme 
was implemented by the U.S. military in the early 1980s (Burt 1981).  
 
Much of the research literature links the subsequent development and growth of 
workforce drug testing during the 1980s to the U.S. Federal government. Macdonald 
and Wells (1994) detail that the early to mid 1980s heralded anti-drug campaigns in 
the U.S., and Gilliom (1994) suggests that it was at this time that the Federal 
government began to advocate urine testing in the workplace. Gilliom (1994) reports, 
for example, that the President’s Commission on Organised Crime identified a link 
between organised crime and drug use and called on the Federal Government to, 
‘Provide an example of the unacceptability of drug use’. It went on to suggest that 
‘The President should direct heads of all Federal agencies to formulate immediately 
clear policy statements with implementing guidelines, including suitable drug testing, 
expressing the utter unacceptability of drug use by Federal employees’ (President’s 
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Commission on Organised Crime 1986 cited in Gilliom 1994; see also Autry and 
Friedeman 1992: 2; Husbands 1993: 12). Executive Order 12564 (1986) was passed 
on September 15th 1986 in response to President Reagan’s call for a ‘drug-free 
workplace’. Autry and Friedeman (1992: 2) detail that Executive Order 12564 (1986) 
states that, ‘The Federal Government, as the largest employer in the nation, can and 
should show the way towards achieving drug-free workplaces through a program 
designed to offer drug users a helping hand’ (Executive Order 12564 1986 cited in 
Autry and Friedeman 1992: 2). 
 
A number of articles indicate that Executive Order 12564 (1986) directed each federal 
agency to construct a comprehensive drug and alcohol policy and also recommended 
similar action for private employers, although the latter was not enforceable in law. 
The review by Husbands (1993) notes that drug testing was encouraged across the 
private sector, ‘Drug testing of employees by private companies who wanted to 
contract with the Department of Defense became a condition of doing business 
through the adoption of an interim contractor regulation in 1988, which was made 
final in 1991’ (Husbands 1993: 12). Husbands (1993: 12), details how Executive 
Order 12564 (1986) required the head of each federal agency to establish a 
programme to test employees in sensitive positions for illicit drug use, ‘sensitive’ 
being defined as including those serving as presidential appointees; as law 
enforcement officers; in positions of national security; in positions responsible for the 
protection of life and property; in jobs of public health and safety; and in jobs 
requiring a high degree of trust and confidence. In establishing Executive Order 
12564 (1986), President Reagan also asserted that ‘the profits from illegal drugs 
provide the single greatest source of income for organised crime, fuel for violent 
street crime and otherwise contributes to the breakdown of our society’ (Reagan cited 
in Husbands: 1993:12). Reagan stated ‘that federal employees who used illegal drugs 
were less productive, less reliable and more likely to be absent from work, thus 
causing the federal government billions of dollars in lost productivity on an annual 
basis’ (Reagan cited in Zwerling 1993: 3). Gilliom (1994: 35) reports that Reagan’s 
attorney Edwin Meese further stated that ‘Since most American’s work, the workforce 
can be the chokepoint for halting drug abuse’. 
 
Macdonald and Wells (1994) and Schwenk and Rhodes (1999) detail that in 1988 the 
Drug Free Workplace Act required public and private companies that held Federal 
contracts worth U.S.$25,000 or more to have a comprehensive drug policy in 
accordance with Executive Order 12564 (1986). Federal regulations for workforce 
drug testing were revised in the mid 1990s (Ozminkowski et al 2001: 59) and again in 
2001. According to Ozminkowski et al (2001), these regulations require a two-step 
laboratory process involving immunoassay screening and confirmatory testing by gas 
chromatography/mass spectrometry. All testing results must be channelled through a 
medical review process before being reported to the employer. ‘The regulations 
require that federally mandated tests (i.e. for federal agency workers such as those 
regulated by the Department of Transportation and the Nuclear Regulatory 
Commission) must be conducted in laboratories certified by the U.S. Department of 
Health and Human Services (DHHS)’ (Ozminkowski et al 2001: 59). These authors 
go on to state that whilst most private sector drug tests are not subject to federal 
regulations, the majority of workplace testing in the U.S. is conducted in laboratories 
following the federal guidelines (Ozminkowski et al 2001: 59). New Health and 
Human Services Mandatory Guidelines, as reported by Hitchens (2001), which will 
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apply to the 20% of workplaces that mandate regulatory testing, such as the 
Department of Transportation, civilians in the Nuclear regulatory area, will change the 
types of specimens used, the types of laboratories that can process them and the type 
of information that can be determined. Following the implementation of the Drug Free 
Workplace Act 1998, Fine and Reeves (1996) detail that Federal agencies issued a 
variety of policies mandating the random testing of contract workers in positions 
related to public safety or national security. Fine and Reeves (1996) also acknowledge 
that state and local governments, although not required by the Drug Free Workplace 
Act 1988, also promulgated regulations and policies establishing not only drug 
awareness programmes but also substance abuse testing of employees, including 
random testing. The link between drug testing and treatment was established in the 
1960s when testing was given a key role in treatment programmes (Jacobs and 
Zimmer 1991). The eventual combination of treatment and testing helped to silence 
those critical of testing programmes.  
 
During this period of legislative development and enactment, the literature 
acknowledges the limited emphasis placed upon safety concerns. Indeed, the 
underpinning justification of workforce drug testing from the outset was to combat 
organised crime and to promote a drug free workplace and society (Husbands 1993). 
It was only from the late 1980s onwards that the justification for workplace drug 
testing expanded somewhat from an aspect of the Federal government’s ‘war on 
drugs’, motivated by a concern for lost productivity and performance, towards a more 
health and safety orientated strategy and programme. Safety concerns, according to 
Macdonald (1995) only received legislative support, with the passing of the Omnibus 
Transportation Employee Testing Act of 1991 which legislated existing U.S. 
Department of Transport guidelines requiring drug testing of transport workers in 
safety critical roles (Husbands 1993: 13). During this period, Zwerling (1993) 
suggests that employee organisations and Trade Unions were concerned about the 
potential impact and effect of workforce drug testing, with many arguing that 
employers should only be concerned with the employee’s ability to perform their job, 
rather than concerning themselves with off duty activities. Indeed, the research 
literature highlights that during this relatively short period, there were a number of 
judicial challenges to drug testing in the workplace. Zwerling (1993), for example, 
acknowledges that between 1987 and 1991, the U.S. Department of Justice spent 
approximately U.S.$725,000 defending drug testing legislation, with two cases 
reaching the Supreme Court (National Treasurers Employee Union challenged U.S. 
Customs Service, and railway organisations sued to enjoin regulations promulgated by 
the Federal Railroad Administration). In both cases the Supreme Court upheld the 
legality of the Federal government’s drug screening programme. Willette and 
Radehjian (cited in Autry and Friedman 1992) report that the courts have ruled that 
employees accept some loss of privacy when they enter the workplace. There 
continues to be resistance to workplace drug testing, promoted principally by some 
civil liberties groups and worker organisations and trade unions. 
 
Research has indicated that workforce drug testing has expanded considerably across 
U.S. industry and commerce since the 1990s. This has been established through 
examination of worker experiences and attitudes, by analysis of the prevalence of 
testing across U.S. industry and by exploration of the costs of the drug testing 
industry. There is little research on the size of the testing industry.  
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With regard to the prevalence of drug testing, the research literature indicates that up 
until fairly recently the U.S. has experienced an exponential growth in the 
implementation of workforce drug testing (Brunet 2002). Testing for substance abuse 
in the workplace is becoming increasingly popular with employers, with estimates of 
88% of U.S. employers either testing now, or with plans to test in the near future 
(Business Wire 2001). Konovsky and Cropanzano (1993) report that in 1986 
approximately 25% of all Fortune 500 companies had some drug screening 
programme in operation, with Sujak et al (1995) indicating the figure rose to 50% in 
1988. Kaestner and Grossman (1995: 55) cite evidence that in 1990, 46% of all firms 
with 250 or more employees had some form of drug testing programme, while Axel 
(1991) sites evidence for 1990 that approximately half of all U.S. companies with 
over 1000 employees tested applicants and / or current employees. In a review by 
Konovsky and Cropanzano (1993) it is indicated that the average number of all 
companies undertaking some form of drug testing was around 40% in the early 1990s. 
Macdonald (1995: 703) reports evidence for 1993 that approximately 85% of major 
firms had some form of drug testing programme in place. Ambrose (2000) reports that 
drug testing in U.S. organisations has increased 277% between 1982 and 1995. She 
reports that in 1982 less than 5% of the Fortune 500 companies conducted drug tests. 
In 1995 the figure was 95%.  
 
Some of the research literature indicates that the direction of change has not been 
solely one way, since, as Macdonald and Wells (1994: 123) report, ‘a proportion of 
companies in the United States have abandoned their programs’. This reduction is 
usually, but not always, a result of the discontinuation of testing amongst smaller size 
companies, combined with a questioning of the size of use amongst particular 
employee groups (Macdonald and Wells 1994). Similarly, Beck (2001), suggests that 
the rapid growth in drug testing in the U.S. may be slowly reversing. Citing evidence 
from the American Management Association (AMA), she suggests that after reaching 
a high of 81% in 1996, the percentage of U.S. companies utilising drug testing fell to 
70% in 1999. Brunet (2002) reports that the 1996 figure reflected a threefold increase 
in the number of companies testing employees from 1987. 
 
With regard to employees reportage of their attitudes towards and experiences of 
being tested, Fendrich and Sookim (2002), in analysis of 102 questions drawn from 
20 different surveys administered between the mid 1980s and the late 1990s report 
that ‘these data suggest that workplace drug testing programs have been on the rise in 
the 1990s’ (2002: 85), from approximately 44% in 1994 to 49% in 1997. This growth, 
they argue, corresponds with increasing rates of support for workforce drug testing 
across the general population. While they acknowledge that the data presented does 
not necessarily equate directly with the number of employers operating drug testing 
programmes, they argue that their findings are in accordance with an employer based 
survey carried out by Hartwell et al (1996, cited in Fendrich and Sookim 2002: 92), 
which estimated that approximately 40% of all U.S. businesses tested applicants and 
or current employees for drug use. 
 
Research carried out in 1988 by the U.S. Bureau of Labour Statistics found that the 
most important determinant of the incidence of drug testing was the size of the 
organisation measured by the number of employees. The more employees employed 
by an organisation, the more likely it is to test. For example, in organisations with 
more than one thousand employees, 43% tested for drugs and alcohol. In 
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organisations of less than thirty employees, only 2% tested for drugs. The U.S. Bureau 
of Labour Statistics estimated that since smaller establishments made up most of the 
workforce, approximately 3% of all establishments had testing programmes at the end 
of the 1980s. A 1990 follow up study reported very little difference (Francis and 
Wynarczyk 1998).  
 
Research also identifies that rates of testing differ by industry. Bader and O’Hara 
(1991) provide evidence that drug testing is more common in manufacturing 
industries, and not very common in financial and service sector businesses. Zwerling 
(1993) suggests that high rates of drug testing can be found in mining, 
communication, public utilities and transportation industries, low rates are usually 
found in the retail and service sectors and in construction industries. Indeed, with 
regard to the construction industry, research carried out by Gerber and Yacoubian 
(2001) indicate that it ranks near the bottom of companies that test. In comparison to 
an average national estimate of 38.6% of all workers tested in the workplace in 1997, 
Gerber and Yacoubian (2001) indicate that the figure for the construction industry 
was 25.8%. Additionally, they note that only 55.6% of construction workers indicated 
that their workplace had a written alcohol and / or drug policy (the national average 
was 70.3%). With regards geographical variation, the research literature offers limited 
information; and little evidence is forthcoming about the extent and nature of testing 
across private industry, although Brunet (2002) suggests that during the period of the 
late 1980s and early 1990s, private sector employers rapidly implemented drug 
detection procedures and policies, including testing.  
 
A number of researchers have acknowledged that in estimating the prevalence of 
workforce drug testing, account must also be taken of the fact that Federal and State 
law can differ, producing a situation where national companies will be required to test 
in one state, but not in another (Brunet 2002: 193). Moreover, following President 
Reagan’s call for workforce drug testing in 1986 (Executive Order 12564 1986), 17% 
of the federal workforce had to submit to random drug testing. Brunet (2002: 193) 
reports that many state and local government agencies quickly followed suit, and by 
1990 ‘More than half of all state police departments and one quarter of all sheriff and 
municipal police departments required job applicants to submit to mandatory drug 
tests’ (Brunet 2002: 193). Mieczkowski and Lersch (2002) detail that out of 50 states 
in the U.S., law enforcement agencies in 42 states use drug screening for new 
applicants or new officer recruits. They go on to suggest that examination of local law 
enforcement agencies (cities, counties and townships) reveal that in excess of 80% of 
local law enforcement agencies also screen applicants. 
 
Whilst it remains the case that drug testing varies between industry type and 
characteristic, as well as employee group (Macdonald and Wells, 1994: 122), 
Konovsky and Cropanzano maintain ‘that a large proportion of the American 
workforce will be tested for drug use at least some time in their careers’ (1993: 171). 
At the end of the 1980s, Murphy and Thornton (1990), estimated that the number of 
employees tested could be upwards of 4 million workers per annum, with this figure 
including only those ‘organizations regulated by the federal government’ (Konovsky 
and Cropanzano, 1993: 171). Smith (1996) has estimated that the number of 
employees tested for drugs amounted to approximately 30 Million U.S. workers in 
1996. Williams (1998: 15) in a more recent, but speculative journalistic review 
suggests that the U.S. figure is 15 million people tested for illicit drug misuse. Similar 
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estimates can be found in the work of Macdonald and Wells (1994), Macdonald 
(1995), and DuPont et al (1995). Ozminkowski et al (2001: 60), estimate that the 
volume of current workplace drug testing in the U.S. is nearly 40 million tests 
annually, with approximately 95% yielding negative results. 
 
Within the research literature, much less evidence is available with regards the size 
and cost of the drug testing industry. In terms of financial cost, Hoffman and Silvers 
(1987 cited in Beswick 2002) and Williams (1998) both suggest that drug testing has 
become a multi-billion dollar a year industry in North America today. In 1993 
Zwerling (1993) estimated that the drug testing industry was worth U.S.$300 million 
in terms of the manufacture of the equipment and chemicals. Such figures remain 
estimates, and vary. For example, Rockmore et al (1997) estimated the industry was 
worth U.S.$230 million. With it has emerged a workforce involved in testing for 
alcohol and illicit employee drug use and a service sector that supports and promotes 
it; for example by providing training, verification, substance misuse clinics, the 
analysis of tests, the selling of testing products, Employee Assistance Programmes 
and ‘beat the testing’ services (see for example Moore and Haggerty 2001). The 
analysis of urine, blood, saliva, perspiration, eye or hair requires skill and expertise 
that are not available in the general workplace. It was therefore inevitable that 
laboratories possessing those skills would sell their services to industry. Additionally, 
a consultancy culture comprising of management ‘experts’ has emerged offering 
advice and support on what works in testing methods and practices (see for example 
Fay 2000; Frankenfield and Kleiner, 2000). Research indicates that there in operation 
various drug and alcohol testing associations and related organisations, including the 
European Workplace Drug Testing Society (EWDTS) and the Drug and Alcohol 
Testing Industry Association (DATIA). Furthermore, the research literature has 
indicated that testing has become integrated into a welfare orientated approach (EAP) 
to substance abuse, especially given that employees have realised that it has also 
become necessary to implement some kind of post testing programme (Butler 1993). 
 
The research literature indicates that the origins of EAPs can be traced to the late 
nineteenth century, a period when the first attempts to “…eliminate the long-accepted 
use of alcohol in the workplace” were made (Denenberg and Denenberg 1983: 35). 
EAPs were originally called Occupational Assistance Programmes (OAPs). The 
research literature suggests that the history of these welfare support programmes in 
the U.S. is complex. Spicer (1987) argues that the development of EAPs is similar to 
the growth of the public health sector generally. A review of the research indicates 
that the growth of EAPs can be linked to three factors that came to the fore in the 
1930s. First, the rapid emergence of alcoholics anonymous. Second, a sudden and 
enlarged need for productive workers during the second world war. Third, as a result 
of a growing concern amongst industrial physicians. Additionally, U.S. society was 
emerging from a period of distrust of addiction treatment policies and of health care 
professionals. Consequently problems previously regarded as ‘invisible’ began to be 
seen as resolvable with measurable benefits to be gained by employers willing to 
tackle such problems. EAPs expanded in the 1940s and 1950s and by the 1960s, 
employers, trade unions, worker representatives, and other organisations became 
involved in them. This movement provided assistance for employees with problems 
(such as mental health, family and emotional issues). Support for these initiatives 
came from state and local government, as well as health care providers. Since the 
1970’s the number and scope of EAP programmes has increased dramatically. As 
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employers became more interested in EAPs, the emphasis of the programmes shifted 
away from emotional or psychological problems to concentrate on the deterioration of 
work performance and productivity. This development paralleled the emergence and 
development of workforce drug testing. As the use of workforce drug testing policies 
has expanded during the 1980s onwards, they have often been integrated into EAPs 
rather than regarded as an entirely separate entity. Consequently, an increasing 
number of organisations have introduced testing located within an EAP framework. 
 
The ‘employee welfare’ industry is now extensive, particularly in the United States 
and Canada, as external contractors are involved in consultation, training and service 
delivery of EAPs. Local associations and national professional associations such as 
the Association of Labour Management Administrators and Consultants on 
Alcoholism (ALMACA) emerged as a response to the emerging body of EAP 
practitioners. Research indicates that two types of EAP are in operation today - 
generally distinguished by use of the terms ‘internal’ \ ‘external’. ‘Internal’ 
programmes are located within organisations with EAP professionals working for and 
with the organisations own employees. ‘External’ programmes are those in which 
organisations bring in external EAP professionals to set up and run their programmes. 
 
Banta and Tennant (1989) identify several advantages of EAPs.  From an employer’s 
perspective, the EAP can potentially reduce healthcare costs, improve attendance, 
productivity and safety by identifying problem workers. From an employee’s 
perspective, they can promote feelings of goodwill, appreciation and loyalty. They 
can also provide an employee with the opportunity to seek help for substance abuse 
problems. By identifying substance abusers the EAP will encourage employees to 
confront any personal problems in an open manner, thus improving the quality of their 
lives and, by association, the workplace. Reducing the negative effects of substance 
abuse on the reputation of the organisation can improve community relations, as can 
the negative consequences of dismissal. The provision of welfare in this way has the 
potential to improve relations between employers, unions and employees. 
 
Banta and Tennant (1989) also identify a number of potential disadvantages of EAPs. 
The cost can be high, especially for smaller sized employer organisations, where 
savings are at best speculative; the number of employees successfully rehabilitated is 
often small, as a large percentage either drop out of rehabilitation or resume abuse at a 
later time. Banta and Tennant (1989) also acknowledge that it is difficult to measure 
the effectiveness of EAPs in terms of costs and welfare, as data is restricted for 
confidentiality reasons. Indeed, the value of rehabilitating an existing employee 
cannot easily be measured (in monetary terms alone) or compared against the cost of a 
replacement worker. A National Council of Alcoholism and Drug Dependence survey 
in the U.S. (cited in Campbell and Langford 1995) attempting to assess the 
effectiveness of EAPs, and suggested that for every dollar invested, employers 
generally save between $5 and $16. It is estimated that the average annual cost per 
employee for an EAP programme is between $12 and $20. Where research studies 
have attempted to estimate the cost effectiveness of EAPs the precise figures vary, but 
most companies report a saving. Additionally, employers may be vulnerable to legal 
claims if an employee is dissatisfied with the provision of treatment or counselling.  
 
MacDonald and Dooley (1991) point to a degree of sectoral prevalence of EAPs, 
concluding that government health and education services are more likely to have 
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EAPs than construction and retail sectors (see also Gerber and Yacoubian 2001). It is 
difficult to assess the accuracy of information regarding the numbers of employees 
entering treatment programmes for drug or alcohol abuse. While MacDonald and 
Wells (1994) estimate that drug and alcohol abuse constitute around 10% of primary 
diagnoses in the workplace, a much larger proportion of employees are referred for 
other reasons including marital or financial problems which have had a causal effect 
on drug or alcohol abuse. Although this research is dated, MacDonald and Wells 
(1994) indicate that around 73% of employers permit family members to use the EAP 
programmes in their organisations. 
 
By the end of the 1990s, research indicates that workplaces with drug testing 
programmes could be found in all employment sectors, with the transportation, 
communication and utilities sectors most likely to have testing programmes 
(Macdonald and Wells 1994). Of the employers operating testing policies in a 
Canadian study conducted by Macdonald and Wells (1994), two thirds indicated that 
they tested all employees, the remainder tested only those employees considered to be 
in safety critical roles. The most common drugs tested for were alcohol, cocaine/crack 
and marijuana, with few employers reporting tests for heroin, amphetamines and 
prescription drugs. The consequences of positive test results were dependent upon the 
nature of testing programmes, with over two thirds of those operating pre-
employment screening indicating that they would not employ individuals testing 
positive for drugs. The most common responses to positive tests for other types of 
testing mechanisms were referral for either in-house or external treatment 
programmes, with individual cases dealt with according to individual circumstances. 
Health Promotion Programmes (HPP) were found to be increasing in the workplace, 
with a significant relationship between the size of the organisation and the existence 
of a HPP. The construction industry, the sector least likely to have an EAP, 
experienced the highest accident rate. This could indicate a relationship between the 
existence of an EAP and a reduction of accidents, though the authors admit that little 
evidence exists to support this supposition. 
 
In addition to mapping out the emergence and development of workforce drug testing 
in the U.S., and the emergence and development of related EAPs, the research 
literature has also offered explanation for the growth in workforce testing. The first 
factor, according to Francis and Wynarczyk (1998: 173) relates to the perceived 
growing ‘epidemic’ of drug use and the associated high levels of violence and 
property crime across urban areas of the U.S. from the 1960s onwards, and 
particularly during the 1970s and 1980s. Arthur and Doverspike (2001: 77) suggest 
that ‘in recent years, the pervasiveness of drug and alcohol abuse in the United States 
has become a growing concern’. Banta and Tennant (1989) identify that such 
perceptions have been compounded by; the extensive publicity given by the national 
media to drug abuse problems; the national crusade against illicit drug use initiated by 
the Reagan administration and continued by the Bush administration; and an increase 
in the amount of readily available and inexpensive illicit drugs. Indeed, research 
indicates that it was during the 1980s that drug use was increasing in the U.S. in terms 
of prevalence, and further; the age of individuals experiencing drugs for the first time 
was at an all time low. Given this, the research literature suggests that the workplace 
was seen as one site with the potential to deter and detect drug taking, both at work 
and in society more generally (Quale 1983 cited in Gilliom 1994).  
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A second factor identified within the research literature as responsible for the 
implementation and expansion of workforce drug testing is the U.S. Federal 
governments ‘war on drugs’ discourse and practice aimed at eliminating the drugs 
market. The perceived association between drugs and crime, especially organised 
crime, also increased society’s general intolerance of illicit drug use and led 
government and the media to locate the drug user as the ‘scourge of society’. For 
Gilliom (1994: 17), ‘the controversy over employee drug testing is inseparable from 
the broader intensification of the society’s focus on illegal drugs in the mid 1980s’. 
Potter and Orfali (1990) identify that the Reagan administration offered a five-
pronged attack on the ‘war on drugs’. This included law enforcement and education, 
and was heavily federally financed. As Potter and Orfali (1990) detail, spending 
increased dramatically during the mid 1980s, reaching U.S.$1.2 billion in 1985. 
Moreover, ‘Federal spending on radar, tracking aircraft and other measures to detect 
airborne smugglers increased dramatically, to nearly U.S.$205 million in 1989 fiscal 
year from about U.S.$18 million in 1982, the year Reagan declared ‘war on drugs’’. 
Blackwell (1994) has argued that the public perception of the ‘drug problem’ was 
constructed through such developments, allowing for increased public spending on 
police, customs, armaments, surveillance, technology and prison construction. As she 
argues, ‘Drug war discourse has generated strong public support for a supply side 
‘tough guy’ approach to drug policy’. As Gilliom (1994: 34) points out, the 
conservative law and order philosophy that prevailed in the 1980s eschewed strategies 
[those dealing with poverty and inequality] as ineffective and turned instead to 
heightened surveillance and tougher punishments. Testing was a central tool in the 
arsenal’. 
 
A third factor identified by the research literature concerns the promotion of evidence 
that several critical accidents involved alcohol and drug use (Zwerling 1993; 
Husbands, 1993; Gilliam 1994; Macdonald and Roman 1994). The research literature 
certainly indicates that these have played a role in the development of testing in 
security and critical sensitive industries. Four critical accidents dominate in the 
literature. In May 1981 a Marine Corps aircraft crashed aboard the aircraft carrier 
Nimitz. Nine of the fourteen people who received fatal injuries showed evidence of 
cannabinoids in the autopsy test results. The pilot was also identified as having taken 
prescribed antihistamine, and the publicity surrounding this crash accelerated the 
Navy’s decision to implement across the board drug testing (Zwerling 1993). By 
1982, all branches of the U.S. military operated a drug-testing programme 
(MacDonald and Wells 1994). In January 1987 the Conrail rail crash in Maryland 
(Amtrak incident Gust and Walsh 1989 cited in Parrot Undated) killed 16 passengers 
and injured one hundred and seventy four people. The engineer and breakman tested 
positive for marijuana. As a consequence, on 21 January 1987, the U.S. Department 
of Transportation proposed rigorous drug testing programmes for railroad workers, 
airline pilots, air traffic controllers and others in safety related positions. A third 
accident involved the grounding of the Exxon Valdez oil tanker in 1989 causing 
billions of dollars of property damage. This incident was linked to alcohol abuse. The 
forth major accident occurred in 1991, when a speeding subway train in New York 
City derailed, killing five people. Authorities indicated that the driver had been using 
alcohol. During this period, as detailed earlier, workforce drug testing was opposed by 
worker organisations and trade unions on the basis that it was unnecessary to invade 
the individual privacy of employees. These accidents significantly weakened trade 
union and other libertarian arguments forwarded by employee representatives and led 
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to a resurgence of public support for workplace drug and alcohol testing programmes 
as a means of promoting health and safety in the workplace (Jacobs and Zimmer 
1991). Indeed a 1991 survey of 1493 human resource managers indicated that over 
two thirds of the sample agreed ‘strongly’ with the notion that employers have the 
right to drug test their employees. However, these findings should be seen in context; 
only 45% of those surveyed worked in an organisation that operated a drug testing 
policy (Zwerling 1993). In the same year, the Omnibus Transportation Employee 
Testing Act of 1991 was implemented and legislated existing U.S. Department of 
Transport guidelines requiring drug testing of transport workers in safety critical roles 
including, mass transit, aviation, commercial motor vehicle operation, railroads and 
the marine and pipeline industries. For the first time, intrastate truck drivers were 
included within the legislation and the Act authorised alcohol testing alongside illicit 
drug testing. 
 
A forth factor acknowledged within the research literature is the role of the media in 
the construction of a moral panic over illicit drug use (Kravitz and Brock 1997; 
Blackwell 1994). Research has highlighted how drug users have been charged with an 
increase in crime rates, the spread of disease and increasing levels of unemployment. 
The latter situation has been compounded by evidence that almost fifty percent of job 
applicants have abused drugs and have consequently been refused employment. For 
Kravitz and Brock (1997) ‘concerns about employee drug use constitute a ‘moral 
panic’ that is fuelled by those who will profit from the panic (e.g. drug testing 
laboratories) and by politicians who use the drug ‘problem’ to avoid dealing with 
more important and controversial issues’. However, as Banta and Tennant (1989) also 
argue, the publicity and panic that surrounds drug taking is not limited to the media. 
They point out that the medical profession has demonstrated that drug use can lead to 
negative psychological and physiological after-effects. Educationalists have voiced 
concerns over the number of students taking illicit drugs and the impact of such use 
on their education and welfare. Truancy, high dropout rates and crime on, or against, 
school property have all allegedly been exacerbated by increased drug abuse among 
students. In the home, parents have begun to associate rebelliousness and poor grades 
with drug abuse and the industries involved in drug testing have used these fears to 
promote home testing kits (Moore and Haggerty 2001), selling the idea that children 
are at risk of death or addiction as a result of the drug ‘epidemic’ in society. Indeed, 
the publicity given to the problem of drugs has raised the consciousness of the 
American public. A national survey found that the percentage of people concerned 
with alcohol and drug misuse increased in the 1980s and is now listed as one of the 
biggest concerns of Americans today (Banta and Tennant: 1989).  
 
A fifth factor detailed in the research literature for concretising workforce drug testing 
policies across U.S. industry and commerce, especially from the late 1980s onwards, 
is the development of a reliable technology for testing and the birth of an industry 
capable of delivering it (Zimmer and Jacobs 1990). Such developments have allowed 
for relatively quick and cheap programme delivery (Zwerling 1993). For Zwerling 
(1993) during the 1960s and 1970s thin layer chromatography (TLC) became the 
screening method of choice. It was easy to use; yet needed trained analysts but was 
inappropriate for mass screening. During the mid to late 1970s, radio-immunoassays 
(RIA) and enzyme-multiplied immunoassays (EMIT) began to appear. These allowed 
for a quicker testing process and in consequence more tests to be carried out. For 
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example, Zwerling (1993) suggests that by 1993 between 4000 and 7000 urine 
samples per hour could be delivered using this method.  
 
Blackwell (1994) identifies three further factors as explanation for the growth of 
workforce drug testing. ‘The convergence of supply and demand side interventions at 
a national level; development of citizen groups which redefined the drug problem to 
include all drug users, not simply those causing harm, thus making zero tolerance the 
norm; and the need to maintain labour discipline in the promotion of business interest’ 
(Francis and Wynarczyk 1998: 173-174). 
 
In comparison with the literature on drug testing programmes in the U.S., research 
examining the extent and development of drug testing programmes in Canada and 
Europe is sparse (Macdonald and Wells 1994; Butler 1993; Verstraete and Pierce 
2001). Verstraete and Pierce (2001) suggest that ‘In some parts of Europe, e.g. in the 
United Kingdom and some Scandinavian countries, WDT (workplace drug testing) is 
increasing in importance, but it is not as widespread as in USA’. This is partly a 
consequence of the limited nature of workforce drug testing in Canada (Butler 1993) 
and Western Europe (Verstraete and Pierce 2001), and in part a failure of the research 
community in Canada and Europe to engage with the topic area. Seijts (2002: 136) 
indicate, that in today’s global economy, while many organisations manage 
workforces in more than one country, ‘little research, however, has examined the 
relative perceived fairness and acceptance of drug and alcohol testing programs across 
borders’. Certainly, little comparative and international research into workforce drug 
testing more generally has been carried out. As Francis and Wynarczyk (1998) point 
out in relation to the UK research, ‘…we would argue, there has been a neglect, 
especially within the British social science literature of any exploration: of whether 
there is a growing problem surrounding illicit drug use and the workplace; of the 
consequences of such workplace use; of the effectiveness and efficacy of workplace 
drug testing programmes/mechanisms; of the consequences of such programmes and 
mechanisms for workers rights and employee/employer relations, as well as broader 
theoretical debates surrounding workplace testing, employment, discipline and the 
surveillance society’. Francis and Wynarczyk (1998) suggest a number of points can 
be made regarding developments in workforce drug testing beyond the U.S.. The first 
point is that what developments have taken place within these countries have followed 
those implemented within the U.S.; either because of the exchange of ideas and 
practices and or because of the global expansion of American owned companies 
across Canada and Europe.  
 
Second, Francis and Wynarczyk (1998) note that in Canada and Europe workforce 
drug testing is a relatively recent phenomenon, much more so than in the U.S. (see 
also Verstraete and Pierce 2001: 5-7). Third, they suggest that this is in part a result of 
there being little in the way of legislation promoting drug testing programmes 
(Verstraete and Pierce 2001; Macdonald and Wells, 1994: 123), and that which has 
been enacted is fairly recent. Forth, knowledge of the extent of workforce drug testing 
is highly variable outside of the U.S.. What is known is that the extent and level of 
testing is much less than that detailed for North America (Macdonald and Wells 
1994). The evidence that exists is usually speculative or localized. For Macdonald 
(1997: 252) those organisations operating within a safety critical sector are leading the 
way in terms of workforce drug testing across Canada and Western Europe, largely 
due to the legislative requirements imposed by governments. ‘Although the United 
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States has embraced drug testing and has argued that it should be globally 
implemented, other industrialised countries around the world have been much more 
cautious. The U.S. goal to promote a drug free workplace does not appear to be 
reasonable to other countries given the invasiveness of the approach. Rather the only 
acceptable reason for drug testing in other countries is to reduce the likelihood of 
industrial accidents. Policy statements from various countries, such as Canada, 
Australia, France, Sweden and the Netherlands, reveal either implicitly or explicitly 
that safety is the only reasonable justification for workplace drug testing programs’. 
While the issue of drug and alcohol use in the workplace is unavoidable for these 
organisations, it is not uncommon for other larger organisations to have some form of 
policy on drug or alcohol use, although this may not be linked to a drug testing 
programme.  
 
Husbands (1993), in a research review of developments beyond the U.S. suggests that 
it is difficult to explain the discrepancy between the way in which the U.S. has 
embraced testing in comparison to the rest of the world. Two potential reasons, he 
suggests, may be that drug and alcohol use is not as urgent a problem as in the U.S. 
and / or that there may be a reluctance to place additional strain on the traditionally 
difficult relationship between labour and management. Nevertheless, either as a 
consequence of legislation and / or individual employer practice, workforce drug 
testing has been implemented outside of the U.S.. Husbands (1993) provides a useful 
review of developments beyond the U.S.; particularly in France, Canada, Germany, 
Netherlands, Norway, Sweden and the UK. Verstraete and Pierce (2001) offer a 
review (in places brief) of workplace drug testing in Europe, Belgium, Netherlands, 
Spain and Portugal, France, Finland, Sweden, Luxembourg, Germany, Italy and 
Austria, Greece, Switzerland, Denmark, Ireland, United Kingdom, while Seijts et al 
(2002) offer some useful comparative analysis between Canada and U.S.. However, it 
is clear that there is a need for further comparative and international research into this 
area. 
 
Within Canada, some research literature suggests that drug use is relatively small in 
comparison to the U.S. (Husbands 1993). However, Butler (1993) suggests that 
among employers, employees and other stakeholders a divergence of opinion exists 
over the nature and extent of substance misuse in Canada. Seijts et al (2002: 136) 
suggest that in comparison with the U.S., there is much less public awareness about 
the problems associated with drug use and fairness and acceptability of workforce 
drug testing, and, as a result, Canadians have yet to put drugs as high on the political 
agenda as have Americans. Nevertheless, Husbands (1993) suggests that while 
debates over mandatory testing programmes for the Canadian workforce remain 
unresolved, there is widespread support for preventative measures on substance use in 
society. This has developed in line with a stronger social democratic and trade union 
movement than exists in the U.S. (Seijts et al 2002). The Canadian model focuses 
upon the employers right to test only in very specific employment situations, with the 
employer having to demonstrate that sufficient grounds exist for suspicion of 
employee alcohol and illicit drug use. The Canadian Labour Congress (CLC) note that 
workers in safety sensitive positions such as transportation are subject to drug testing. 
Such tests are performed as part of medical examinations and following an accident. 
At both Federal and provincial levels, the emphasis is on EAPs, alongside education, 
early identification of problems and awareness campaigns (Butler 1993). Butler 
(1993) highlights the Canadian focus upon EAPs and strategies to avoid testing. For 
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example, in Canada, Employee and Family Assistance Programmes (EFAP) provide a 
service to all employees including those that are retired, disabled, in ill health, as well 
as there spouses and dependents. EFAP also aims to address a whole spectrum of 
personal problems (ILO 1991). Seijts et al (2002) report that approximately 15% of 
Canadian corporations are conducting some form of workforce drug and alcohol 
testing (see also Butler 1997), while, Macdonald and Wells (1994: 123) suggest that 
in 1990 just under 20% of companies employing more than one hundred employees 
had some form of drug screening programme (see also the discussion by Butler 1993); 
located within particular companies especially concerned with health and safety 
matters. 
 
The general consensus within the CLC is that workforce drug testing is a ‘labour-
management issue largely imported from the U.S.’ (Husbands 1993: 23). In 1988, 
drug-testing legislation in the U.S. encouraged American multi-national enterprises to 
impose mandatory drug testing on Canadian subsidiaries. The CLC has remained 
critical of proposals to introduce mandatory drug testing, even in safety critical 
industries, stating that ‘the law would be aimed at use rather than abuse, and as such 
supposes the employer’s (or government’s) right to exercise control over an 
individuals lifestyle and to invade the most private areas of their life’ (Husbands 
1993: 23). The Public Service Alliance of Canada (PSAC) also opposes alcohol and 
drug testing in the workplace stating that ‘The PSAC opposes all forms of workplace 
drug and alcohol testing for any reason whatsoever…there is no conclusive evidence 
of a link between drug and alcohol abuse and workplace safety…[T]esting is an 
invasion of privacy, and threat to worker’s dignity… the solution to drug and alcohol 
use, abuse and misuse can be achieved through prevention, education, rehabilitation, 
union counselling and joint employee assistance programs’. (Husbands 1993: 23-24).  
 
Moving on to the UK, the research by Verstraete and Pierce (2001) indicates that 
workforce drug testing appears to be more widespread than in other European 
countries. Within the UK, the Transport and Works Act 1992 provides for the 
mandatory testing of railway workers, tramway workers and other safety critical 
employees if there is reasonable cause to believe that they are unfit to carry out their 
job because of alcohol or drug impairment (Husbands 1993: 17). In addition, 
Husbands (1993) suggest that workforce drug testing is carried out in other critical 
and security sensitive industries including the energy sector such as oil companies, 
and the nuclear industry. Other industries involved in promoting pre-employment, 
post accident and or reasonable cause testing include some police forces and transport 
companies. Research evidence regarding the numbers of employers testing across the 
UK is unavailable or estimates only. Campbell (1997: 6) for example has suggested 
that the percentage number of UK firms who test employees for illicit drug misuse is 
at present approximately 10% but rising (see also Sullum 2000), while Williams 
(1998: 15) details that firms that tend to have health and safety concerns including 
London Underground and Virgin Atlantic Airways. Verstraete and Pierce (2001), 
estimate that between 220,000 and 330,000 tests are carried out each year, with 40% 
in the military, 35% in prisons and 25% in companies. They also indicate that there 
are two major laboratories and three smaller ones operating across the UK. 
 
The focus of concern in France is very much alcohol orientated, as opposed to illicit 
drug use, which is considered a minor problem. Verstraete and Pierce (2001), indicate 
that twenty laboratories perform drug testing, clients are mainly from the automobile 
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industry and airlines. No evidence is provided as to the size of the industry, the 
numbers of companies testing or the number of employees tested. With regard to 
legislative measures, there are provisions in the Labour Code that prohibit employees 
entering, or remaining, in the workplace while intoxicated. Judicial decisions have 
placed restrictions upon testing policies for libertarian reasons, and while workplace 
drug testing is allowed, it is only in very specific employment sectors and roles, for 
example the transport sector. In France, trade unions have traditionally resisted the 
introduction of drug or alcohol testing, unless performed within a medical assessment 
by a physician; only those in safety critical positions should be targeted (Husbands 
1993).  
 
Research indicates that workforce testing for either drugs or alcohol is limited in 
Germany, although accident prevention legislation does allow drug testing in specific 
circumstances, such as in the chemical industry (Verstraete and Pierce 2001). There 
are no specific laws that tackle the issue of substance abuse and while there is 
provision for testing, this is only on the basis of reasonable suspicion, such as 
observation of slurred speech or aggressive behaviour. Verstraete and Pierce (2001) 
indicate that the Netherlands does have legislative guidelines for alcohol testing for 
those employed in transport and navigation, but all testing has to be performed by the 
police authorities. Verstraete and Pierce (2001) suggest that one laboratory carries out 
nearly all workforce drug testing in the Netherlands (approximately 20,000 tests per 
year). The consensus in the Netherlands appears to be that few organisations support 
workforce testing and few companies test for drugs and alcohol. The impact of 
alcohol on workplace performance has been acknowledged, however, resulting in a 
move to eliminate alcohol use from the workplace. In the Netherlands, testing is 
limited to those in safety critical positions although employer’s organisations do not 
find that testing constitutes an invasion of privacy, nor do they consider the low 
prevalence rates of substance abuse a reason for not testing. Conversely, employees 
organisations view testing as undesirable, and do not accept that it has any bearing on 
impairment. Workers organisations suggest that testing within multi-national 
companies is linked to reducing insurance claims rather than health and safety. 
Verstraete and Pierce (2001) indicate that Norway does have legislation prohibiting 
certain categories of workers (military personnel; transport workers) from being under 
the influence of drugs or alcohol while at work. Workforce testing is relatively rare. 
Moves to introduce testing policies have been unpopular, but some sectors such as 
shipping, have found that testing policies must be in operation in order to compete for 
international business. 
 
Similarly, in Sweden, there is existing legislation authorising drug and alcohol testing 
for those in the transport sector, and testing can be performed either on a routine basis 
or following reasonable suspicion. Brannstrom and Hopstadius (1994: 4) report that in 
Sweden ‘approximately 40 companies are testing drugs. The use of tests occurs within 
shipping, transport services, engineering industry’. It has been estimated that between 
10% and 20% of all private sector employees work in an organisation that has a 
testing policy; policies are usually framed within health and safety guidelines. 
According to Verstraete and Pierce (2001) in 1998, 24000 tests were performed. The 
emphasis is largely upon the eradication of illicit drugs rather than alcohol, and some 
of the testing guidelines have been written to comply with U.S. Federal guidelines. 
The Swedish Trade Union Confederation has developed guidelines stating that ‘Tests 
may not be introduced without prior negotiations; the persons integrity and 
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information regarding him or her must be protected, even at the pre-employment 
stage; …testing of staff may only take place in relation to work in which safety 
considerations are important; a totally reliable means of testing must be used…the 
employer must take responsibility for rehabilitation [and] negotiations on replacement 
should only take place after negotiations concerning rehabilitation have been 
completed; [and] voluntary testing is a way of working towards prevention’ 
(Husbands 1993: 25).  
 
Verstraete and Pierce (2001) also provide research evidence on Belgium, where 
workforce drug testing is well established in the automobile industry and by the state 
police. In  Spain and Portugal workforce drug testing is performed in the military (for 
example the Portuguese Navy) as well as transport and communication industries. In 
Finland, drug testing is recommended for maintaining the employment relationship 
(‘e.g. in order to protect the employer, the customers or the other workers’ (Verstraete 
and Pierce 2001: 4); Luxembourg has no specific legislation, although some private 
companies perform on site testing; Italy, Denmark and Austria, Verstraete and Pierce 
(2001) report no data is available; in Greece, testing is performed in the security 
services and professional drivers when a licence is revoked for drug abuse. In 
Switzerland workforce drug testing is only performed in the area of public 
transportation, military, private schools and few private companies, including the 
automobile and pharmaceutical industries; Ireland they report carries out 
approximately 20,000 workplace drug tests annually, with testing mostly on white 
collar workers (information technology, pharmaceutical, call centres. 
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Much of the research on the appropriateness or otherwise of workforce drug testing 
has focused upon the rationale for testing which, from an organisational viewpoint, 
has mostly been packaged, in one of two key arguments. Like much of the literature 
on workforce drug testing, the majority of it is North America. 
 
The first frequently cited rationale is that workforce drug testing promotes workplace 
safety by reducing the number of injuries and accidents resultant from employee illicit 
drug and alcohol use or inappropriate licit drug use whilst at work or impairment from 
recent use whilst away from work. The second reason commonly cited in the literature 
is that workforce drug testing is justified as illicit drug or alcohol use is detrimental to 
an employees’ performance and productivity.  
 
In addition to these key arguments, there are a number of further justifications 
including the notion that workforce drug testing will reduce general workforce use 
and wider societal drug use. It is also suggested that workforce drug testing may have 
a positive effect on an organisation’s image and reputation. It is argued that employers 
have the right to discover which employees use substances, and remove them from the 
workplace, either through disciplinary action or treatment programmes and services. 
 
Workforce drug testing techniques vary. Research identifies that most organisations 
utilise urine testing. Types of workplace drug testing programmes also vary. There are 
varying degrees of criticism levelled at the different types of testing programmes. 
Research indicates that pre-employment and post accident testing have enjoyed the 
most support and are particularly common across business and industry.  
 
The remainder of this section provides a review and summary of the research 
literature examining: (a) arguments forwarded for workforce drug testing; (b) 
arguments forwarded against workforce drug testing; and (c) testing techniques; and 




Arguments for Workforce drug testing Francis and Wynarczyk (1998: 176-178) offer 
a useful overview of the arguments within the literature forwarded by supporters of 
workforce drug testing. First, drug taking is a major societal problem, and therefore it 
is a problem that has major consequences for the workplace environment. Second, 
that the use of alcohol and drugs poses major risks within the workplace environment, 
no matter what the work entails. Hecker and Kaplan (1989: 693) detail such 
consequences in terms of the possible risks drug use poses to an individuals ‘own 
health and safety, risks to the safety of fellow employees and / or the public from drug 
induced impairment, and risks to the production process’. Third, drug testing is seen 
as effective in reducing employee and employer risks. Effectiveness is measured by 
the extent to which programme objectives are achieved. Usually these are in terms of 
reducing occupational injury, increasing employee productivity and performance and 
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reducing workforce alcohol and drug use. Francis and Wynarczyk (1998) also suggest 
a more general criterion is that testing may contribute to the reduction of societal 
levels of use. ‘With the threat of being caught at work, so this deterrent argument 
goes, individuals usage of drugs outside work decreases. As a result, societal levels of 
drug misuse are supposed to decline also’ (Francis and Wynarczyk 1998: 178). 
 
In addition, researchers have identified a series of further arguments in favour of 
workforce drug testing (Macdonald and Wells 1994; Macdonald and Roman 1994; 
Banta and Tennant 1989). It has been argued, for example, that workforce drug testing 
promotes public confidence in an organisation and determines medical fitness for 
work in addition to reducing the cost of medical plans. Within the workplace context, 
drug testing has also been seen as a mechanism to reduce and / or prevent workplace 
theft (Lehrer 1987 in Parrot Undated). Research also suggests that it may promote 
enhanced employee morale, particularly in light of evidence that 69% of organisations 
surveyed by the Incomes Data Services  (Income Data Services 1998 cited in Jackson 
1999) identified that an employees alcohol use had resulted in deteriorating working 
relationships with co-workers (the corresponding number for drug use resulting in 
deteriorating relationships was 57%). An article in the Financial Times (02/03/98) 
cited the Institute of Management, and detailed that approximately 17% of employees 
are impaired at work as a result of drug use, and that the same number again are 
affected by other employees drug use. Furthermore, the research literature identifies 
that in order to provide rehabilitative, welfare and educational services it is first 
necessary to establish which individuals have substance abuse problems, and testing 
can, therefore be justified in terms of employee welfare. The research literature also 
identifies that an associated benefit of workforce drug and alcohol testing may be that 
illegal or socially unacceptable behaviour by employees is discouraged. Research has 
suggested that alongside the ‘dark figure’ surrounding the extent of illicit drug taking 
at work, it is even more difficult to establish the number of employees that supply 
other employees with illicit substances. Research carried out by May (1999) estimates 
that up to 44% of employees could be supplying co-workers with illicit substances.  
 
Gerber and Yacoubian (2001) conducted research in the U.S. that focused upon the 
extent of drug testing in the construction industry. A survey circulated to company 
officials, which asked them to rank the reasons for the implementation of drug testing 
in order of importance indicated that the most important justification identified was to 
promote the safety of employees and those that use company products and services. 
The second most important reason was to promote the company’s image in a positive 
manner and the third highest-ranking reason was that drug testing acted as an effective 
deterrent for employee drug use.  
 
Workforce drug testing – arguments against The research literature also identifies a 
number of arguments forwarded that reject workplace drug testing (Macdonald and 
Wells 1994; Macdonald and Roman 1994; Banta and Tennant 1989; Francis and 
Wynarczyk 1998). Drug testing, it is argued, may contravene employee rights to 
privacy and may, for some, constitute a humiliating and intrusive procedure, which 
also provides the possibility of legal action if testing is not carried out in adherence to 
strict guidelines and legislation. False positive results can lead to the further 
embarrassment and complication of incorrectly labelling an employee as a drug or 
alcohol user. These difficulties can cause tensions in labour/management relations. 
Additionally, the research literature has suggested that the effectiveness, efficacy and 
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cost effectiveness of such programmes have not been empirically supported to date. In 
the meantime, a number of researchers maintain that drug testing programmes remain 
an expensive way of responding to potential drug and alcohol misuse. Critics contend 
that a more appropriate method of controlling substance misuse in the workplace is to 
improve reference checking, the interview process, and the training of supervisors and 
to establish EAPs (Butler 1993; Campbell and Langford 1995; Banta and Tennant 
1989). 
 
Workforce drug testing techniques The research literature identifies that there are 
many and varied drug testing techniques. These include breath/saliva, blood, urine, 
hair, perspiration and eye testing (Bean 2002). Research identifies that breath tests are 
one measure of alcohol intoxication1. Breath tests have been accepted in some courts, 
as evidence of workplace alcohol abuse (in the U.S. for example). While Cohen 
(1984) concedes that testing for alcohol can indicate a level of impairment it is still a 
complex issue as individuals have different tolerance levels. Moreover, some 
employment cultures require alcohol consumption as a social requirement of the job. 
Breath alcohol analysis is used to determine the levels of alcohol in the blood but 
cannot detect drug use, and is therefore, of limited use to an employer with a 
comprehensive drug and alcohol policy. It is usual that positive breath tests are 
followed by a confirmatory technique, usually a blood test. Blood tests are the most 
accurate measure of concentration of alcohol in the bloodstream but are the most 
invasive and require laboratory analysis. 
 
Research identifies that the most commonly used testing technique is the urine test, 
although this test can take several forms. Urine tests are usually performed ‘based on 
the principle that what is ingested, injected or inhaled into the body must eventually 
be excreted’ (Husbands 1993: 18)2. Testing urine involves techniques based on 
biological (immunological) assays due to their suitability for mass screening. The 
most common of these is Thin-Layer Chromatography (TLC) (Schur and Broder 
1990). It is one of the oldest forms of urinanalysis, and is relatively inexpensive3. 
Radio-immunoassay (RIA) provides a different form of test, while extremely 
sensitive, RIA is expensive in terms of time and level of expertise necessary to 
interpret the results. The Enzyme Immunoassay (EIA) test has a long history of 
application in drug testing and the Enzyme-Multiplied Immunoassay Technique 
(EMIT) is one of the most commonly used techniques in drug testing laboratories. 
EMIT is considered a highly accurate test, (NYPD 1990; Ozminkowski et al 2001 ). 
 
Gas Chromatography (GC), or Gas Liquid Chromatography (GLC) is often, but not 
exclusively, used as a confirmatory technique as it can detect up to three-dozen types 
                                                 
1 This technique is based on the principle that after alcohol enters the blood stream; vapours diffuse from the blood 
to the lungs. As the amount of alcohol entering the lungs from the blood supply corresponds to the amount of 
alcohol the blood is delivering to the brain, expelled breath provides an accurate indicator of the extent to which an 
individual is currently impaired by alcohol. 
2 The original drug can be excreted unchanged, but usually drugs are broken down by the body’s metabolism, and 
those parts or metabolites can be detected in urine. In some instances metabolites appear in urine for some time 
after either drug use or its mental and physical effects have taken place, although this is drug type specific. 
3 The technique itself involves the use of an absorbent material, usually silica, which is placed on glass. Drops of 
the sample are then placed on the silica, and it is possible to identify different components of the sample by the 
different absorption rates. 
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of drugs (Husbands 1993)4. Gas Chromatography with Mass Spectrometry (GC/MS) 
can be considered as the state of the art drug testing technique, as it is extremely 
sensitive and specific. Disadvantages of employing this method include the length of 
time required to provide a result and that it is also a relatively expensive technique. 
This test also has an increased potential for false positive results.  
 
Hair testing cannot measure impairment or time of ingestion. Perhaps the key benefit 
of hair testing is that it is non-intrusive in comparison to other methods such as blood 
and urine testing. It is however, expensive. It has been suggested that while the 
average number of positive tests identified through urinanalysis range from 3-5%, the 
corresponding figure for hair testing is 18% and it is therefore significantly more 
accurate (Nadell 2001). Moreover, drugs may be detected in hair for a significantly 
long period of time after the drug has been ingested. Perspiration testing is a relatively 
recent technique and is often used to test for cocaine, codeine, and metabolites, 
Samples are subject to Gas Chromatography/Mass Spectrometry (GC/MS). It is a less 
invasive procedure than blood or urine testing and is also thought to provide a more 
convenient sample collection process (Huestis et al 1999). Bean (2002) also indicates 
that perspiration provides a longer time scale in which drugs can be identified and 
measured in comparison with urine samples. Eye testing is another relatively new 
technique and involves measuring the intake of drugs through eye movements (Bean 
2002). 
 
Drug testing, with the exception of alcohol testing, is problematic in that it cannot 
deduce impairment “there is no way of extrapolating how intoxicated a person is from 
doing a drug test” (Naylor 2001:86). This may result, Naylor suggests, in an increased 
likelihood of uncovering ‘soft drug’ users i.e. cannabis users as cannabis is 
identifiable in the body for a longer period of time (up to 28 days). As Naylor goes on 
to state: “…recreational drug use doesn’t affect your ability to work, any more than 
emotional problems, bad management or lack of motivation. Unfortunately you can 
only test for drugs” (Naylor 2001:90). Cohen (1984) however, points to evidence that 
suggests that cannabis use does impair performance and research has shown that 
limited use can cause impairment for up to ten hours. 
 
Workforce drug testing types The research literature identifies that there are several 
different types of workforce drug testing both in terms of the stage of employment at 
which the test is implemented, and the method used to select employees for testing. 
MacDonald and Roman (1994) provide an overview of the nomenclature of workforce 
testing policies (see also Lane 1992). 
1. Pre-employment screening - potential employees are tested for alcohol and drugs 
before an offer of employment is made. Pre-employment screening is the most 
common and widely accepted form of workforce drug testing. The research 
literature indicates that trade unions are less likely to object to this form of 
screening, and few liability concerns exist, as there is no legal obligation to satisfy 
the demands of non-employees. Pre-employment testing does not necessarily 
reduce drug taking in the workplace as candidates can simply abstain from drug 
use prior to interview, resuming drug taking habits after employment is secured. 
                                                 
4 The gas chromatography technique vaporises the urine sample at high heat, which is then separated by carrying 
the vapour through a tube using pressurised helium. The vaporised sample is then fed into a mass spectrometer 
where the molecules are shattered resulting in a ‘molecular fingerprint’ or mass spectrum of the sample (Klinger 
1991). 
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2. Random testing - drug testing is performed on a random basis and all employees 
have an equal chance of selection. This often involves testing employees without 
prior notice. Random testing has generated the most controversy, both amongst 
employee groups, as well as the research community, for several reasons. Trade 
unions typically criticise this programme for infringing the privacy of employees, 
there is also the potential for improper use as the employer decides who is tested 
and when testing occurs. Critics have argued that random testing strains working 
relationships by facilitating feelings of oppression, trepidation and insecurity in 
employees. The strain on working relations can potentially have as adverse an 
effect on productivity as substance abuse itself. Random screening programmes 
are also relatively expensive and inefficient. Alternatively, random testing has 
been described as the most effective method of deterring workforce drug use as 
employees are less likely to misuse drugs or alcohol whilst under the constant 
threat of testing. 
3. Periodic testing - the most common example of this is testing on an annual basis 
as part of a medical check-up, usually completed to a predetermined timetable. 
Periodic testing has obvious limitations in that employees, receiving notice of 
screening, can abstain from drug use at that time. Any positive test from periodic 
testing is, however, likely to stand up to legal scrutiny. A study by the United 
States Centre for Disease Control, comparing periodic and pre-employment testing 
programmes, found that pre-employment tests were two and a half times more 
likely to yield positive test results than any other form of testing (Husbands: 
1993). Furthermore, those employees having drug or alcohol problems will be less 
able to abstain from substance use, making this approach more appropriate in 
identifying problematic drug or alcohol users as opposed to infrequent users. 
4. Probable cause testing - there are two types of probable cause testing. First, post 
accident testing, which as the phrase suggests, involves screening employees that 
have been involved in an industrial accident or injury. Second, testing employees 
who have displayed behavioural signs of drug or alcohol use. In relation to post 
accident testing, there is no obligation on the part of the employer to show that 
impairment may have been the cause, or a contributing factor in the accident. 
There are rarely legal implications surrounding this type of testing as employers 
are responsible for maintaining a safe workplace and therefore have a right, or 
responsibility, to investigate the cause of accidents. This type of testing may lead 
to a reduction in the reporting of minor accidents for fear of being tested. Testing 
following the identification of behavioural signs of drug or alcohol use may 
require training employers and supervisors to assist them in recognising 
symptoms. Training of supervisors to recognise substance abuse may lead to a 
stronger legal case following a positive test. Alternatively, symptoms may be 
misdiagnosed, leaving the employer open to accusations of workplace bullying 
and harassment. This could be particularly problematic in terms of racial or gender 
discrimination. 
5. Reasonable suspicion - employees may be tested for alcohol and drugs following 
behavioural signs such as lateness or high absenteeism. It should be noted that the 
grounds for testing as a result of reasonable suspicion are less rigorous than for 
probable cause testing. While based on the same premise as probable cause 
testing, reasonable suspicion testing attracts more criticism than probable cause 
testing, due to the less stringent criteria used to identify what constitutes 
reasonable suspicion, in comparison with what constitutes a probable cause. 
Furthermore, criteria used to determine reasonable suspicion include absenteeism, 
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lateness and tardiness, which can also be symptoms of a non-drug, or alcohol 
related problem such as depression, family problems and assorted medical 
conditions. For example, medical conditions such as diabetes can produce 
symptoms similar to those of drug or alcohol use. Critics of testing policies cite 
such evidence in their arguments against workforce testing; it is possible for tests 
to identify medical conditions, even pregnancy, which can be considered breaches 
of employee privacy.  
6. Post-treatment testing - employees are subject to alcohol and drug testing after 
having received some form of treatment for alcohol or drug abuse problems. 
 
Other types of drug testing such as voluntary and transfer or promotion testing are not 
widely used, and as such little is known of the impact of this type of testing upon the 
workplace and relationships therein. They include: 
7. Transfer or promotion testing - employees may be tested after a job transfer or 
promotion. 
8. Voluntary testing - employees may choose to be tested but it is not a formal 
requirement. 
 
MacDonald and Roman (1994) identify three possible outcomes of positive drug test 
results. In the case of pre-employment screening it is usual that the applicant will not 
be appointed, but they may be afforded the opportunity to reapply following treatment 
for the drug or alcohol abuse identified through the screening process. Other 
consequences of testing include dismissal, rehabilitation, treatment or no further 
action, and the sanction chosen may depend upon the rationale underpinning the 
testing policy. For example, in a company or organisation that views alcohol or drug 
use as a disciplinary issue, an employer will be more likely to dismiss a drug positive 
employee. The Institute of Personnel and Development surveyed 1500 personnel 
professionals in 1996,of which 10% conducted pre-employment screening and 5% 
conducted random testing. Of those that conducted random testing, 18% of 
respondents indicated that drug positive employees should be dismissed (Financial 
Times 02/02/98). Alternatively, for employers that view drug or alcohol use as a 
welfare issue, it is more likely that remedial treatment will follow a positive test 
result. It should be noted, however, that there are provisos on the levels of remedial 
treatment offered by the employer, and it is usual for the employee receiving remedial 
treatment to be tested both during and following treatment.  
 
There are also pragmatic reasons for opting for rehabilitation rather than dismissal; 
the costs of hiring and training a new employee may exceed the costs of rehabilitation. 
Furthermore, dismissal of an employee may reduce the likelihood of seeking 
treatment and alternative employment. The treatment model may be seen as less 
effective in terms of increasing productivity and increasing health and safety levels, as 
their effectiveness, especially in the long term, is open to question. As different types 
of treatment are associated with different success rates, no single treatment, or 
combination of treatments, can be regarded as the correct course of action for all 
individuals with drug or alcohol related problems.  
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4. EMPLOYEE ALCOHOL AND ILLICIT DRUG USE AND 





Occupational accidents and injuries represent a significant workplace problem, posing 
significant costs to employees and employers every year (Macdonald and Pitney 
2000). Kesselring and Pittman (2002: 293) report that the U.S. workforce suffers 
approximately 6500 job related deaths from workplace injuries, 13.2 million non-fatal 
injuries, 60,300 deaths from disease and 862,200 occupational illnesses per year. 
Kesselring and Pittman (2002) report that occupational accident, injury and illness 
costs U.S. business and industry approximately $171 billion dollars per annum. These 
figures correlate with high prevalence rates for alcohol and illicit drug use across the 
general U.S. population, including substantial sections of those in employment. 
 
It is within this context that researchers, working from within numerous disciplinary 
perspectives, have examined the nature and strength of the relationship between 
employee alcohol and / or illicit drug use and workplace occupational accidents and 
injuries. It is perhaps of no surprise that the overwhelming bulk of research emanates 
from North America, particularly the U.S., but also Canada. Since the late 1960s a 
relatively large body of research has emerged which ‘has sought to demonstrate the 
association of employee substance abuse patterns to the frequency of accidents and 
injuries both on and off the job’ (Martin et al 1994: 5). Despite differences in 
approach, the fundamental research question has remained the same: what role do 
alcohol and illicit drugs play in causing occupational accident and injury?  
 
The academic and scholarly research literature reviewed in this section provides 
insufficient evidence to conclude that employee illicit drug use plays a substantial 
causal role in occupational accident and injury. A number of studies do provide 
evidence of a link between illicit drug use and occupational accident and injury. 
Others, however, do not make the link, although there is some research evidence in 
relation to the causal role played by employee alcohol use in occupational accident 
and injury. There is also evidence relating to the causal role played by non-substance 
misuse factors in occupational accidents and injuries. 
 
The remainder of this section provides a review and summary of the research 
literature examining: (a) the relationship between illicit drug use and occupational 
accident and injury; (b) the relationship between alcohol use and occupational 
accident and injury; and (c) the relationship between non drug factors and 




In addition to the reportage of findings from research examining the strength and 
nature of the relationship (between employee illicit drug and alcohol use and 
occupational accident and injury), there can be found within the literature, discussion 
of particular research approaches, presentation of industry specific ‘case study’ 
research, as well as examination of the nature of ‘causality’, and specifically of the 
role played by non drug factors in causing occupational accidents and injuries.  
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Within the literature there are differences between studies that compare workplace 
injuries of drug users and nonusers, determined through self-report studies; and those 
that compare accident rates of drug positive and drug negative employees, determined 
by pre-employment tests (Macdonald 1995). For Macdonald (1995: 130), ‘studies that 
assess differences between drug positives (those testing positive for drug use) and 
drug negatives (those testing negative for drug use) in terms of workplace problems 
are the most relevant studies to use when assessing the effectiveness of drug screening 
in the workplace’. This is because such studies do not rely on self-report data and thus 
are less open to bias.  
 
The studies carried out by Zwerling et al. (1990), Crouch et al (1989) and Normand et 
al. (1990) are examples of research that compare accident rates of drug positive and 
drug negative employees, determined by pre-employment screening. Zwerling et al 
(1990) carried out research with U.S. postal workers in Boston. The focus of the 
research was 2,537 applicants who had accepted the offer of employment. The study 
was concerned with the consequences of substance misuse upon accident, injury and 
disciplinary action, as well as on absenteeism and turnover (the latter two are 
discussed in the next section). Zwerling et al (1990) found that those who had tested 
positive for marijuana or cocaine were significantly more likely to have reportable 
accidents and work injuries. More generally, Zwerling et al (1990) identified 
statistically significant differences between drug users and non drug users with regard 
to accidents, injuries and disciplinary action. A two year follow up study identified 
that the risks of adverse outcomes declined among drug positive employees after the 
first year (Ryan et al 1992). Crouch et al (1989) report that drug users were five times 
more likely to have had a reportable vehicle accident than a non-drug using 
comparable sample, matched by age, sex, occupation, years of service and geographic 
location, although the authors suggest the findings should be treated as preliminary, 
especially given that the study was concerned with pre-employment drug use, thus not 
indicating regular drug use. Normand et al (1990) carried out a longitudinal study of 
5,465 U.S. Postal Service applicants using a predictive design. Again, various criteria 
were used including absenteeism and turnover in addition to accidents and injuries. 
The former are discussed in the next section. With regards the latter two, the research 
suggests that differences in injuries and accidents between employees who reported 
illicit drug use and those who did not was not statistically significant.  
 
Research carried out by Hingson et al (1985) and Bross et al (1992) offer comparisons 
between accidents and injuries of drug users and non users as determined through self 
report studies. These studies indicate varying degrees of association between general 
workplace drug misuse and employee injury and accident (Martin et al 1994). The 
study by Hingson et al (1985), which utilized a telephone survey of a random sample 
of 2,565 residents of New England, identified that 26% of employees who reported 
weekly use had also experienced an accident in the previous year, compared to 17% 
of their non drinking counterparts (see also the discussion in Martin et al 1994). The 
study also found that workers who consumed approximately five units daily were 
more likely than drug users and those who did not drink to have an accident or require 
medical assistance. Martin et al (1994: 7) also states that, ‘40% of respondents who 
reported weekly on the job drinking had experienced injury producing accidents in the 
previous year, and 8% had required hospitalisation’. The study by Bross et al (1992), 
focused upon chemically dependant workers in a manufacturing setting. It found 
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workers reporting drug use to be more likely to experience ‘strains and sprains, 
fractures and dislocations, and lacerations and contusions’ (Martin et al 1994: 7).  
 
Much of the research literature provides inconclusive evidence as to the nature and 
strength of the relationship between illicit drug use and occupational accident and 
injury. In a relatively early review of the research carried out in the U.S. and Canada, 
Zwerling (1993: 14) notes, after reviewing three studies (Lewis and Cooper 1989; 
Parkinson 1986 (cited in Zwerling 1993); Alleyne et al 1991 (These studies are 
discussed below)), that while evidence of an association between illicit drug use and 
fatal occupational injury is lacking, these studies do not rule out the possibility of 
there being one either. With regards non fatal occupational injuries, Zwerling 
concludes that the conflicting results reported by Zwerling et al (1990) and Normand 
et al. (1990) could be consistent with a weak association between injuries and 
accidents and cocaine and marijuana use in the postal service. Similarly, Beswick 
(2002), in a recent review of twelve research studies, reports that there is only limited 
evidence to lend credence to the view that illicit drug use is associated with 
occupational accidents and injuries. For Beswick, ‘five studies have found some 
association between drug use and workplace accidents, whereas seven others have 
found little or no evidence of a link between drug use and workplace accidents’ 
(2002: 7). Beswick goes on to state that ‘Therefore the evidence appears inconclusive’ 
(2002: 7). The twelve research studies reviewed by Beswick (2002) are by Moody et 
al (1991), Shannon et al (1993), Holcom et al (1993), Pollack et al (1998), Hoffman 
and Larison (1998), French et al (1995), Alleyne et al (1991), Leirer et al (1991), 
SAMHSA (1994), Kaestner and Grossman (1988), Macdonald (1995) and Lewis and 
Cooper (1989). 
 
A critical reading of a number of these studies confirms the divergence and variance 
in findings of the research. The research studies differ enormously in terms of type of 
study, methodology and findings. All were carried out either in the U.S. or Canada. 
Moody et al (1991) analysed data on post accident and post incident testing of 736 
railroad employees in the U.S.. The findings of the research indicate that in a small 
but significant amount of cases, employee illicit drug use played a causal role in 
accidents, although the authors go on to acknowledge that the number of accidents 
attributed to alcohol and illicit drugs is less than that for car accidents. Moody et al 
(1991) detail that cannabis was the most commonly detected substance. Shannon et al 
(1993), in their Canadian study of the extent and strength of the relationship between 
illicit drug and alcohol use and 470 occupational fatalities found that among 
employees, the detection rate of cannabis appeared high. Their research also reports a 
lack of evidence of other illicit drug use amongst employees, and indicates the 
relevance of non-drug factors to explaining occupational fatalities. 
  
Drawing upon the findings from a questionnaire distributed at work to municipal 
workers in one U.S. town, Holcom et al (1993) identify the existence of a relationship 
between substance use and occupation injuries in high risk positions (no relationship 
was found between substance use and occupation injuries in low risk positions). Their 
research also acknowledges the relevance of personal and work related factors in 
explaining occupational accident and injury, including dysfunctional personal 
backgrounds and stress and dissatisfaction with work. Alleyne et al (1991) in a study 
of occupational fatalities in Alberta, Canada, which assessed investigation data 
relating to 459 deaths at work over an eight year period offer evidence that alcohol is 
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most commonly associated with fatal injuries. More generally, Alleyne et al (1991) 
argue that alcohol is generally the more popular choice of substance used, with 
younger employees more likely to test positive for cannabis.  Lewis and Cooper 
(1989) in their analysis of autopsy results relating to occupational fatalities in Texas, 
U.S., provide evidence that alcohol is more likely to be associated with fatal injuries, 
as are prescription drugs. Only one case of illicit drug use was found.  
 
A number of further issues can be gleaned from the literature on the relationship 
between illicit drug and alcohol use and occupational accident and injury. First, where 
an association between illicit drug use and accident and / or injury is reported in the 
research, it appears to be highest for young employees. Pollack et al (1998) in a study 
of the risk of on-the-job injury for substance users compared to non substance users 
found higher rates of injury for substance users, most of whom had used alcohol. The 
greater prevalence of alcohol is supported by research carried out by French et al 
(1995) and Alleyne et al (1991). Kaestner and Grossman (1988) in an analysis of 
survey data suggest that drug use is significantly related to accidents for young adult 
males, but also report no such relationship for females. Second, there is evidence to 
suggest that injury and accident can arise from impairment resultant from actual on-
the-job use (Hoffman and Larison 1998; Moody et al 1991), although this point is 
disputed by Alleyne et al (1991). Drawing upon data derived from the National 
Household Survey on Drug Abuse, Hoffman and Larison (1998) undertook research 
into the relationship between drug use, accidents and turnover. They state that ‘if drug 
use is related to accidents in some respects, it probably involves impairment that 
results from on-the-job use’ (1998: 360). In stating this, they acknowledge more 
generally that drug use is not associated with work related accidents, but may be 
related to the potential of being dismissed or resigning, although this is, to a degree, 
also dependent upon the nature of the employment and occupation. Third, the 
percentage of workplace injuries attributed to substance use is smaller than that for 
automobile accidents resultant from substance use. Fourth, compared with national 
averages, employees tended to have substance use profiles similar to or lower than 
those of the general U.S. and Canadian population, and that illicit drugs are not used 
as extensively as alcohol among employed people. Fifth, substance misuse / use may 
be associated with high-risk positions. Finally, for SAMHSA (1994) current illicit 
drug use and alcohol use amongst U.S. workers deserves serious attention from policy 
makers. Moreover, the use of drugs on-the-job has been exaggerated with little 
empirical evidence to support the notion of wide scale workplace drug use (see the 
work of Newcomb 1994). 
 
Much of the research carried out to date has been industry specific. This is 
unsurprising, but is not solely a consequence of the practicalities and cost of carrying 
out manageable, valid and robust research. It is also a consequence of the fact that, as 
research evidence has indicated, the nature and type of industry is a crucial variable 
by which to assess the nature and strength of the relationship between illicit drug use 
and occupational accident and injury (Kesselring and Pittman 2002). For Kesselring 
and Pittman (2002), whose research study attempted to evaluate the relative efficacy 
of expenditure on drug testing by industry and commerce, and which drew upon data 
extracted from the Bureau of Labour Statistics for the years 1989, 1990 and 1991 (this 
data includes injuries and illnesses per 100 workers by state and by industrial 
classification) and across forty states, the ‘evidence strongly suggest that the most 
overwhelming determinant of occupational injury is the industry of employment … in 
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this model, neither the legal environment of the state nor any of its demographic 
characteristics had any significant statistical effect on injuries’ (Kesselring and 
Pittman 2002: 300). 
 
Zwerling (1993: 15) in reviewing the academic and scholarly research literature in 
relation to the transportation industry, noted that ‘alcohol impairment is present in 
about 10% of occupational fatalities. The data are especially strong among heavy 
truck drivers. Those with a clinical history of alcohol abuse may also have a slightly 
elevated risk of non-fatal occupational injuries compared to those without such a 
history. However, the data here are not entirely consistent. The relationship between 
fatal injuries and illicit drug use is more difficult to define… In the heavy trucking 
industry, the evidence suggested that those with marijuana positive urines were not at 
increased risk of fatal injuries while those with urines positive for amphetamines and 
cocaine may have been. There was very little evidence concerning the association of 
drug use and non-fatal injuries’. He concludes by stating that ‘in summary there is 
good evidence, at least in a single industry, that those individuals with positive pre-
employment drug screens tend to have higher rates of absenteeism which lead to 
higher rates of disciplinary action’ (1993: 17). 
 
Much of the research carried out suffers from methodological and conceptual flaws 
(Macdonald and Wells 1994; Martin et al 1994). Presented together, Macdonald and 
Wells (1994) suggest that these limitations include the fact that several drugs are often 
combined into one category; users are often simply compared with non users; no 
break down of on-the-job-use and off-the-job-use is available; causality remains an 
insufficiently researched issue; moderate and heavy use is undistinguished; past and 
current use is never differentiated; sample sizes are small, response rates are often low 
and therefore non-generalisable; and comparisons across studies is difficult to 
undertake. Additionally, many research studies are limited to one industry, company, 
state and / or country. For example, many research studies focus upon particular types 
of employees and their workplaces (such as those working in the construction industry 
or the transportation industry). Often the research is ‘localised’. That is research has 
focused upon one workforce and their workplace within one geographical location, 
such as U.S. Postal Workers in Boston (see Normand et al 1990). Little geographical 
comparative research has been carried out (across states within the U.S., or across 
countries). Similarly, little comparative analysis of different workforces and their 
workplaces has been undertaken. Moreover, a number of studies fail to differentiate 
between alcohol and illicit drug use in the presentation of their findings.  
 
A similarly large body of research has focused upon the relationship between alcohol 
problems and occupational accidents and injuries (Webb et al 1994; Stallones and 
Kraus 1993; Zwerling 1993; Martin et al 1994; Macdonald 1995, 1997). A critical 
reading of the research indicates that there is more substantial evidence of the causal 
role played by employee alcohol use in causing occupational accident and injury. This 
is especially the case for problem drinking and alcohol dependence (Macdonald 
1997). As Martin et al (1994) acknowledge, ‘with few exceptions … studies of 
problem drinkers … support the hypothesis that accident rates are higher for these 
workers’. Martin et al (1994: 6) go on to point out that a number of studies indicate 
that employees injured on the job are more likely to have measurable blood alcohol 
levels than the control group (these studies included Weschler et al 1969; Lewis and 
Cooper 1989; Alleyne et al 1991; Lederman and Metz 1960). 
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As previously noted, Zwerling (1993) provides a useful, if somewhat early, review of 
the research literature on alcohol use and fatal and non-fatal occupational injuries. 
Regarding the former, Zwerling (1993: 11) suggests that research identifies acute 
alcohol impairment present in about 10% of fatal occupational injuries. He concludes 
his review by stating that ‘alcohol plays a relatively restricted role in fatal 
occupational injuries’. A reading of the studies reviewed by Zwerling, including those 
by Berkelman (1985), Baker (1982) and Smith (1988) (cited in Zwerling 1993), 
indicates that this is an appropriate and balanced assessment of the research. 
Regarding non-fatal occupational injuries, Zwerling suggests that alcohol impairment 
is present in 5% of non-transport cases (1993: 12). A reading of the studies reviewed 
by Zwerling, including those by Wechsler et al (1969), Papoz et al (1986), Trent 
(1991) indicates  again that this is an appropriate and balanced assessment of the 
research. 
 
With regards problem drinkers Zwerling (1993) suggests that ‘…there was no 
statistically significant association between average alcohol consumption over a seven 
day diary or a history of binge drinking with occupational injuries’ (1993: 13). 
Certainly it is the case that other studies have shown similarly mixed results. Zwerling 
does acknowledge that acute alcohol addicts may suffer impairments when sober, 
such as the effects from a hangover. Overall, for Zwerling, while alcohol abuse may 
be weakly associated with occupational injuries, ‘the wide variety of methodological 
difficulties in the various studies of the association of a history of alcohol abuse and 
occupational injuries should make the reader cautious in drawing conclusions from 
this literature’ (1993: 12). This is a view also supported by Webb et al (1994) and 
Stallones and Kraus (1993), both concluding insufficient evidence of an association 
between alcohol use and occupational injury. 
 
Scott Macdonald (1995; 1997) and Macdonald and Wells (1994) offer a more recent 
review and slightly different reading of the research on alcohol use and occupational 
injury. In reviewing the work of Observer and Maxwell (1959), Webb et al (1990), 
Dawson (1994), Schlosser and McBride (1984), Macdonald (1995) suggests that; 
‘overall, some research studies suggest that alcoholics and problem drinkers are more 
likely to be involved in industrial injuries than non problem drinkers. Other studies 
have failed to find a relationship’. The latter include those conducted by Beaumont 
and Hyman (1987), Buchanan (1988), Hertz and Emmett (1986) and Powell et al 
(1971). Macdonald (1995) further reviews those studies that examine the relationship 
between blood alcohol concentration and performance and injuries (Coambs and 
McAndrews 1994; Lederman and Metz 1960; Baker et al 1982; Hollo et al 1993) 
(alcohol tests and breathalysers are able to determine an individuals Blood Alcohol 
Concentration (BAC), which correlates closely with degree of impairment). For 
Macdonald, both laboratory and epidemiological studies are conclusive that higher 
BACs are associated with decreased psychomotor coordination (1995: 705), and 
epidemiological studies have shown adverse effects of alcohol impairment, as 
measured by BAC readings, on work injuries. As well as reducing inhibitions, 
increasing risk taking and impulsive behaviour Macdonald concludes that such 
‘research evidence is conclusive that impairment by alcohol is related to occupational 
injuries’ (1995: 705) (see also Macdonald 1999). 
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Research has also identified the potential causal role played by non drug factors in 
occupational accident and injury (Macdonald 1995). For Macdonald (1995) too little 
weight or attention has been given to the role of third variables in explaining 
occupational injury. For Macdonald (1995: 705-706), ‘Three requirements of 
causality are that a relationship exists between two variables, that the cause precede 
the effect and that an observed empirical relationship cannot be explained by a third 
variable. Virtually all-empirical studies on the subject have addressed the question of 
whether a relationship between drug use and job injuries exists, and some studies have 
found significant relationships. However, little or no efforts have been made to assess 
whether the relationships found could be better explained by a third variable.’ These 
‘third variables’ may include work characteristics such as noise and dirt on the job, 
inadequate work procedures, poorly maintained equipment, inadequate training, 
supervision and management, excessive noise, heat and vibration, shift patterns, the 
monotonous nature of work, as well as demographic variables, lifestyle characteristics 
and individual health characteristics such as sleep depravation and illness. The general 
conclusion forwarded by Macdonald, is that although some research studies indicate 
that ‘a relationship exists between drug users and on the job injuries’, ‘since few 
studies have explored the role of drugs in work injuries, definitive conclusions cannot 
be drawn’ (also see Macdonald and Wells 1994: 130).  
 
Drawing upon findings from research conducted during the early 1990s with 882 
Ontario, Canada, employees responding to a household survey, Macdonald questions 
illicit drug use as a major causal agent in job injuries. (Macdonald 1997: 254). He 
reports that any ‘relationship only holds up for males and youngest age groups’ (1995: 
717), along with alcohol and some licit drug use. Rather, for MacDonald (1995: 718), 
‘many job injuries stem directly from the workplace itself. Dangerous working 
conditions, noise and dirt on the job, and conflicts at work appear to be the greatest 
predictors of job injuries. Sleeping problems, which may be exacerbated by shift 
work, also seems likely to be another direct cause of job injuries. Also, evidence 
exists for a causal role of alcohol problems and licit drug use in job injuries. Accident 
prevention programs might be more effective by focusing efforts on reducing the 
influence of these factors rather than illicit drug use.’ 
 
While it may seem plausible that there is the potential for occupational accident and 
injury resultant from alcohol use, especially compounded by wide-scale societal 
alcohol use, research indicates that this may be less so for occupational injury 
resulting from illicit drugs. What is interesting therefore, is that most tests are directed 
at illicit drugs rather than alcohol (BNA 1986). As Macdonald (1997) points out, 
‘while low rates of drug use do not, in themselves remove the possibility that 
substances lead to accidents, they do provide an indication of the magnitude of the 
problem. If few people use drugs, and fewer still use drugs on the job, then the 
proportion of job accidents caused by drugs is probably low’ (Macdonald 1997: 256). 
Indeed, a number of commentators have criticized the focus on illicit drugs as 
misguided as alcohol abuse is a much larger problem and accounts for a larger 
proportion of morbidity in terms of health effects and accidents (see for example 
Osterloh and Becker 1990: 507).  
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5. ALCOHOL AND DRUG USE AND EMPLOYEE 





Lowered employee productivity and performance represents a significant workplace 
cost (Elmuti 1994). Drawing upon research carried out by the U.S. Office of Applied 
Statistics, Mieczkowski and Lersch (2002) report that among full time employees, 
turnover, absenteeism, resignation and dismissal rates are significantly higher for drug 
users than non drug users. The association between lowered employee productivity 
and performance and increased employer costs with alcohol and illicit drug use has 
been promoted by many over a number of decades. In 1983, for example, Dan Quale, 
the U.S. senator, in accounting for the decline in U.S. productivity levels since 1977, 
listed nine explanatory reasons (focusing upon legal and regulatory issues), before 
adding that employee alcohol and drug use was a further and major contributory 
factor. Quale speculated that, during this period, lost productivity arising from 
employee alcohol and illicit drug use amounted to $30.1 billion a year (Zwerling 
1993: 5). 
 
Writing in the early 1990s, Millard estimated that ‘substance abuse raises the cost of 
insurance by $50 billion each year and costs more than $36 billion in lost 
productivity, medical expenses, profits and damages’ (see also Elmuti 1994: 24). 
Moreover, Millard (1991: 46) suggested that employees who misuse ‘drugs not only 
take more sick days, but are more likely to make compensation claims against 
employers’. While the true costs of alcohol and illicit drug use on productivity and 
performance is not known, a number of researchers and commentators have offered 
estimates. For example, Nadell (2001: 29) reports that the National Institute of Health 
estimate an alcohol and / or drug abusing employee costs his or her employer between 
$7,000 to $10,000 annually, stating that ‘this is not a difficult figure to believe when 
considering all of the costs connected with drug and alcohol abuse including non-
production, lateness, absenteeism, errors, accidents, insurance claims, turnover, and 
the discouraging effects of non-abusing co-workers. There is also the potential for 
theft, violence and lawsuits’ (see also Frankenfield and Kleiner 2000). Jardine-
Tweedie and Wright (1998: 535) have recently estimated that drug abuse alone costs 
U.S. industry and the public over $100 billion per year in annual loses, while more 
general estimates suggested the cost to the U.S. economy of employee substance 
misuse ranges from $60 billion to $140 billion annually (Elmuti 1994: 24), and 
between $6 billion and $200 billion annually for the U.S. and Canada combined 
(Seijts et al 2002). Such estimations have been disputed by the American Civil 
Liberties Union (1999), stating that they have little or no basis in fact. The conflicting 
political interests of these commentators undoubtedly account for their opposed 
conclusions regarding the costs of drug and alcohol use. 
 
Estimation of such costs are not confined to the U.S., although, much less research 
has been conducted on estimating the cost of employee alcohol and illicit drug use for 
business and industry in Europe (Loup 1993). It is reported that in 1992 substance 
abuse cost the Canadian economy more than $18.4 billion, a figure which represented 
2.7% of GDP or $649 per capita (Jardine-Tweedie and Wright 1998). Jardine-
Tweedie and Wright (1998) go on to say that the authors of the reports from which 
A literature review on the state of knowledge of drug testing at work 
 45
this data was extracted provide a very conservative approach to estimating the costs of 
substance abuse. They argue that total costs will be significantly higher, as many 
indirect costs cannot be quantified, such as diverted management and supervision 
time, friction amongst staff, damage to an employees public image and so on. In the 
UK, it has been suggested that alcohol related absence alone costs business £2 billion 
a year, while employee drink and drug use costs industry and commerce £3 billion 
annually (Makbool 1998). In a recent survey conducted by the London Chamber of 
Commerce, 22% of London businesses reported absenteeism as a consequence of 
drug misuse amongst employees. 
 
Several workplace risk factors are associated with employee alcohol and illicit drug 
use. For our purposes here, these workplace risk factors are categorised fourfold. 
First, absenteeism. Second, labour turnover. Third, impaired employee performance, 
and finally other workplace outcomes. Such employer risks are usually discussed 
either in terms of the economic cost analysis framework or the human capital cost of 
illness (DiNardo 1994). 
 
The academic and scholarly research literature reviewed in this section provides some 
evidence that alcohol use, and particularly alcohol abuse, is associated with decreased 
productivity and performance. With regard to illicit drugs, the evidence appears to be 
less conclusive, although some studies provide cursory evidence of an association. A 
number of writers indicate an association between illicit drug and alcohol use and 
other workplace factors. A number of commentators also point out that not all patterns 
of workplace drug misuse need be viewed in the generic category of costs. In the 
previous section we outline various problems associated with research undertaken on 
alcohol and illicit drug use and occupational accident and injury. Similar criticisms 
can be directed at many of the studies reported here. Certainly, questions relating to 
the ability of these studies to assess the nature and strength of causality remain. 
Furthermore, other problems arise, for example, many research studies focus upon 
one workplace location, making generalisability difficult. This is a problematic 
feature given that alcohol and drug use prevalence may vary by industry and 
geographical location (Kravitz and Brock 1997; Macdonald and Wells 1994). Other 
comments relate to the differences in methodology, between comparisons of positive 
and negative tests and the use of survey data. Additionally, it can be suggested that 
with regard to the substance misusing employee, the amount and type of drug 
consumed, the frequency and method of usage and the degree of addiction remain 
critical influences and are under researched.  
 
The remainder of this section provides a review and summary of the research 
literature examining: (a) the relationship between alcohol and illicit drug use and 
absenteeism; (b) the relationship between alcohol and illicit drug use and turnover; (c) 
the relationship between alcohol and illicit drug use and impaired employee 
performance and (c) other workforce outcomes resultant from employee alcohol and 
illicit drug use. We conclude the section by reviewing a number of research studies 
that provide alternative ways of assessing the relationship between alcohol and illict 
drug use and productivity and performance. In several instances we review research 
already discussed in the previous section. This is unavoidable as a number of research 
studies focus upon occupational accident and injury as well as productivity and 
performance. 
 




According to Martin et al (1994) who carried out an international literature review 
including research from the U.S., France, Sweden, Australia and the UK, there does 
appear to be an association between higher rates of absenteeism amongst employees 
who drink. In particular, for Martin et al (1994: 5), occupational ‘absenteeism seems 
to be a marked characteristic of employed problem drinkers’. First, they suggest that 
rates of between two and eight times that of non-problem drinking are reported within 
the research literature. Second, they suggest that this association generalizes cross-
nationally.  
 
Albeit dated, research carried out by Maxwell (1960) on 406 recovered alcoholics 
indicted that 53% of the sample reported high levels of absenteeism during their 
problem-drinking period. More generally, these individuals reported higher than 
average rates of on-the-job absenteeism. This included temporary absences from work 
(44%), leaving work early (39%), taking longer lunch breaks (40%) and arriving late 
to work (33%). Trice (1962), utilising a similar methodology with one group of 84 
Alcoholics Anonymous members and one group comprising 552 Alcoholics 
Anonymous members presents similar findings. In particular, Trice (1962) reports that 
over 70% of respondents reported that their rates of occupational absenteeism 
increased as their drinking became more problematic, with respondents in the second 
group reporting much greater than average rates of absenteeism. When compared with 
a control group, research carried out by Pell and D’Alonzo (1970) further indicates 
that alcoholics and problem drinkers are likely to have much greater levels of reported 
absenteeism rates.  
 
Over recent years there has developed a literature on absenteeism rates and the use of 
drugs other than alcohol. Normand and Salyards’ (1989) study of 4220 applicants to 
the U.S. Postal Service (354 tested positive and 3866 tested negative for illicit drugs) 
found that involuntary separation and job absenteeism rates were higher for those that 
tested positive for illicit drug use than for those who tested negative. Those testing 
positive for cocaine were more likely to be absent from work than those testing 
positive for marijuana. Normand et al (1990) found that the use of marijuana, 
barbiturates, and cocaine among 4396 job applicants to the U.S. postal service (395 
tested positive and 4001 tested negative; positive and negative applicants were 
employed for the purpose of data collection) were associated with greater staff 
absence and involuntary termination of employment. Employees identified as drug 
users had a 60% higher absenteeism rate and a 47% higher rate of involuntary 
termination than applicants not identified as drug users. Sheridan and Winkler (1989) 
in a study of employees in the Georgia Power Organisation found similar rates of 
absenteeism amongst those testing positive and negative, although they found 
variations within some occupational categories. Sullivan et al (1990) in a national 
sample of 300 registered nurses recovering from alcohol and / or drug abuse, found 
that failure to attend work was the most frequently mentioned ‘on the job’ effect of 
individual drug dependence. 
 
Crouch et al (1989) report that their research of employees at the Utah Power and 
Light Company found that drug positive rather than drug negative employees were 
more likely to have higher absence and sickness rates. Martin et al (1994: 5) report 
that Bross et al (1992), in their five year study of chemically dependent workers at a 
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manufacturing site, detail similar results identifying that chemically dependent 
‘workers average 5.71 periods of multi-day absence (totalling 181 days) compared to 
0.86 periods of multi-day absence (totalling 25 days) among workers in a non-
chemically dependent control group’, while Zwerling and Ryan (1992: 596) in their 
review suggest ‘a weak association between a positive employment drug screen and 
the adverse employment outcomes of absenteeism, injuries, accidents and turnover’ 
before going on to suggest that ‘the evidence is strongest for absenteeism’. Indeed, 
Zwerling et al (1990) report that a year after being hired, those testing positive for 
marijuana and those testing positive for cocaine had higher rates of absenteeism (7% 
and 19% respectively) than those originally testing negative for drug use (4%). For 
Hoffman and Larison (1998), in their analysis of data from the U.S. National 
Household Survey on Drug Abuse, drug use appears to be associated with a greater 
number of absences and a higher risk of being dismissed or voluntarily leaving a job.  
 
It has been suggested by some commentators that one of the most hypothesized 
employer costs associated with alcohol and drug use is that of poor employee 
performance. At best it can be suggested that there is conflicting evidence as to the 
relationship between and the effects of alcohol and illicit drug use amongst employees 
on productivity and performance (see Beswick 2002; Martin et al 1994). Evidence 
drawn from research carried out by Maxwell (1960), Trice (1962) and Trice and 
Roman (1978) offer support for claims of an association between declining 
productivity and alcohol use, especially alcohol abuse. Maxwell (1960) reports that in 
his research problem drinking indicated lowered work performance. Lowered work 
performance is defined as a tendency to postpone undertaking tasks and 
responsibilities, to under perform in terms of the quantity and quality of work carried 
out, and to commit errors and mistakes more frequently. Trice (1962) reports similar 
findings in his research, with virtually all of his respondents displaying lowered 
performance at work resultant from alcohol use. For Martin et al (1994), one of the 
most comprehensive attempts to assess the effects of alcohol and illicit drug use and 
productivity and performance can be found in the work of Blum et al (1992). In this 
study of 136 problem drinking and non problem drinking employees, assessed on four 
categories of performance at work (conflict avoidance, technical performance, ability 
to exercise self direction at work, functioning in interpersonal relationships all cited in 
Martin et al 1994: 8), Blum et al (1992) report, that ‘collateral assessments of the 
focal respondent’s job performance in each of the four domains were significantly 
lower for those workers who were in the upper quartile (i.e. 52 or more drinks per 
month) on monthly alcohol consumption’.  
 
With regards illicit drug use and productivity and performance, Walsh et al (1991), 
Burt (1981), White et al (1988) and Sullivan et al (1990) all provide cursory evidence 
of lowered productivity and performance resultant from illicit drug misuse. Walsh et 
al (1991) in a study of 224 alcohol and drug users participating in an EAP at an 
industrial plant report that cocaine use was found to be associated with supervisory 
warnings. Burt (1981) detail that 10% of employees who admitted drug use in the 
previous twelve months reported problems in their performance and productivity, 
while Sullivan et al (1990) report similar findings. Schwenk and Rhodes (1999) 
review research carried out and published by Kagel et al (1980) and Kaestner (1994) 
and indicate that there is no evidence to suggest that marijuana has a tendency to 
make people less productive; ‘the relationship between marijuana use and job 
performance, if any, is the result of a third variable cause’ (Schwenk and Rhodes 
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1999). Other studies unable to provide any correlation include Haas and Hendlin 
(1987). McDaniel (1988), drawing upon self report data on the drug usage of 
applicants for military service, report that individuals indicating abstinence from drug 
use prior to enlisting were less likely to be discharged for unsatisfactory performance 
within four and a half years of their application. McDaniel (1988) also acknowledges 
first time drug use and frequency of drug use as related to military discharge for 
performance reasons. However, Comer (1994) argues that drug use contributes only a 
small amount after controlling for the effects of personal and job factors. 
 
With regard to employee turnover, Martin et al (1994: 8) suggest that ‘as in the case 
of job performance, evidence for a relationship of substance abuse to labour turnover 
is unclear’, although, as Martin et al (1994: 9) go out to state, ‘the relationship 
between turnover rates and the use of drugs other than alcohol appears to be better 
established in the literature’. This is a finding shared by a number of research studies 
conducted in the U.S. and Canada by Sullivan et al (1990), White et al (1988), Kandel 
and Davies (1990), Sheridan and Wrinkler (1989) and Kandel and Yamaguchi (1987), 
with a number reporting particular evidence for the younger age groups, young males. 
In research carried out by Zwerling et al (1990), it is reported that employees who use 
illicit drugs have higher turnover rates. In particular, Zwerling et al (1993) identified 
that employees testing positive for marijuana and cocaine had higher rates of 
involuntary turnover (14% and 7% respectively). Those testing negative had an 
involuntary turnover rate of 6%. Macdonald and Wells (1994: 131), report that 
Sheridan and Winkler (1989) found similar rates of absenteeism among drug positive 
and negative employees. Schwenk and Rhodes (1999) review four studies and 
conclude that employees who test positive on pre-employment drug screens are more 
likely to experience high rates of turnover than those who test negative. The study by 
Normand et al (1990), also found higher rates of involuntary turnover. With regards 
the relationship between alcohol use and employee turnover, a number of studies 
indicate that problem drinkers continue to be employed as their dependency increases 
or stabilises (see Trice 1962, Trice and Roman, 1978, Straus and Bacon, 1951 and 
Strayer, 1957). Kandel and Yamaguchi (1987) carried out a longitudinal study of 
young adults turnover, with the exception of marijuana, they report drug use was 
predictive of job loss, even when other job loss predictors were controlled for, 
including income, job type and education. 
 
A final area of research has uncovered the association between substance misuse and 
what can be termed ‘other workplace outcomes’ including employee problem 
behaviour. Often, these ‘other workplace outcomes’ have arisen from the findings of 
research studies examining measures of lowered productivity and performance 
discussed above (see for example Lehman and Simpson 1992; McDaniel 1988; 
Normand et al 1990; Zwerling et al 1990; Bross et al 1992). Zwerling et al (1990) 
suggest alcohol abuse and use may be the primary association. For Kravitz and Brock 
(1997: 66), other studies merely show correlation ‘and thus the observed associations 
do not imply causation’. Indeed, they go on to state that ‘whether the association 
between drug use and employment problems is strong enough to ensure a positive 
utility of drug testing is another’ (1997: 66). Lehman and Simpson (1992) carried out 
a study of municipal workers using subjective outcome measures and found that 
employees who reported substance misuse away from / at work within the previous 
year were more likely to report psychological and physical withdrawal from work and 
to have experienced ‘antagonistic work behaviours’, such as ‘putting little effort in’, 
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‘day dreaming’, ‘leaving work early’, ‘arguing with co-workers’ and ‘disobeying 
orders’. Bross, Pace and Cronin (1992) undertook a case control study of 
manufacturing plant workers, that found that chemically dependant workers had 
significantly more hypertension and mental disorders than the control group. 
 
Research has also identified that not all patterns of workplace alcohol and illicit drug 
misuse need be viewed in the generic category of costs (Gill and Michaels 1992; 
Register and Williams 1992; Martin et al 1994: 24; Kravitz and Brock 1997; 
MacDonald and Pudney 2000). While job performance decrements are definite costs 
to the workplace, Martin et al (1994) argue this does not necessarily hold for 
absenteeism. Instead, absenteeism may reduce costs in comparison to those incurred 
had the employee remained within work. 
 
Gill and Michaels (1992) report findings from their research that drug users earned 
higher wages that non drug users, while Register and Williams (1992) report that, 
apart from long term use and on the job use, employee use of marijuana had a positive 
effect on wages. Moreover, it is important to note that the introduction of workforce 
drug testing, far from addressing lowered employee productivity, may well further 
negatively effect the performance and productivity of employees. It may adversely 
affect employee attitudes towards the company or organisation, and / or it may also 
stimulate union activity. As Kravitz and Brock (1997: 67) point out, ‘negative 
reactions to drug testing could decrease organisational productivity and profits’. It is 
also interesting to note that in the study of U.S. Postal Service applicants conducted 
by Normand et al (1990), 85% of the original applicants who tested positive for drug 
use remained in employment after one year, thus indicating that despite their 
prediliction to using drugs, they were able to carry out the tasks they were employed 
to do. 
 
For MacDonald and Pudney (2000: 1090), the traditional model that illicit drug use in 
particular has reduced labour market experiences, resulting in lowered aggregate 
levels of human capital accumulation, reduced overall productivity and living 
standards manifesting itself in lowered wages has been questioned by recent research, 
including their own more recent research. Most of the literature is again, according to 
Macdonald and Pudney (2000) U.S. based. Taking their focus as the effect of illicit 
drug use on labour market outcomes, and drawing upon analysis of UK data, 
MacDonald and Pudney (2000) suggest that the association between drug use and 
productivity is likely to be very complex and vary according to the age and gender of 
the individual. Moreover, they find very little evidence to support any relationship 
between illicit drug use and occupational attainment. Rather, they conclude by stating 
that ‘We find compelling evidence to suggest that drug use, especially cocaine, 
opiates and crack cocaine is associated with increased risk of unemployment’ 
(Macdonald and Pudney 2000: 1096). 
 
From this discussion, a number of points can be identified. There does seem to be 
some evidence that alcohol use, and particularly alcohol abuse, is associated with 
decreased productivity and performance. With regard to illicit drugs, the evidence 
appears to be less conclusive, although some research studies do provide cursory 
evidence of an association. There is also evidence to suggest that other workplace 
related outcomes are associated with substance misuse, particularly alcohol use and 
abuse. However, the research also highlights the need for caution when assessing the 
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strength of the relationship between alcohol and illicit drug use and productivity and 
performance. A number of research studies, as Cromer (1994) points out, alert the 
reader to the potential for non drug predictors, including social and individual factors 
to effect workforce performance and productivity. As Cromer (1994: 260) states, 
‘Despite conventional wisdom, drug testing has not been definitively linked to 
organisational gains in safety or productivity’. 
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The effectiveness of workforce drug testing programmes is, according to Macdonald 
and Wells (1994: 127-128) measured by the extent to which objectives are achieved. 
Francis and Wynarczyk (1998) point out that drug testing can be implemented in a 
number of ways, and therefore effectiveness partly depends upon the type of 
programme, its implementation, its aims and objectives and the particular risk 
involved. In some countries, particularly the U.S., and for some employees working in 
specific industries or businesses, workforce drug testing is adopted because there is a 
legislative mandate to do so (Mendelsohn and Libbin 1988; Oswald and Harrison 
1992). For example, certain Federal transportation employees in the U.S. are required 
to undergo mandatory drug testing. 
 
Beyond ensuring that legislative requirements are met, the two major objectives of 
drug testing are to reduce occupational accident and injury and to reduce workforce 
productivity and performance problems (e.g. absenteeism and turnover). These two 
objectives are based largely on the assumption that alcohol and drug use are related to 
occupational accident and injury and workforce productivity and performance 
problems. We have discussed the research relating to these assumptions in the 
previous two sections and highlighted the inconclusive nature of much of the research 
findings published over the course of the last four decades. In addition, empirical 
studies have been carried out into the effectiveness of workforce drug testing. Some 
studies have indicated that the frequency of industrial accidents and performance 
problems have reduced considerably following the implementation of workforce drug 
testing, although others have been unable to report such findings. We discuss these in 
this section. 
 
The effectiveness of testing is also promoted on the grounds that it is able to reduce 
general drug use across society. It is argued that workforce drug testing can achieve 
societal reductions in drug use through specific and general deterrence (Macdonald 
and Wells 1994). ‘Specific deterrence refers to the identification of individual drug 
users and intervention by punishment … General deterrence refers to the process 
where users who have not been caught are deterred by the threat of being caught 
(emphasis in the original)’ (Macdonald and Wells 1994: 128).  
 
The evidence is inconclusive and is therefore unable to determine whether drug 
testing programmes actually reduce occupational accident, injury and performance 
problems. This point is cogently made by Macdonald and Wells (1994: 139), ‘too few 
empirical studies on the effectiveness of drug screening programs exist at this time to 
prove that programs are effective in reducing drug use among employees, accidents 
and performance problems in the workplace, or drug problems in society as a whole’. 
We also acknowledge the findings of Francis and Wynarczyk (1998: 187) in their 
review of the literature, ‘measuring the effectiveness of workplace drug employee 
testing programmes is … problematic’. 
 
The remainder of this section provides a review and summary of the research 
literature examining: (a) those research studies which focus directly on the 
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effectiveness of workforce drug testing to reduce workforce and / or workplace 
problems; (b) research studies which have attempted to map out the extent and nature 
of workforce reductions in drug use as a result of drug testing programmes and (c) the 
research on the deterrent effect of workforce drug testing in reducing general societal 
alcohol and drug use. In several instances we review research already discussed in the 
previous section. This is a consequence of a number of research studies focusing upon 




The effectiveness of workforce drug testing is premised upon a positive relationship 
between employee alcohol and illicit drug use and occupational accident and injury, 
and productivity and performance problems. However, as the previous two sections 
have highlighted, the research is inconclusive as to the nature and strength of this 
relationship. The effectiveness of workforce drug testing programmes is determined  
by the extent to which their objectives are achieved. Workforce drug testing is seen as 
a tool capable of identifying those employees that are not performing appropriately 
with regard to effort, efficiency and safe working practices. Testing is therefore based 
upon the identification of either those individuals who choose deliberately, and 
knowingly, to contravene company policies on substance abuse, or those in denial of a 
dependency problem, whose behaviour is determined by addiction. By identifying, 
and responding to these individuals, testing programmes are seen to provide a 
significant contribution to the creation and maintenance of a productive, safe and 
healthy workforce (IDS 2002; Blum et al. 1994; Pinsonneult 1994). Advocates of 
testing indicate that workforce drug testing can reduce absenteeism, turnover, 
accident, cost, injury, mistakes, theft, productivity and performance problems (Comer 
1994). Mieczkowski and Lersch (2002) argue that with regards police officers, drug 
testing also can have an impact on identifying, controlling and suppressing police 
corruption related to drug crime. 
 
Gerber and Yacoubian (2001) suggest that few studies have examined the relationship 
between drug testing and accident and illness rates. One study that has attempted to do 
this was conducted by Feinauer and Havlovic (1993), who looked at the nature and 
strength of this relationship across businesses in Wisconsin during 1984/1985. In 
doing so, their aim was to assess the effectiveness of drug testing as a strategy to 
reduce occupational injury. The methodology included survey analysis of forty eight 
businesses asked to provide archival drug testing data (pre-employment, post accident 
and reasonable cause) and longitudinal accident and illness data. The findings of the 
research proved inconclusive in relation to the reduction of work injuries in those 
businesses that operated drug testing programmes, although they did offer some 
support for a relationship between post accident testing and a decrease in injury, 
particularly when compared to pre employment screening. Twelve facilities with drug 
testing programmes in place did not experience significant reductions in occupational 
accidents and injuries compared to the thirty six facilities that did not have drug 
testing programmes in place. However, of the twelve businesses that did drug test, 
Feinauer and Havlovic (1993) state that ‘post accident drug testing was significantly 
related to a decrease in accident and illness rates compared to the pre-testing period 
and to facilities using only pre-employment testing’. They conclude that ‘the efficacy 
of pre-employment testing as a strategy for reducing occupational injuries is called 
into serious question by the findings of this study’ (Feinauer and Havlovic 1993: 5), 
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although they do offer some encouragement for the implementation of post-accident 
testing to reduce occupational injuries. Criticisms directed at this study include a lack 
of generalisability, a small sample size, and a limited database. 
 
Research carried out by Parish (1989) focused upon the use of workforce pre-
employment drug screening, and found that of all new employees, 12% tested positive 
for drugs. Parish also found that ‘there were no differences between drug-positive and 
drug-negative employees when job performance variables were compared – 
evaluations and job retentions – at the end of the year. Eleven drug-negative 
employees were fired and no drug-positive employees were fired during the period of 
this study’ (Osterloh and Becker 1990: 508). Parish did not, however, look at alcohol 
use. Crouch et al (1989), suggest, in their research into absenteeism, accidents and 
costs of drug testing policy, that ‘decreasing trends in vehicle and medical accidents 
demonstrate its [drug testing] effectiveness providing a safer working environment’. 
However, this study failed to explore non-drug variables and offered a small sample 
size.) Osterloh and Becker (1990) report a 40% reduction in absenteeism, a 50% 
decrease in disciplinary actions and 50% fewer accident claims by employees of 
General Motors following the introduction of drug testing. 
 
Taggart (1989) reviewed the implementation of a drug testing policy for Southern 
Pacific Railroad. Between 1987 and 1988. He found that overall, 8.4% of all workers 
hired had a positive drug test; 13.3% of workers who had positive drug tests were 
fired within six months compared with 9.5% of workers with negative drug tests. 
There was a decline in personal injury rates (2,234 to 322) and the number of train 
accidents attributed to human failure (from 911 to 54) in the five-year period 
following the introduction of random workforce drug testing policies. He concludes 
that ‘drug testing does make the workplace safer and increases overall public safety 
by substantially reducing accidents and injuries’ (from 10% to 5%), and that testing 
acts as a powerful deterrent to drug use on the job. However, Macdonald and Wells 
(1994) note that the problem with this study, and with a number of similar studies, is 
that they do not always take account of other non-programme workplace 
developments. For example, regarding the study by Taggart in the Southern Pacific 
Railroad Company, Macdonald and Wells (1994: 138) point out that ‘massive 
engineering improvements in the tracking system, the implementation of crew risk 
reduction programs, the expansion of training programmes and other safety 
improvements, … occurred simultaneously with the use of the drug screening 
program (Jones, 1990). These measures may have accounted for the majority, if not 
all, of the reported reductions in accidents, injuries, and productivity problems’. Other 
criticisms that can be directed at Taggart’s study include an absence of rigorous 
controls and absence of data regarding on-the-job use (Beswick 2002). 
 
In spite of the industry specific nature of much research, Gerber and Yacoubian 
(2001) suggest that the construction industry has remained outside of the gaze of the 
research telescope, especially regarding the relationship between illicit drug use and 
occupational accident and injury. As a consequence of this perceived ‘neglect’, 
Gerber and Yacoubian (2001) attempt to assess the perception of substance misuse 
problems, explore factors associated with the implementation of drug testing, and 
examine the impact testing has on performance indicators, on incident rates and on 
employees compensation experiences within the construction industry. In doing so 
they combine an attitudinal survey of company officials (17% response rate from 405 
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questionnaires distributed (69 construction companies 49 of which had implemented 
workforce drug testing programmes)), with longitudinal / cross sectional analyses and 
analysis of incident data. With regards the impact of drug testing on injury incident 
rates, Gerber and Yacoubian (2001) report that those companies that test have 
experienced a general reduction in injury incident rates, from 14.6% per 200,000 work 
hours in 1988 to 8.8% per 200,000 work hours in 1998. ‘The average company that 
drug tests in the study sample reduced its injury incident rate 51% within two years of 
implementation’ (Gerber and Yacoubian 2001), from a rate of 8.9 injuries per 200,000 
work hours to 4.4 injuries per 200,000 work hours. With regard to the impact of drug 
testing on performance indicators, Gerber and Yacoubian (2001) report that the top 
three organisational indicators, as reported by company officials, were an 
improvement in the overall safety the work environment, as well as in the quality of 
job applicants, alongside a reported reduction in workers compensation claims. With 
regards the latter, they state that ‘the impact of drug testing in reducing MODs persists 
over time and is most effective in the first three years immediately following the 
implementation of a program’ (Gerber and Yacoubian 2001: 443). 
 
Elmuti (1994) conducted research in one manufacturing plant of a large, diversified, 
decentralised multidivisional corporation with a total of approximately 958 
employees, located in the mid-western U.S.. The aim was to assess perceptual data on 
employee attitudes together with actual data on attendance and productivity rates. 
Questionnaire and archival data sources were used. The population sample included 
all full time employees from production workers, machine operators, supervisors and 
managers from all levels. Out of a total workforce of 958, 296 questionnaires were 
returned, generating a 31% response rate (Ten questionnaires were soiled, dropping 
the response rate to 30%). Analysis of organisational data drew upon a period 
spanning eighteen months prior to the adoption of a drug testing programme to twenty 
four months after the programme began. Elmuti (1994: 30) reports that following its 
implementation, for each measure assessed (percentage of time spent on production, 
efficiency rate, overall productivity rate, absenteeism, drug related injury) ‘a great 
deal of improvement was shown’, and ‘The results indicate there were significant 
differences (p<0.01) between the two periods in percentage of hours spent on 
production (T=-3.78), absenteeism (T=-4.60) and drug related injuries (T=-3.85)’ 
(Elmuti 1994: 30). Additional benefits of the implementation of workforce drug 
testing as reported by Elmuti (1994) include financial savings resulting from 
reductions in waste, sick leave, drug related injury and worker compensation 
payments. Other advantages include reduced property damage and improved 
performance.   
 
A related argument forwarded by supporters of workforce drug testing policies is that 
the workplace can act as a forum for more general employee drug and alcohol 
reduction and education. This is premised on the belief that the implementation of 
workforce drug testing can have a deterrent effect. A number of research studies 
provide evidence of a reduction in employee alcohol and drug usage resultant from 
the introduction of workforce drug testing. For example, in the study by Taggart 
(1989) reported above, the percentage of positive tests amongst employee dropped 
from 22% to approximately 6% over the five year period.  
  
Zwerling et al (1990), in their analysis of pre-employment testing of 2537 postal 
employees in predicting employment outcome suggest that ‘many of the claims cited 
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to justify pre-employment drug screening have been exaggerated’. This was a view 
reinforced by Zwerling (1993) three years later; ‘there are few data showing the 
effects of workplace drug screening on drug prevalence in the workforce’. They do 
identify that drug positive employees were more likely to be younger and black males. 
Criticisms which can be directed towards this study include the lack of control group, 
possible misclassification of drug screening, short term follow up review and that it 
did not differentiate between drug use on the job and pre-screening positive results. 
Ryan et al (1992) suggest in a follow up study to Zwerling et al that they ‘remain 
concerned about the validity of projections of the benefits to industry of pre-
employment drug screening beyond the first year of employment’ (cited in Beswick 
2002). Criticisms that can be directed at this study relate to the failure to explore 
social and behavioural characteristics, and the failure in providing information on the 
impairment hypothesis. 
 
Zwerling (1993: 10-12) does report evidence of a reduction in drug use amongst the 
U.S. military resultant from the implementation of a drug testing programme. Using 
data from the Department of Defence undertaken by the Research Triangle Institute 
which focused upon all U.S. active military personnel across the world, with the 
exception of recruits, service academy students and persons absent without leave, 
Zwerling (1993) indicates a fivefold decrease in reported drug use. In 1980 the 
percentage numbers of service men that reported having used drugs in the last thirty 
days was 27.6%; in 1982 this figure had reduced to 19.0%; in 1985 the figure had 
reduced to 8.9%; with Zwerling reporting a further reduction to 4.8% in 1990. For 
Osterloh and Becker (1990: 508) the ‘drug testing program of the military (U.S.) has 
been exemplary. The overall positivity rate has fallen from 48% in 1980 to 3% in 
1987’, although as they go on to point out, ‘While these numbers reflect actual test 
positivity rates, the numbers from 1980 must be viewed with some scepticism because 
of the different testing techniques and criteria used in 1980 versus 1983 and 
thereafter’. 
 
Borack (1998) details that the U.S. Navy’s zero tolerance policy on drugs has been in 
effect since 1981, with the Navy utilising an ‘aggressive’ urinalysis programme. The 
objectives have been to deter and detect. For Borack (1998: 18), the ‘deterrence effect 
of testing is the percentage decrease in users relative to those who would use drugs if 
no testing were conducted’. Borack (1998) reports that the number of Navy personnel 
reporting that they had used illicit drugs in the last thirty days reduced from 33% in 
1980 to 4% in 1992. Borack (1998: 24) suggest that drug use in the Navy is estimated 
to be 60.2% lower than the rate of comparable civilian drug use. ‘Drug testing appears 
to be an effective technique for reducing drug use in the Navy. The estimates … 
indicate that approximately 56.5% of drug use is deterred by testing at present rates’. 
 
Willette (1989) identifies that following the introduction of pre-employment drug 
screening, the U.S. Navy reported a reduction in positive tests, from 48% to less than 
5%. Needleman and Romberg (1989), in research carried out on Navy recruits, Navy 
Service School members, Marine Corps Recruits and Marine Corps Service School 
personnel for the years 1983 and 1988 report a significant reduction in the marijuana 
rate for the four groups, the positive cocaine rate increased among all four groups, 
while the positive test rate for amphetamines and opiates remained relatively constant. 
Osbourne et al (1990 cited in Macdonald and Wells 1994; Martin et al 1994) 
conducted research into the effect of the implementation of a drug testing programme 
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in a nuclear power facility. Following the implementation of the programme over one 
year, they reported a reduction from 3% to 1% in the number of employees testing 
positive. Macdonald and Wells (1994) offer a sober response to a number of these 
studies. First, they highlight one crucial issue, the reduction in positive test results 
may be a result of drug users seeking employment in professions where screening is 
not conducted. Secondly, they draw attention to the fact that drug users may be able to 
cheat the testing process. Third, ‘it may be that drug testing programs are 
implemented when unions are at their weakest; if so employees may resist using drugs 
in fear of being laid off or fired’. 
 
In addition to its perceived deterrent effect, workforce drug testing is promoted as a 
means of detecting employee drug use. In part, the effectiveness of the detection 
function of drug testing depends on the nature of the programme implemented and the 
type of drug. There is no reason to believe that the presence of pre-employment 
testing will have an impact on employees’ decisions to use substances once they are 
employed. For cause testing, which occurs after employees have been involved in an 
accident, may be useful for detecting drug users; but as employees do not anticipate 
being in an accident, for cause testing programmes are unlikely to have a deterrent 
effect. Random, unannounced drug testing has more potential to effect employee’s 
behavior. Dupont et al (1995) identify that random tests are effective in identifying 
near daily users, but less effective in identifying infrequent users. The purpose of 
random testing is to intervene with heavy users of illicit drugs to discourage casual 
drug use in the workforce. ‘Based on the nature of illicit drug use and the 
characteristics of random urine drug tests results, this study shows that random drug 
testing can be expected to accomplish both goals reasonably well’ (1995: 16). 
However, because most employers administer random tests infrequently, the actual 
risk of detection may be too low to be a deterrent. There is also evidence, that some 
employees may thwart detectors by altering their own urine or even substituting drug 
free urine samples. Indeed, there is a growing cottage industry of ‘beat the test’ kits 
and related paraphernalia. Mieczkowski and Lersch (2002: 589), suggest that the 
potential for urine to underestimate employee use of particular drugs such as cocaine, 
necessitates the use of ‘multiple drug-testing modalities in order to maximize the 
identification of different drugs’. 
 
A more general argument forwarded by those supportive of workforce drug testing is 
that it can deter general societal drug using behaviours. Indeed, during the early 1980s 
the Organized Crime Commission in the U.S. promoted testing as a key element in a 
wider effort to combat the ‘war on drugs’, and it is a view that has been advocated 
ever since. Drug use, especially in the U.S. has declined over the last decade in the 
population as a whole – continuing a trend that began in the early 1980s. In 1979, 
approximately 14% of American adults reported having used an illicit drug in the 
month prior to the survey; a figure, which dropped to approximately 11% in 1985 and 
6% in 1996. Three points of interest arise here. First, during the same period, the 
percentage of employee testing positive for drugs steadily declined. Second, this 
decline in drug use began prior to the introduction of workforce drug testing, and 
therefore it could be suggested that the declining percentage of positive tests merely 
reflects the decrease in overall drug use – ‘a decrease that occurred among both 
employed and unemployed person’ (American Civil Liberties Union 1999: 15). As the 
American Civil Liberties Union (1999: 15) go on to state, ‘Since 1992, despite slight 
increases in rates of illicit drug use, the percentage of positive drug tests has continued 
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to fall’. A third point identified by the American Civil Liberties Union is that such 
figures relating to a decline in test positives is a result of a) the increase in the 
numbers of employees tested, b) growth in the nature and type of testing mechanisms, 
from for-cause testing (which usually identifies more positives test) to random and 
pre-employment testing (which are more likely to produce lower positive rates) and c) 
the nature and type of industry involved in testing has expanded (from heavy industry 
/ transportation) to industries likely to employ more women and middle aged workers 
(who have low rates of illicit drug use). The American Civil Liberties Union (1999: 
16) conclude by stating that ‘More generally, it can be suggested that much of the 
research conducted on the effectiveness of drug testing suffers from methodological 
and conceptual flaws. For example, limitations often include small sample sizes, a 
general lack of data availability and questionable quality of data, an absence of 
rigorous controls and no differentiation between drug use on the job and pre-screening 
positives’.  
 
The effectiveness of testing has also been promoted in terms of cost savings resultant 
from its implementation. NIDA estimates that the average cost of testing within the 
U.S., when accounting for the entire testing process from sample collection, storage, 
initial screening, confirmatory screening and evaluation by medical personnel, is 
around $40 to $60 per employee. Non-governmental sources indicate that this figure 
is higher at $60 to $85 per employee. In 1999, the United States House of 
Representatives Sub Committee on the Civil Service reported that 28,873 federal 
employees were tested at a total cost of $11.7 million and only 0.53% tested positive, 
resulting in an average cost of $77,000 to identify each employee who used drugs. 
These telling statistics provide powerful arguments in relation to the cost/benefit of 
testing for substance abuse in the workplace. Research has indicated that drug testing 
policies are not economically viable unless 10% of the workforce test positive for 
drugs, a situation less likely in an organisation with few employees. A prevalence of 
less than 1% positive tests would result in the testing policy losing money. If the 
incidence of positive tests is between 1 and 10% then the cost effectiveness of the 
policy will depend upon other cost assumptions (Zwerling and Ryan 1992) In 
addition, Crow and Hartman (1992) argue that the ‘problem’ of workplace drug taking 
has been exaggerated, with the cost effectiveness of screening programmes requiring 
re-evaluation. Concern is expressed about the over-willingness for organisations to 
spend large amounts of money combating perceived drug and alcohol abuse, without 
any prior assessment of the extent of the problem in their workplace. They argue that 
this has resulted in a moral panic facilitated by the media and political actors. They 
also point to the notion of ‘contagious diffusion’, a term used to describe the domino 
effect that may occur when one organisation implements a drug testing policy and 
others follow suit. For Crow and Hartman (1992) the reality is that too little is known 
about the extent and costs of drug taking and of testing, to warrant such a proliferation 
of screening policies. It has been argued that employers have a responsibility to wider 
society to use the workplace as a forum for drug deterrence and education, as the vast 
majority of people experiencing drug or alcohol problems are employed. In extending 
the arguments about the appropriateness of the workplace as a forum for drug and 
alcohol policies, Parrott (undated) argues that it will be necessary to satisfy several 
concerns prior to implementing any testing policies. These will assess whether or not 
1. Drug testing poses a significant workplace problem 
2. The proposed response will solve the problem 
3. The benefits of intervention outweigh the costs 
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4. The response to a positive test is legally and ethically acceptable 
He concludes by stating that the available research data is not sufficient to recommend 
workforce drug testing, suggesting that the data available offers little support for the 
effectiveness of such policies. 
 
However, as Ozminkowski et al (2001: 68) point out, the true cost-benefit calculus 
remains unknown. Elmuti (1994), in his study of a mid western manufacturing plant 
reported that the implementation of workforce drug testing had proved to be cost 
effective over the twenty four months of its introduction. The study by Normand et al 
(1990) estimated that in excess of $100 million would be saved on an annual basis if 
drug testing was implemented, savings would be made in leave time, termination 
procedures and overtime costs. Ozminkowski et al (2001), report on research into the 
cost effectiveness of two testing strategies (urinalysis at the work site versus off site 
testing) carried out in a large manufacturing company. They conclude that ‘overall, 
the variable costs for on-site drug testing were significantly lower when compared 
with costs for off site drug testing … total on-site drug testing costs were about 
$17.31 lower per person tested, once at least 27 employees were tested’ 
(Ozminkowski 2001: 67).  
 
It is worth noting that the effectiveness of drug testing has also been promoted on the 
basis that it increases consumer and customer confidence. However, there is little 
research evidence on the impact workforce drug use has had, or can have, on the 
broader issue of customer and consumer relations. The potential detrimental effect of 
workforce drug use upon customer relations has not been taken for granted. For 
example, a guide on the dangers of drug use at work published in Great Britain by the 
Health and Safety Executive in 1998 states that successfully tackling drug taking 
within the workplace would enhance the public perception of that organization. 
However, at the time of writing, research is needed to determine the association and 
effects, if any, that drug use has on the customer, assuming causality or association is 
simply inadequate and problematic. 
 
Beswick (2002: 37) asks ‘is there any evidence that workplace policies are effective in 
reducing the … business risks? Is there any evidence that workplace policies are 
effective in other areas relevant to employers and employees? E.g. enhancing the 
corporate image’. In response to these questions Beswick (2002: 37), argues ‘A 
cursory glance at the literature suggest not’. In summarizing the research and 
scholarly research literature on the effectiveness of drug testing we would stress 
caution when reviewing the effectiveness of drug testing programmes in the 
workplace (Francis and Wynarczyk 1998: 188). First, prevalence rates remain low. 
Second, the causal link between illicit drug use and employee or employer risk is 
unsubstantiated. Third, research into the effectiveness of workforce drug testing is 
inconclusive. With regards research into pre-employment drug screening, Macdonald 
and Wells (1994) identify a number of limitations that question the efficacy of the 
method of testing. While some pre-employment studies have suggested lowered job 
performance, they neglect to analyse individual user characteristics (type of drug, 
nature of use and degree of addiction), and such studies do not include the large 
variety of over-the-counter and prescription drugs, which may also effect job 
performance. Moreover many studies (as cited earlier) indicate that minimal 
differences exist in terms of lowered job performance between those that test positive 
and those that test negative in pre-employment programmes. Finally, Macdonald and 
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Wells (1994: 137-9) stress caution in measuring the ‘outcome effects’ of regulation as 
measured in the percentage reduction of accidents, injuries and performance problems 
resultant from some form of regulatory mechanism, such programmes fail to take 
account of the possible and actual effect of non-drug testing factors (such as increased 
employee training, superior capital equipment and better management and supervisory 
arrangements) in reducing risk. Indeed, such measures may account for the majority 
of the reduction of risk, thus problematising the effectiveness of workplace regulatory 
mechanisms themselves.  
 
Given these points, Macdonald (1995) suggests that drug testing does not appear 
justifiable especially in light of the punitive consequences of testing positive. He 
concludes by stating that ‘faced with current evidence regarding the relationship 
between drug use and injuries coupled with the numerous issues surrounding testing, 
the intrusive and punitive nature of such programs, the costs associated with 
implementing them, and the negative consequences of testing, drug testing programs 
do not appear to be an effective or desirable means of reducing injuries in the 
workplace’ (Macdonald 1995: 718). 
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The research literature suggests that that difference in perspectives between 
employers and employees toward drug testing programmes can be expressed as of 
competing interests between the employers right to a drug-free workplace and the 
employees right to privacy. While employers who test their respective workforces for 
substance use see workforce drug testing programmes as a reasonable course of 
action, research indicates that some employee groups, worker organisations (including 
trade unions) and researchers tend to see workforce drug testing programmes as 
intrusive and unnecessary. 
 
The research literature suggests employee attitudes toward workforce drug testing 
vary according to their assessment of the ‘fairness’ of the testing programmes and the 
particular testing strategy used (Mastrangelo and Popovich 2000). Within the 
literature there is evidence of a relationship between ‘unfair’ employee perceptions of 
testing and increased conflict with employers, evidenced by a reduction in morale and 
performance, and negative perceptions of the organisation (Ambrose 2000). It would 
also appear that these responses, and the application of testing programmes, are 
contingent on the wider social values and norms of individual employees, in addition 
to their past drug use history (Truxillo et a. 2000). Research also suggests that drug 
testing programmes are more likely to be accepted by employees if worker 
organisations and trade unions are involved in both the development and 
implementation of them (DeCresce et al. 1989; Knowles and Riccucci (2001) 
 
Research also suggests that beyond the workplace, workforce pre-employment 
screening may deter high quality candidates from applying for employment, with 
some employers forgoing this type of testing in times of low unemployment (Sulman 
2000; Ambrose 2000). There is also a developing body of research evidence 
suggesting that chronic substance use significantly impacts on employment status and 
occupational attainment, although non-chronic use appears to have little impact 
(Madonald and Pudney 2000b; French et al. 2001) 
 
The remainder of this section provides a review and summary of the research 
literature examining: (a) the differing attitudes of employers and employees toward 
workforce drug testing; (b) employee reactions to differing drug testing programmes; 
(c) the impact social norms and values, and individual drug histories, have on 
employee perceptions of drug testing; (d) the role worker organisations play in the 
development and implementation of testing programmes; (e) the impact of testing on 
organisational labour supply; and (f) the relationship between drug use and 




Firmly located within the study of personnel management, a number of researchers 
have identified that workforce drug testing is seen as analogous to other pre-
employment selection criteria - as a device for selecting appropriate employees (Blum 
et al. 1994; Trice and Steele 1995; Arthur and Doverspike 1997). The main 
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stakeholders involved in testing in the workplace are employers, employees, and to an 
increasing extent, the members of the judicial system, all promoting their own self-
interests and needs (Knowles and Riccucci 2001). For employers, drug testing 
represents a way to combat the use and abuse of both legal and illegal substances 
amongst employees. Employees, both individually and collectively through trades 
unions, legitimately seek to limit the intrusiveness of testing programmes and to 
ensure fairness. The judicial system is involved in setting the parameters of what is, 
and what is not, legal. 
 
A number of researchers have identified that testing for alcohol and illicit drug use in 
the workplace is a growing trend, especially in the U.S. workplace (Murphy and 
Thornton 1990; Konovsky and Cropanzano 1993; Macdonald and Wells 1994: 
Kaestner and Grossman 1995; Macdonald 1995 Brunet 2002). 
 
Providing evidence from research undertaken in 1988 and 1991 with human resource 
managers in organisations with over 250 employees, in 297 sites in Georgia in the 
U.S., Blum et al. (1994) suggest that while some employers initially elected not to 
follow the testing trend, the numbers of such employers are decreasing.  This research 
suggests that, in both research ‘time’ periods respondents were positive about the 
effectiveness of testing in relation to workplace safety and performance, although 
their replies indicated a clear decrease in the perception that testing posed a threat to 
individual privacy over the same time period. Respondents did not report a concern 
with accuracy and cost of testing programmes. The main conclusions drawn by Blum 
et al. (1994) are that among human resource managers, drug testing is becoming a 
more acceptable, legitimate and worthwhile workplace practice. Increasing exposure 
to, and experience of drug testing does not affect this view.  As might be expected, 
those human resource managers from organisations that did not test were the least 
positive with regard to workplace drug testing. Interestingly, those production sites 
without an EAP were more likely to support testing. Blum et al (1994) conclude that 
isolated testing programmes may be perceived by some employers as a technological 
short cut to solving drug related problems in the workplace, and a substitute for more 
comprehensive (and potentially more expensive) approaches to substance misuse in 
the workplace.  
 
Cranford (1998), while supporting the concept of workforce drug testing, argues that 
in many instances workforce drug testing amounts to treating employees simply as a 
means to an economic end, and therefore testing is fundamentally inconsistent with 
the central values of human resource management (HRM): human worth and personal 
dignity. In looking at the ‘place’ of drug testing in relation to staffing and other 
performance management functions within organisations, he suggests that for some 
employers profit maximisation is the main justification for testing. He concludes that 
if drug testing were not perceived as being in the best interests of the company in 
financial terms, then it would not be the issue it is today. 
 
Cromer and Buda (1996) in a survey of 134 human resource managers (50 of whose 
organisations tested employees and 84 did not) found that those respondents who 
were aware that testing could not assess impairment were more likely to see testing as 
invasive. In a more recent study, Beck (2001) reports that some human resource 
professionals are beginning to question the effectiveness of testing, identifying 
organisational consequences such as a lowering of employee morale and difficulty in 
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recruiting suitable applicants in addition to ethical issues relating to the invasiveness 
of testing. 
 
For employees, some research suggests that workforce drug testing programmes result 
in a perceived continuous need to prove innocence, even when there is no suspicion of 
guilt. (DeCresce et al. 1989; Knowles and Riccucci 2001) Additionally, as testing for 
alcohol and illicit drug use involves forensic, rather than medical testing, a number of 
researchers have identified that scientific principles become merged with legal issues, 
converging workplace and criminal law enforcement (DeCresce et al. 1989, 
Lieberwitz: 1994). Furthermore, the literature suggests that testing can adversely 
affect the work attitudes and behaviours of employees (Comer 1994), producing 
negative attitudes towards the company (Vecchio 1996), and creating suspicion and 
mistrust (Seijts et al. 2002). See also Konovnsky, and Cropanzano, (1991); Sujak et al 
(1995); Arthur and Doverspike (1997); Ambrose (2000). In a 2 year study of 296 
employees from testing firms in the U.S., Elmuti (1994) found employees expressing 
negative feelings and actions toward their employer; exhibiting decreased motivation; 
and a lowering of morale.  
 
Konovsky and Cropanzano (1993: 179) suggest that, ‘Although drug testing is an 
intrusive personnel selection and evaluation device and is often considered a threat to 
employee rights, much of the available data indicate that employees have surprisingly 
favourable attitudes toward drug testing’. For Gilliom (1994), U.S. employees’ 
opinions of testing have been significantly affected by the political and media 
portrayal of a national drugs crisis in the late 1980s, which led many employees to 
accept the significant intrusions into their private lives brought by drug testing 
programmes. For Gilliom (1994), however, this analysis is simplistic as social crises 
may create quiescence but other contexts and values can and will mitigate their 
impact. The individual’s assessment of drug use in their own place of work, and their 
personal beliefs around whether testing violates individual rights to privacy and the 
due process of the law, impacted heavily upon employees’ attitudes towards testing.  
 
Based on a study of the experiences and opinions of individual workers from one 
large U.S. union, Gilliom’s (1994) research, while not claiming an insight into all 
employees’ views, does offer valuable insights into the views of individual workers. 
The defining context of employees’ response to testing is for Gilliom, (1994: 62) ‘the 
cultural abstraction known as a right’. Gilliom’s (1994) research provides an overview 











Oppose  67%  43%  34%  34% 
Undecided  10%  12%  19%  10% 
Support  24%  46%  47%  56% 
Total Res.  797  783  773  777 
Source: Gilliom (1994) 
 
The greatest significance of these figures can be seen in the difference between 
programmes based on random testing (67% oppose testing), and those based on 
suspicion (56% support testing). Gilliom (1994) concludes that these disparities can 
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be traced to individual beliefs on the severity of the drug problem, and the extent to 
which drug testing threatens or advances individual values. Alternatively, it could be 
argued that results may be influenced by the respondent’s identification with the 
position of the tested. Gilliom (1994) importantly identifies the relationship between 
different types of testing policies and employees’ attitudes towards such policies. The 
programme most threatening to the employee (random testing) has the least number of 
employees opposing it, and the programme least threatening (testing on suspicion or 
following an accident) has the largest majority of employees supporting it.  
 
Gilliom’s (1994) findings are supported by Butler’s (1993) research carried out with 
Canadian workers in the transportation industry. The following table shows the 
responses from workers within each transport sector. The respondents were employed 
by organisations that operated drug-testing programmes; the post accident test clearly 
emerges as the least problematic for employees. An interesting point is that workplace  
testing programmes are not rejected by the participants, including the testing method 
which is most ‘threatening’ to employees, the random test. 
 
Testing situation Airport Aviation Marine Surface 
Pre-employment 66% - 74% 45% - 88% 41% - 56% 70% - 75% 
On transfer or 
Promotion 
48% - 61% 245 – 48% 29% - 35% 37% - 52% 
Returning to work 
after leave/lay-off 
37% - 53% 22% - 55% 22% - 28% 38% - 52% 
On reinstatement after 
treatment 
74% - 81% 63% - 86% 56% - 67% 78% - 84% 
Following and 
accident/incident 
90% -95% 79% - 98% 72% - 80% 93% - 94% 
For Cause 72% - 87% 48% - 88% 51% - 64% 79% - 81% 
Unannounced random 
testing 
48% - 61% 30% - 71% 30% - 36% 49% - 62% 
As part of routine 
medical check-up 
68% - 80% 54% - 86% 48% - 57% 68% - 85% 
Source: Butler (1993) 
Butler (1993) outlines similar evidence from surveys carried out by Imperial Oil and 
Gallup. Respondents (employees) generally supported testing: for cause (66%); on 
reinstatement (65%); pre-employment (48%); following an accident or incident 
(44%); and random testing (27%). For safety sensitive positions, the figures relating 
to support for drug testing were unsurprisingly higher: for cause (80%); on 
reinstatement (83%); pre-employment (72%); following an accident or incident 
(62%); and random testing (46%). In the Gallup (1994) survey, 95% of respondents 
thought testing should be allowed in certain circumstances, and only 4% reported that 
testing was unnecessary. 
 
Recent research carried out by Mastrangelo and Popovitch (2000) reports that the 
perceived affect drug testing programmes have on organisational climate and 
employee behaviour is based on limited empirical evidence. Following a survey of 66 
manufacturing employees in one U.S. firm, Mastrangelo and Popovich (2000) found 
that while employee attitudes of fairness did indeed negatively impact on employee 
attitudes of testing, those perceptions were significantly influenced by social factors 
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both inside and outside the workplace, as the employees’ subjective norms on testing 
were determined by the attitudes of family and friends toward testing. Mastrangelo 
and Popovich (2000) also agree with Cranford (1998) that the negative impact of 
testing is also mitigated by increased exposure to and experience of testing, eventually 
creating acceptance.  Kravitz and Brock (1997) state that employee responses to drug 
testing programmes vary dramatically, with age; education; political attitudes; 
income; and knowledge about the testing programmes affecting individual responses. 
Despite the apparent ambiguity in these studies, the concept of ‘fairness’ is one that 
runs throughout the literature concerned with employee attitudes to drug testing 
programmes (Crant and Bateman 1989; Konovsky and Cropanzano 1991; Sujak et al. 
1995; Mastangelo and Popovich 2000; Bennet 2000). For Ambrose (2000), as the 
incidence of testing increases so do the concerns of employees, with the 
characteristics of different programmes affecting individual concepts of fairness as 
evidenced above from Butler (1993) and Gilliom (1994). According to Arthur and 
Doverspike (1997) testing programmes will only be perceived as fair if testing is for 
probable cause; following advanced notice, rather than random testing; is specific to 
safety sensitive occupations; with results kept confidential. Any testing programme, 
these authors suggest, should be based on clearly established need, developed and 
implemented with trade union participation, and the consequences of positive test 
results should be rehabilitative rather that punitive. 
 
Perceptions of fairness may also be constructed by personal drug use history. Truxillo 
et al. (2000) in an examination of employee attitudes towards workplace drug testing 
using the variable of personal drug use history, found that those employees who had 
never used drugs reported testing ‘fairer’ than non-drug users with a history of use. 
Current users, as may be expected, found testing less fair. This study highlights that 
the element of self-interest is very important in any understanding of individual 
attitudes toward drug testing. The testing programme most acceptable (or fairest) for 
employees, causing the least disruption to the employment relationship, would appear 
to be those based upon pre-employment and / or for cause; with the least acceptable 
testing programmes appearing to be random testing without notice (Buler 1993; 
Gilliom 1994; Kravitz and Brock 1997; Ambrose 2000).  
 
The impact of drug testing programmes in the workplace is also contingent on other 
social factors. For example Bennet et al (2000) argue that testing programmes require 
a supportive workplace environment, especially supportive employees. Bennet et al 
(2000) argue that co-workers of substance abusers can be part of the problem, in that 
they can actively enable use by making the substance available; or by picking up the 
slack for ‘using’ colleagues. Co-workers can, by facilitating the using employee to 
seek help, also be part of the solution.  This research is supported by that of Delaney 
and Ames (1995) who found that supportive colleagues and positive relationships 
with supervisors have the potential to rule out abuse. This contrasts with Hazeldon’s 
(2002) research findings that suggest that abusing employees do not self-report due to 
the fear that they will lose their jobs. 
 
Key to the success of any testing programmes are the structures for reporting abuse, 
and the role of supervisors within these structures. (Hood and Dunhorn 1995). Hood 
and Dunhorn (1995) following a survey of 498 nurses, offer 2 models of reporting 
strategies for workers confronted by abusing colleagues. Firstly, the vulnerability 
model: where workers in the least secure positions are unlikely to make formal 
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reports, due to a fear of the consequences to themselves. Secondly, the occupational 
hegemony model: where administrators may avoid formal reporting to maintain 
control over their own work environments. To understand the difference between 
policy structure and policy implementation, attention must be paid to who loses and 
who gains from the testing policy. The deficit between the policy aims and policy 
outcomes can be discovered in the differences between what the authors describe as 
the ‘street knowledge’ about what goes on in the workplace, and the ‘book 
knowledge’ about what should happen (Hood and Dunhorn 1995). The occupational 
hegemony model offered by Hood and Dunhorn (1995) places supervisors at the heart 
of policy implementation, and as the general literature on the role of the supervisor in 
the workplace suggests (Delbridge and Lowe 1997), they are the people in the middle, 
acting as buffers between senior managers and the shop-floor.  In contrast to the 
occupational hegemony model offered by Hood and Dunhron (1995), Bamberger and 
Sonnerstuhl (1995), from their study of referral networks, conclude that ‘peer 
counsellors’, especially when they come from the lower ranks of an organisation, are 
more successful conduits for referral than supervisors and those in senior positions, as 
these individuals have difficulty in gaining access to the networks of the lower ranks 
 
Worker organisations have been major players in the drug testing arena, seeking to 
protect the rights of employees from unnecessary or unwanted government intrusion. 
They have also been vociferous critics of employee drug testing on the grounds that 
testing is an unfair, proving unwarranted intrusion into employees’ privacy rights. 
Despite U.S. Supreme Court rulings, trade unions have continued to wage 
constitutional challenges to drug testing policies and programmes, seeking to 
represent the rights of their members. In addition to case law, trade unions have relied 
on labour and administrative law to influence drug testing, in particular pushing a 
number of states in the U.S. to make drug testing and its various procedures 
mandatory issues of bargaining. In short, unions view drug testing as a ‘threat to 
members rights, and, therefore, a threat to the unions’ security as the employees’ 
exclusive bargaining agent’ (Knowles and Riccucci 2001) Thus, the formulation, 
implementation and assessment of any workforce drug testing policy will arise 
through a process of negotiation.  At the heart of any negotiation over testing 
programmes will be the need to balance management rights with employees’ privacy 
(Alvi 1994).  
 
DeCresce et al. (1989) suggest that organised labour in the U.S. is, at best, ambivalent 
towards workforce testing. While a number of U.S. trade unions have disputed 
workplace drug testing policies, others have acknowledged that employers and 
individual employee’s concerns about safe working environments deserve 
consideration. For example, some unions, representing employees who work in safety 
sensitive occupations have welcomed programmes with an acceptable testing policy 
combined with opportunities for welfare and support. (DeCresce et al. 1989) 
 
Research has also indicated that other trade unions in the U.S. have taken the view 
that testing policies are first and foremost a threat to employee rights, and as a 
consequence, to the trade unions’ position as the exclusive bargaining representative. 
In order to maintain this position when faced with the proposed introduction of drug 
testing, trade unions have, according to DeCresce et al. (1989) negotiated, arbitrated 
or capitulated. They go on to argue that trade union challenges to testing policies will 
be reduced if employers emphasise the seriousness of the need to test; promulgate a 
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policy that accounts for the limitation of testing systems; and develop procedures that 
provide a greater certainty of outcome. Where testing policies have been resisted, the 
principle weapon of the trade unions has been either to attempt to invalidate the 
arguments for testing as a whole, or to challenge the procedural practices and 
disciplinary outcomes in individual cases (DeCresce et. al. 1989). Some unions have 
attempted to shift the focus away from testing policies towards EAPs. and co-
operation increases when a trade union has been involved in the formulation of the 
testing policy, and where officials are included in the training sessions given to 
supervisors. The most successful outcomes are achieved when supervisors and 
stewards work together before formal discipline is imposed. 
 
Research suggests that employees in non-union workplaces are forced to promote 
their rights individually or as a group, but overall, they lack the benefit of protection 
provided by a collective-bargaining contract, not to mention the institution of the 
union itself. Thus they tend to find themselves confronted with drug-testing 
programmes that are less well defined and are devoid of any concern for employee 
rights (Knowles and Riccucci 2001).  
 
There is a also a growing body of evidence that suggests that testing for alcohol and 
drug use, (especially pre-employment testing which is by far the most common type 
of drug testing (Current 2002)), can impact negatively on recruitment. It is argued that 
pre-employment testing has resulted in large numbers of well qualified potential 
employees excluding themselves from organisations that test. (Lloyd 1998; Crant and 
Bateman 1999, Murphy et al. 1990; Ambrose 2000; Sulum 2000; French et al. 2001) 
For example, Lloyd (1998) reports evidence from three large employing organisations 
in the U.S. where there is evidence that ‘fear of pre-employment testing programmes’ 
may be deterring candidates from applying for posts’. In particular, the Colorado 
Department of Transport demonstrates that, prior to the introduction of pre-
employment testing, an average of 3,000 applications were received for each position. 
Following the introduction of pre-employment testing, this figure had fallen to 
approximately 300 applications per post. The Colorado Department of Transport also 
reported a 50% positive test rate in the first year of testing, a figure now standing at 
2%, cursory evidence that suggests habitual drug users exclude themselves from the 
labour market. Crant and Bateman (1990 cited in Bader and O’Hara: 1991) from a 
survey of undergraduate business students, concluded that the respondents would be 
less inclined to apply for posts in organisations that test for drug or alcohol use. The 
authors argue that this does not indicate a fear of testing positive for substance use, 
but rather, that respondents would prefer to work in organisations where drug testing 
programmes were unnecessary. For Crant and Bateman (1990), this is further 
evidence that drug testing policies have the potential to negatively impact upon the 
labour market and recruitment efforts. Population statistics suggest a decline in the 
pool of entry-level employees in the U.S., and this combined with reluctance of some 
potential employees to apply to organisations with drug testing policies, may lead to 
an even greater labour market impact.  
 
In 2000 the American Civil Liberties Union argued that testing was making it harder 
for employers to attract highly qualified applicants (Sulum 2000). Ambrose (2000) 
argues that the attitude of applicants toward testing can generalize to the employer, 
and may affect job search behaviour, acceptance patterns and loyalty to the employer 
post-hiring. This can be a major problem at times of low unemployment with a 
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reduced pool of candidates to choose from (May 1999). Such has been the seriousness 
of this problem that, as a response, firms short of employees are lowering their 
recruitment standards. This has included the suspension of pre-employment testing in 
times of labour shortage (Lloyd 1998; Beck 2001 Spell and Blum 2001). In the most 
recent literature concerned with the consequences of pre-employment testing, 
Mastrangelo and Popovich (2000) suggest that job seekers now perceive pre-
employment testing to be more acceptable than other commonly used personnel 
procedures such as personality testing. 
 
Research indicates that one of the most significant impacts on the labour market is not 
that of workforce testing, but the impact drug and alcohol use has on labour market 
participation.  French et al. (2001), in estimating the relationship between illicit drug 
use and labour market status, found a significant association between chronic drug use 
and unemployment, with non-chronic use not statistically related to unemployment. 
Most significantly in this study is the lack of any meaningful association between 
casual drug use, unemployment and labour force participation. In a study of drug use 
in England and Scotland, Macdonald and Pudney (2000b) make the distinction 
between hard and soft drugs. Their findings underpin those of French et al. (2001) in 
relation to hard drug use, but report a positive relationship between soft drug use and 
occupational attainment in younger people. In a similar study Macdonald and Pudney 
(2000) found no association between past drug use and occupational attainment. With 
alcohol, Macdonald and Pudney (2002) found positive returns with moderate use of 
alcohol, returns that decrease as consumption increased. 
 
The impact of drug use on wages is at best ambiguous, and vary according to the 
substance of abuse and the characteristics of the individual user. For example, 
Kaestner (1991; 1994b) and Gill and Michaels (1992) find a positive association 
between the use of marijuana and cocaine and wages. Kandel et al. (1995) concluded 
that this positive association disappears with age, becoming a negative association 
with increased age and use. However, using the same data as Kandel et al., (1995), 
Burgess and Propper (1998) saw no impact of drug use and wages. For Macdonald 
and Pudney (2000) the ambiguities over the relationship between drug use on wage 
levels is caused by inadequate data.  
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8. WORKFORCE DRUG TESTING, SURVEILLANCE AND 





Alongside the growing popularity of workforce drug testing has arisen a concern 
within the research literature about the process and outcome of testing (Ambrose 
2000; Cromer 1994). For a number of researchers, workforce drug testing can be 
delivered discriminately, produces ‘false positives’ whereby non-alcohol and / or drug 
using employees are identified as ‘users’, and there is a potential infringement of an 
employee’s right to privacy. For a number of these researchers, workforce drug 
testing represents an extension of surveillance and social control, in which traditional 
distinctions between an employee’s personal and professional life become ‘blurred’ or 
indistinguishable. 
 
Most of the research literature is North American, although over recent years there 
has been an increase in the number of articles written by researchers working in the 
UK and Europe. Some of it draws upon empirical field research studies, although 
much of it is speculative and theoretically based, drawing upon contemporary debates 
popular within various academic disciplines including politics, criminology, sociology 
and economics. 
 
This section provides a review and summary of the research literature examining (a) 
questions relating to the fairness and accuracy of workforce drug testing and (b) 




McCahill and Norris (2002) locate discussion of workforce drug testing in a review of 
three consequences of contemporary technologies of surveillance. First, they suggest 
that individuals can be disproportionately targeted (e.g. on the grounds of age, sex and 
race). Cromer (1994) reports that the research conducted in the late 1980s on U.S. 
Postal Service employees raised questions as to the possible ethnic discrimination in 
workforce drug testing (see the work by Normand et al 1990; Zwerling et al 1990). 
For example, the study by Zwerling et al (1990) identified that ‘despite having lower 
absenteeism, fewer injuries and no more accidents, the African-American workers 
were 143% more likely to be terminated’ (Cromer 1994: 261). McCahill and Norris 
(2002) also identify that ‘some writers have argued that technologies such as hair 
testing have a built in bias that discriminates on the grounds of race’ (2002: 132). 
 
Second, McCahill and Norris (2002) suggest that information gathered can be used 
inappropriately or not in accordance with stated aims and objectives. For example, 
research has noted that licit substances and ‘medical conditions’ may be identified as 
part of the testing process. McCahill and Norris (2002) detail that the results of drug 
testing have been used to screen female candidates for pregnancy and to ascertain the 
medication employees and applicants are prescribed. McCahill and Norris (2002) also 
highlight, drawing upon the work of Holtorf (1998 cited in McCahill and Norris 2002: 
135-136) ‘that information from drug tests is also being shared via computer 
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databases with other employers, government agencies, and insurance companies, 
leading to a form of ‘high-tech blacklisting’’. 
 
Third, they suggest that workforce drug testing has the potential to produce ‘false’ 
information that may have negative consequences for employees (McCahill and 
Norris 2002: 121). One crucial example concerns the production of ‘false positives’ 
(DeCresce et al 1989). Research has identified that false positives can occur when 
employees have consumed over the counter medications and prescription medications 
(DeCresce et al 1989); and as a result of digesting certain foods (the metabolites of 
certain foods are similar to, and can be mistaken for, those of illicit drugs). An 
example here, according to McCahill and Norris (2002: 138) are poppy seeds, which 
are ‘collected from the same plant that produces morphine and codeine and can 
produce a false positive’. Another determining factor in the production of false 
positives, as identified in the research literature, is the testing process itself (Cromer 
2000).  
 
For Gilliom (1994), research has identified that error is an inescapable factor with 
regards the process of workforce drug testing. In research carried out by Morgan 
(1988), it is suggested that EMIT will be ‘mistaken’ in between 5% and 38% of cases. 
While the Gas Chromatography / Mass Spectrometry (GC/MS) method is 100% 
accurate under laboratory test conditions, Morgan (1988) has suggested that even this 
technique could be inaccurate in between 3% and 5% of cases. For Gilliom, while the 
accuracy of testing has improved considerably over recent years, and therefore these 
figures are of less value today, research continues to identify factors that can impact 
upon the accuracy of testing (Abbasi et al 1988; Elliot 1989; Feit and Holosko 1990). 
 
A particular element of the testing process that research has indicated is open to error 
is the chain of custody stage. Ensuring that the testing process is professionally 
delivered, that test samples are not mixed up, and that test results are attributed to the 
person who provided the corresponding sample, are all factors that can produce error. 
One important issue here concerns human failing. Gilliom (1994) reports that ‘while 
error rates can be brought down to a tiny level with expensive replication and 
verification, the ever present spectres of human error, cost cutting and the 
imperfections of science mean that mistakes will always be made’ (Gilliom 1994: 8). 
Another aspect concerns the nature and quality of the ‘testing’ industry. Research 
suggests that as testing has expanded, and respectable laboratories have received 
increasingly heavy workloads, there has been a growth in inexpensive and low quality 
laboratories. As the BNA (1986: 30-31) point out, ‘unskilled laboratories are entering 
the business to cash in on the boom in drug testing’. Cromer (1994) reports that in the 
U.S., the National Institute has set standards for laboratory certification for Drug 
Abuse; however, less than 7% of U.S. drug testing laboratories had met these 
standards in the early 1990s. 
 
Research has also acknowledged that positive test results do not establish impairment 
(CWD 1993; Gilliom 1994; DeCresce et al. 1989; Cromer 1994). Drug tests can only 
distinguish between employees who have been exposed to a drug and those who have 
not (Cromer 1994), and can only measure whether metabolites are present or absent in 
the body. These metabolites are, according to Gilliom (1994), ‘a poor indication of the 
time or degree of drug use because individuals vary in the rate at which they process 
them. Since both the generation of metabolites and the generation of urine vary both 
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with individuals and circumstances (e.g. heavy water consumption or exercise), there 
is no way to establish a urine-based measure of the recency or intensity of drug use’ 
(1994: 9). A positive result does not indicate patterns of alcohol and drug use or the 
nature of dependency. Moreover, it does not provide any information as to how 
exposure to the drug occurred, and the detection period differs across drug types. 
Macdonald (1997) highlights that alcohol tests can determine whether an employee is 
under the influence of alcohol and the degree of impairment (Macdonald 1997: 252). 
 
As time of ingestion and degree of impairment cannot be identified, some researchers 
have suggested that drug testing has simply become an insidious means of subverting 
the normal requirement of ‘just cause’ before an employer can discipline or discharge 
an employee (DeCresce et al 1989). Baumrin (1990) explores ‘social welfare versus 
worker freedom issues’ arising from drug testing and suggests that the benefits of the 
social welfare argument have not been substantiated, whilst employee freedoms have 
been challenged. Furthermore, researchers suggest that testing has the potential to 
negatively impact upon the relationship between the employer and the employee. As 
DeCresce et al (1989: 133) state, ‘The threat that the employer may regulate what [the 
employee] can and can not do on their own time may eventually convert loyal and 
dedicated employees to suspicious and antagonistic employees, or lead them to 
resign’.  
 
Such concerns have led a number of researchers to develop arguments suggesting that 
workforce drug testing is a technique of surveillance and a form of social control (see 
for example Hecker and Kaplan 1994; Gilliom 1994; McCahill and Norris 2002; 
Moore and Haggerty 2001). Locating the development of testing within a wider 
social, political and cultural context, Hecker and Kaplan (1994) advance what they 
see as a contemporary control paradigm - ‘the new sobriety’ (1989: 701). Drawing 
upon arguments from sociology and political science about the growth of an ever 
increasing disciplinary society based upon sophisticated ‘scientific’ systems of 
surveillance, regulation and control supported by technological advances, Heckler and 
Kaplan (1994) view drug testing as part of a movement towards a ‘Brave New 
Workplace’ (1989: 694). For these writers, the difference between earlier historical 
periods and the present are ‘more the specific techniques than in the essence of 
workplace surveillance, discipline and control, which are integral to industrial and 
post-industrial capitalism’. For example, Hecker and Kaplan (1989) detail how 
employers are increasingly using technology to listen to, and watch employees 
through CCTV, the recording of phone calls, and the monitoring of emails. In the case 
of substance abuse, medical technology has allowed the panoptic workplace to extend 
its surveillance, control, and discipline into the body of the worker and into his or her 
off-duty life. In this sense, drug testing, rather than being a necessary requirement to 
deal with a social problem, is simply a logical extension of the control process made 
possible because the technology exists. In other words, some employers may test for 
substance simply because they can. Certainly there is evidence that workforce drug 
testing has been implemented by many employers with little or no research to 
ascertain whether alcohol or illicit drug use is a problem in their organisation, and 
with little or no understanding of the shortcomings of testing (Crow and Hartman 
1992). 
 
For Gilliom, (1994) the expansion of testing can only be understood within the 
broader social and political context of the last thirty or forty years, and in particular 
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the Reagan administration’s ‘war on drugs’ programme; ‘the controversy over 
employee drug testing is inseparable from the broader intensification of the society’s 
focus on illegal drugs in the mid 1980s’ (Gilliom, 1994: 17). For Gilliom (1994: 43) 
‘the conservative law and order philosophy that prevailed in the 1980s eschewed … 
strategies (dealing with poverty and inequality) as ineffective and turned instead to 
heightened surveillance and tougher punishments … testing was a central tool in the 
arsenal’. Indeed, for Gilliom (1994), drug testing is not an isolated policy, but part of 
a wider programme of control that is expanding across a variety of sectors, 
workplaces and more informal settings in which new means of systematic surveillance 
are enhancing various organisations and enforcement agencies ability to monitor 
behaviour. Examples Gilliom (1994) provides include computer matching for welfare 
fraud, income tax evasion, computerization of police records, and eavesdropping on 
phone calls.  
 
According to Heckler and Kaplan (1989) such developments raise various issues for 
employee rights and union resistance. Additionally, Heckler and Kaplan argue that 
wide scale support for testing raises serious problems as to the extent to which 
detractors of testing are able to be critical of such developments without being derided 
for questioning the effectiveness and efficacy of the new ‘surveillance’. Hecker and 
Kaplan (1989) summarise the dilemma facing trade unions by stating that ‘The 
seemingly depoliticised positive overtones of the concept of the “drug free 
workplace” make any resistance to measures that are aimed at controlling private 
habits seem like the advocacy of insobriety and inefficiency’. (1989:704) 
 
The central argument of these writers is that whilst drug testing policies tend to be 
viewed as protecting the collective interests of all (employee, employer and customer 
alike) in a society where drug consumption is widely prevalent, particularly alcohol 
consumption, they can also represent an additional workplace control mechanism, one 
which extends beyond the workplace. For the first time, testing policies have given 
management access to, and some control over, the body of the employee, (Blaze-
Temple 1990). This control extends outside the workplace and working time, giving 
the employer influence over the social and physiological life of the employee. This 
intensification of surveillance and, by implication social control, not only blurs the 
boundary between work and non-work activities but places a premium upon the latter 
not being detrimental to the former. The employee must not only be an appendage to a 
machine but constantly monitored to ensure their being a healthy and productive 
appendage (Francis and Wynarczyk 1998). Acknowledging the potential for drug 
testing as a mechanism of surveillance and control, demands acknowledgement also 
that employers have never been omnipotent, and employees have often done 
everything in their power to resist, circumvent, even ignore, all other forms of control 
(Blaze-Temple 1990; Beaumont and Hyman 1987; Ackroyd and Thompson 1999).  
 
Moore and Haggerty (2001) examine the development and growth of home drug 
testing kits and the industry responsible for it. They suggest that as a less state-centred 
approach to anti-drug strategies has developed (as a result of the perceived failure of 
the war on drugs in the U.S.), home testing has emerged as a means of state-free drug 
regulation offered to specific populations. Indeed, they go on to suggest that the war 
metaphor, so closely related to strategies promoting the reduction in drug use in the 
U.S. is slowly being supplanted, or at least augmented by the reintroduction of a 
disease metaphor. They suggest that rather than allowing for an environment where 
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harm reduction can be embraced, the disease metaphor leaves existing governmental 
strategies largely unreconstructed, while at the same time allowing for the emergence 
and expansion of new strategies of drug control to regulate populations traditionally 
outside the main thrust of anti-drug initiatives. ‘The advent of home drug testing is 
congruent with neoliberal trends towards mobilizing private entities like the family to 
engage in regulatory practices that were previously concerns of the state … Home 
drug testing is theorised as a tool of surveillance that offers a very particular scientific 
gaze trained on the seemingly indefensible adolescent body’ (2001: 377). 
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9. The Extent and Nature of Societal Alcohol and Illicit Drug Use and 





This section reviews the research literature on the extent and nature of alcohol and 
illicit drug use as it relates to the general population and to those in employment. The 
data presented is based upon the most recent survey evidence available in the U.S. and 
the UK. Comparisons are also made with previous surveys and research studies.  
 
While there is a wealth of research evidence relating to the prevalence of alcohol and 
illicit drug use, statistical and other data is at best partial and at worst unreliable 
(Francis and Wynarczyk 1998). For Beswick (2002), measures, both qualitative and 
quantitative on societal and workplace use differ across countries; surveys tend to 
focus on the young and are not longitudinal; while information and data collected by 
enforcement agencies such as the police and customs are collected to meet the 
demands of the enforcement communities rather than for an exploration of underlying 
trends; and they identify those who are ‘known’ to them through detection and 
enforcement.  
 
With regards alcohol and illicit drug use in the workplace, Martin et al (1994:3) report 
that, ‘there have been few systematic attempts to document these behaviours [alcohol 
and illicit drug use] empirically among employed persons’, and those that do suffer 
from serious methodological and conceptual weaknesses (Macdonald and Wells 
1994). In consequence, as Francis and Wynarczyk (1998) point out, while it is 
relatively easy to assert that alcohol and drug use is a major workplace problem, it is 
much more difficult to empirically demonstrate. In part, the lack of information is the 
result of the difficulties of measurement. Fillimore and Caetano (1982) have 
documented the difficulties associated with securing reliable estimates of employee 
alcohol prevalence rates, and for the most part obtaining reliable documentary 
estimates of workplace illicit drug use is similarly, if not more problematic. Findings 
range from gross average ‘guesstimates’ based upon a proportion of employees across 
a number of companies, to details about individual addicted persons. Such variety in 
the use of ‘operations and populations’ to assess levels of maladaptive uses of alcohol 
and drugs contributes to uncertainty, given that estimates generally vary depending 
upon the population studied and the measures utilized (Martin et al 1994: 10). 
 
International comparisons of the prevalence of drug use are equally as complex. For 
example, as the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) point out ‘Illicit drug use is strongly related to age. A major pitfall for 
cross-national comparisons is that they do not take into account that prevalence rates 
refer to different age groups’ (EMCDDA 2001:107). They go on to state: ‘Prevalence 
rates for illicit drugs are usually higher for males than females. Therefore, prevalence 
rates should be reported separately for males and females’ (EMCDDA 2001:107 
original emphasis).  
 
Research has also identified conceptual and definitional problems surrounding 
measuring workforce alcohol and drug use. There are differing ways of defining both 
nature and boundaries of use. Workplace drug use is, as Newcomb (1994: 40) 
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highlights, the ingestion of alcohol or drugs at work during periods of explicit 
employment. ‘Based on this definition’, Newcomb continues, ‘a three martini lunch or 
two joint break would not be considered drug use on the job’ as such use is during the 
employees free time, and often well away from the actual place of employment. 
Difficulties in defining the nature and boundaries of workplace drug misuse further 
problematise the availability, accuracy and reliability of the data on workforce 
prevalence. 
 
The remainder of this section provides a review and summary of the research 
literature examining: (a) an overview of general societal prevalence of illicit drug and 
alcohol use in the U.S. (the majority of U.S. evidence is taken from the National 
Household Survey of Drug Abuse (NHSDA) (SAMHSA 2001)); (b) survey data 
relating to the prevalence of illicit drug and alcohol use in the UK, primarily England 
and Wales (the British Crime Survey provides most of this evidence); and (c), an 
overview of evidence relating to employee illicit drug and alcohol use in the U.S. and 
in the UK. Comparisons are also made with previous surveys and research studies. 
Evidence from other countries is extremely sparse and has therefore not been 




Prevalence of drug and alcohol use in the U.S. general population The National 
Household Survey on Drug Abuse (NHSDA) 2001 reported that an estimated 7.1% of 
the U.S. population aged twelve and older had used an illicit drug in the month prior 
to the survey being carried out (SAMHSA 2001). This percentage figure represents an 
increase in usage from the NHSDA conducted in 1999 in which an estimated 6.3% of 
the population were considered current illicit drug users. Significant increases were 
noted in 2001 for the current illicit drug use of marijuana and cocaine, as well as for 
licit substances including painkillers and tranquillizers. Overall, the research indicates 
that marijuana is the most commonly used illicit drug in the U.S.. In 2001, marijuana 
was used by over three quarters of current illicit drug users (76%) (SAMHSA 2001). 
 
There is substantial variation in drug use by age in the U.S.. The 2001 survey 
reflected findings in previous years that drug use increases with age up to a peak age 
of eighteen to twenty years, after which drug use declines (SAMHSA 2001). The age 
distribution of drug users however, is also related to the type of drug used. For 
example, hallucinogen and inhalant users were primarily aged between twelve and 
twenty-five whereas cocaine and non-medical psychotherapeutic drug users were 
reportedly aged mostly over twenty-five. Again, reflecting findings of previous 
surveys, the NHSDA 2001 (SAMHSA 2001) reported that drug users in the U.S. were 
primarily male. There was a significant relationship between illicit drug use and use 
of licit substances, namely alcohol and tobacco. The rate of current illicit drug use 
among youths who smoked cigarettes was approximately nine times higher than illicit 
drug use among youths that did not smoke. Of those youths that were considered 
heavy drinkers in 2001, 65.3% were also considered current drug users. Only 5.3% of 
non-drinkers were considered current illicit drug users. 
 
Regarding alcohol use, almost half of those surveyed in 2001, aged twelve and over 
reported being current alcohol users (48.3%) (SAMHSA 2001). This represents an 
increase of both the rate of alcohol use and the number of alcohol consumers since 
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2000. Slightly more than one fifth of those surveyed reported binge drinking at least 
once in the thirty days prior to the survey. In 2001, 5.7% of those surveyed reported 
heavy drinking. Heavy and binge drinking was most likely to occur in those aged 
between eighteen and twenty-five. Similarly to illicit drug use, alcohol consumption 
increased with age and peaked at age twenty-one. However, unlike illicit drug use 
which declined after this time, alcohol consumption remained steady. 
 
Prevalence of drug and alcohol use amongst the general population of the UK and 
Europe The Youth Lifestyles Survey 1998 (Stratford and Roth 1999) reported that 
27% of twelve to thirty year olds had used drugs in the past year (men: 32%; women: 
22%). There were distinct differences between age groups within this category, with 
those aged twenty-one reporting the highest level of drug use (54% of those surveyed 
had used drugs in the past year). The survey also indicated that drug use declines with 
age with 25% of those aged between twenty-six and thirty having taken drugs in the 
past year. Fifty percent of young drug users (aged 12-30) took drugs on average once 
a month or more. Thirty-two per cent reported drug use on average once a week. 
Similarly, the Office for National Statistics surveyed young people in England and 
Wales in 1998 and found that the most commonly used drug was cannabis with 32% 
of males and 22% of females aged sixteen to twenty-four reporting use in the last year 
(Social Trends 1998). The same survey reported an increase in alcohol use in the last 
week amongst pupils from 24% in 2000 to 26% in 2001.  
 
The Department of Health (2002) conducted a Survey in 2001 of school children aged 
eleven to fifteen which reported that 12% of pupils had used drugs in the last month 
and 20% had used drugs in the last year. Boys were more likely to have used drugs in 
the last month than girls and cannabis was the most frequently used drug. 42% of 
pupils reported having been offered one or more drugs in the last year. Over three-
quarters of school children that participated in the Youth Survey 2002 (MORI 2002) 
reported that they had tried alcohol (78%). Regular drinking was more prevalent in 
older children aged fifteen and sixteen. Almost half of the respondents in this age 
group reported drinking at least once a week. Regular drinking was also found to be 
more common amongst white children, and amongst boys. Regional differences in 
drinking habits were also established in this survey. In particular, school children in 
the North-East of England were more than twice as likely as those in London to drink 
regularly. The Youth Survey 2002 found that 22% of children had been offered 
cannabis. Older children were more likely to have tried illicit drugs, and the 
proportion of children that had actually ever used cannabis was 14%. When breaking 
this down by age, children aged fifteen to sixteen are the most likely to use cannabis 
(33%). Boys are marginally more likely to take illicit drugs than girls and, as with 
alcohol, children from Black and Minority Ethnic groups are less likely to use 
cannabis and tobacco than white children. 
 
The Office of Population Censuses and Surveys (OPCS 1993/4 cited in Beswick 
2002) estimates that 1.5% of the female population and 2.9% of the male population 
in the UK are dependent upon one or more drugs (Beswick 2002).  The Regional 
Drug Misuse Database reported that in England in September 2000, 33,100 drug users 
presented themselves to drug misuse agencies. Heroin was the most frequently used 
drug. These statistics have to be noted with caution as they are likely to be an under 
representation of the actual numbers of drug users as only those with significant drug 
misuse problems are likely to attend such agencies (Beswick 2002). When examining 
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those drug users that have presented for treatment between 1993 and 1998, a steady 
increase in drug misuse in England and Scotland can be identified, the number of 
people presenting for treatment in Wales did not dramatically change (Bean 2002). 
 
The 1994 British Crime Survey (BCS)5 provided ‘best estimates’ of the number of 
people that could be using four specific substances, aiming to address the issue of 
underreporting that plagues self report surveys. The estimates, broken down by drug 
type are provided below and describe use in the last month by sixteen to twenty-nine 
year olds, the most prolific drug users (Ramsey and Percy 1996 in Bean 2002) 
Cannabis: 1486,000, Amphetamines: 303,000, LSD: 152,000, Ecstasy: 121,000.  
 
The 1998 BCS indicated that the highest level of drug misuse occurred amongst 
young people aged between sixteen and twenty-nine. One quarter of this age group 
had used an illegal substance at some point in the last year and 16% had done so in 
the last month. Of all of those surveyed, almost half (49%) had used an illegal 
substance in the last month or year. The comparison between the estimates for 1994 
and 1998 should be noted with caution as they are comparing slightly different age 
groups, across different categories of drugs. The figures for 1998 are as follows 
(Ramsey and Partridge 1999 in Bean 2002), Cannabis: 1095,000, Cocaine: 65,000, 
Opiates: 65,000, Any Drug: 1220,000. The BCS 1998 also indicated that the gap 
between male and female drug use might be widening. Female drug use remained at 
around the same level as it had been in previous surveys (19%) whereas male drug use 
increased from 23% in 1994 to 28% in 1998, cannabis use, in particular increased 
significantly (Mirrlees-Black et al 1998 and Ramsey and Partridge 1999). The BCS 
1998 also suggested that the highest rates of drug use occurred in deprived areas and 
amongst the unemployed. Evidence suggests that responsibility for children and being 
married may be protective factors. 
 
The BCS 2000 (Kershaw et al 2000) suggests that women are more experimental with 
regard their drug use but women also ‘grow out’ of drug use at an earlier age. Thirty-
four percentage of those surveyed (aged between sixteen and fifty-nine) reported 
having used drugs at some time in their life. Within this, those aged between twenty 
and twenty-four were the most likely to report lifetime use (58%). The corresponding 
statistics for drug use in the last year was 11% overall, again the twenty to twenty-
four age group were most likely to report drug use in the last year (30%). Regarding 
drug use in the last month, 6% of the sample overall reported recent drug use. Once 
again the group aged twenty to twenty-four were most likely to have experienced 
recent drug use (20%). 
 
DrugScope, facilitated by several government agencies, edited a report on the UK 
drug situation in 2001 for inclusion in the EMCDDA 2002 ‘Annual Report on the 
State of the Drugs Problem in the European Union and Norway’. Drawing primarily 
                                                 
5 Drug misuse first became a substantial self-report focus of the British Crime Survey in 1992 and involved the use 
of an additional self-complete paper questionnaire, in which individuals were asked about their drug misuse over 
their lifetime, during the past year and within the last month. More recent surveys (conducted during 1994 and 
1996) have involved a computerized system of self-completion, allowing for greater comparisons to be made 
across years and a greater accuracy of response. Within both reports, cross tabulations between drug misuse and 
employment status are provided, allowing for a number of generalized findings about illicit drug misuse within the 
workplace to be made. 
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upon findings from the BCS 2000, it summarised a significant increase in cocaine use 
amongst sixteen to twenty-nine year olds from 6% in 1998 to 10% in 2000. Cocaine 
use is more common than use of amphetamines and ecstasy. Evidence suggests that 
this may be due to a more positive attitude towards cocaine compared to other illicit 
substances, as it is perceived to be more socially acceptable and easier to control. The 
BCS 2000 also indicated an increase in cocaine use in the North of England although 
London has consistently higher rates of ‘any drug’ use than all other regions. In the 
UK in 2000, ecstasy and heroin use remained stable and relatively low in comparison 
to use rates of other drugs (DrugScope 2001). Cannabis was the most commonly 
reported used drug in the UK in 2000, 44% of those aged sixteen to twenty-nine 
reported using cannabis, an increase from 1998 (DrugScope 2001). Cannabis use is 
also more prevalent than use of other illicit substances in the U.S. and other European 
Union countries.  
 
In the European Union as a whole, cannabis is the most commonly used illicit drug 
(EMCDDA 2001; 2002). For cannabis, amphetamines and ecstasy use, England and 
Wales had the highest prevalence rates amongst all adults of all of the EU countries 
included in the comparison. Spain had the highest rate of cocaine use, but England 
and Wales were the second highest consumers. Regarding younger adults (15-44), 
England and Wales had the highest prevalence rates for all types of drugs. The 
comparisons provided by EMCDDA have to be interpreted with caution as the sample 
sizes; age ranges and methods of data collection and analysis vary between countries, 
as do the years in which the surveys were performed. 
 
Prevalence of drug and alcohol use in the U.S. workforce Data on the prevalence of 
substance misuse in the workplace are often based on guesstimates. For example, 
Backer (1987 in Newcomb 1994) estimates that the rate of dangerous drug use 
amongst the U.S. workforce could be anywhere between 10% and 23%.  Newcomb 
(1994) offers an early summary of studies estimating workplace prevalence. First his 
review identifies that 61% of trade union representatives / members thought that drug 
use was a problem in the workplace, with 95% of employers having had experience of 
drug problems among employees. Second, with regard to general population 
estimates, Newcomb identifies that apart from occasional cannabis use, alcohol use is 
the most frequently reported drug use on the job; most people use drugs away from 
the worksite, and most surveys estimate that less than 10% of employees report using 
substances on the job. Finally use of drugs in the workplace is more common among 
men than women. Newcomb (1994: 413) concludes by stating that ‘therefore, while 
there is certainly cause for concern regarding drug use on the job, since it obviously 
occurs to at least a modest extent and can have tragic consequences, the extent and 
scope of this problem appears limited’.  
 
More recent research evidence continues to indicate that alcohol is generally thought 
to be the most commonly used substance in the U.S. workplace. Despite this many 
organisations do not test for alcohol. The NHSDA (SAMHSA 2001) found that of 
those in full time employment and aged eighteen and over, 59.3% were current 
alcohol users. The corresponding percentage for those who were unemployed was 
52.5%. Regarding binge and heavy drinking, NHSDA report a higher prevalence rate 
for unemployed individuals (SAMHSA 2001). With regards illicit drug use, the 
National Institute on Drug Addiction (NIDA) suggests that 10% of the U.S. workforce 
use drugs whilst on the job. Furthermore, it is estimated that 44% of employed drug 
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users sell drugs to other employees (May 1999). The NHSDA 2001 reported that 
current employment status is highly correlated with illicit drug use. Of those aged 
eighteen and over, an estimated 17.1% of unemployed adults were current illicit drug 
users. The estimate for those employed full time was 6.9% and 9.1% for part time 
employees (SAMHSA 2001). 
 
From the research evidence in the U.S., there appears to be correlation between risks 
associated with job type and substance use. Holcom, Lehman and Simpson (1991 in 
Newcomb 1994) found that 13% of employees in ‘high-risk’ occupations (measured 
by potential for accident) admitted using a psychoactive drug at work. The 
comparable figure for ‘low risk’ employees was 8%. Regarding On-The-Job 
substance abuse, Mastrangelo and Jolton (2001) and Newcomb (1994) cite Hollinger 
(1988) who suggests that prevalence of on-the-job substance abuse varies by 
occupation in the U.S.. It is estimated that 3.2% of hospital employees partake in on-
the-job substance abuse in comparison with 7.2% of retail employees and 12.8% of 
manufacturing employees. Schneck et al (1991 in Newcomb 1994) found that 6% of 
transportation employees reported having used alcohol at times which would result in 
on-the-job impairment. The corresponding percentage for illicit drug use was 3%. 
Guinn (1983 in Newcomb 1994) conducted a relatively small piece of self report 
research on long distance drivers in which over 80% indicated that they had used a 
substance in the previous year to remain ‘awake and alert’ whilst driving (‘substance’ 
did not include over the counter medication). In this particular occupation, employees 
could perceive substance use whilst at work as performance enhancement. 
 
Quest Diagnostics, a U.S. drug testing company report drug positivity rates for U.S. 
employees by comparing the number of positive drug test results with the number of 
drug tests performed. A decline in positivity rates was reported from 2000 to 2001. 
The reduction was relatively small from 4.7% in 2000 to 4.6% in 2001. However, 
amongst safety sensitive workers positivity rates reached 2.9% in 2001, again a 
decrease on the previous year but also the lowest percentage ever recorded (Teterboro 
2002). From 1997 to 2001 safety sensitive employees have consistently provided 
lower positivity rates than the general U.S. workforce (Teterboro 2002). Testing ‘for 
cause’ produced the highest positivity rates for both safety sensitive and general 
workforce employees (Teterboro 2002). The drug most often identified in both groups 
of employees was marijuana, although alcohol was not included. Of all employees 
tested by Quest Diagnostics in 2001 (6.3 million tests), 60.6% of positive results 
related to marijuana. The second most commonly found drug was cocaine. 
SmithKline Beecham Clinical Laboratories found similar results in 1998 (May 1999). 
Steelcase Corporation compared competing drug detection methods and found an 
18% drug positivity rate amongst U.S. job applicants when hair testing was used. 
Urine testing typically produces a 3-5% drug positivity rate (Nadell 2001). There are 
associated difficulties with hair testing however, and the research was conducted 
using a smaller sample than those reporting for urinanalysis. 
 
Prevalence of drug and alcohol use in the UK workforce Jackson (1999) cites 
evidence from a joint Trades Union Congress, Alcohol Concern and Institute for the 
Study of Drug Dependence (now DrugScope) conference held in 1998, which 
suggests that around 75% of people with alcohol problems and 25% of people seeking 
help with drug problems are employed in the UK. Furthermore, 29% of full time 
employees have used illicit drugs and 46% of companies or organisations have 
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received reports of alcohol misuse by employees in the last year. This represents a rise 
from the corresponding percentage reported in 1996 (35%). Similarly, 18% of 
companies or organisations had received reports of illicit drug taking by employees in 
the last year (Jackson 1999). 
 
Eckersley and Williams (1999) cite evidence that 17% of employees will be using 
illicit drugs in such a way that their work performance will be affected. The 
corresponding figure for alcohol use is 30%. Moreover, they estimate that between 
35% and 45% of full time employees will be using drugs. It is important to note that 
the relationship between drug and alcohol use and impairment has not been 
sufficiently well established to give much credence to these statistics. Furthermore, 
the authors are supportive of drug testing.  
 
A survey carried out by Alcohol Concern and DrugScope (BBC News 07/08/01) 
indicated that 30% of companies have experienced employee absence due to drug use. 
MacDonald (2002) conducted research into the impact of drug use upon labour 
market participation and in doing so provide a useful overview of the prevalence of 
drug use in England and Wales and Scotland, including the drug use of those in 
employment and those unemployed. For clarity, unemployed individuals are defined 
as those that are actively seeking work and therefore excludes students, retired 
individuals, those that are considered disabled or suffering from illness and home 
makers. He contends, “There is some debate about causality between drug use and 
employment status. Sociological research tends to conclude that “high unemployment 
serves to foster drug use” (Peck and Plant 1987:67) rather than the other way round” 
(MacDonald 2002:2). 
 
As may be expected, given our discussion in section one, estimates of, and research 
into, workplace illicit drug misuse in England and Wales, is generally less expansive, 
especially at a national level, and are certainly no more informative of actual rates. 
That said, findings from recent sweeps of the British Crime Survey (see Ramsay and 
Spiller 1997; Ramsay and Percy 1996) provide some comparable material. Ramsay 
and Percy (1996) generalize that those in full time employment have a lower level of 
drug taking than those who are not employed (with the exception of the 30-59 age 
group); that those not employed were more susceptible to misuse within the last 
month across all age bands; and that there was no clear pattern for those employed 
part-time. In the more recent British Crime Survey, Ramsay and Spiller (1997: 21) 
indicate that the data collected suggest that ‘drug misuse is spread relatively evenly 
across all social groups, manual and non manual, inner city and suburban, rich and 
poor’. As the authors of the report go on to state, ‘while low income is a modest 
pointer to drug misuse in general … not having a job is at least as important a factor, 
if only in the case of the 16-29 age group’ (Ramsay and Spiller 1997:22). In particular 
the authors indicate the contrast between those aged 16-29 who are employed and 
those not, suggesting that as many as 45% of that age group who are unemployed 
reported drug misuse within the last year.  
 
The British Crime Survey 2000  (Kershaw et al 2000) indicates that certain types of 
drug use have declined amongst the employed and unemployed since 1994 namely 
use of LSD and mushrooms. Cocaine use has declined amongst the unemployed since 
the 1998 BCS but has increased amongst the employed. Overall, use of any drug has 
remained stable for those who are employed but has decreased for those who are 
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unemployed since 1998. Despite this, drug use is consistently higher amongst the 
unemployed for all drug types. 
 
While far from conclusive about the size or nature of the problem, the data derived 
from the various sweeps of the BCS does provide some patterns of drug misuse 
amongst those individuals who are in both full-time and part-time work across the 
UK, patterns which are similar to those reported by Martin et al (1994); namely that 
illicit drug misuse at work is comparatively rare amongst employees; that it is mostly 
a youthful phenomenon; that there is no significant differences in response between 
those employed part time and those employed full time; and that there is some 
evidence of differences in consumption by occupational level. While such data must 
be read with caution, it seems to be the case that illicit drug misuse within the 
workplace setting is both a relatively rare and a predominantly youthful activity, and 
that other pressures may also affect misuse, most notably a persons lifestyle 
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